BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Abdalla EK, Vauthey JN, Ellis LM, Ellis V, Pollock R, Broglio KR, Hess K, Curley SA. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg. 2004;239:818-25; 825. [PMID: 15166961 DOI: 10.1097/01.sla.0000128305.90650.71] [Cited by in Crossref: 1198] [Cited by in F6Publishing: 1026] [Article Influence: 66.6] [Reference Citation Analysis]
Number Citing Articles
1 Brouquet A, Vauthey JN, Contreras CM, Walsh GL, Vaporciyan AA, Swisher SG, Curley SA, Mehran RJ, Abdalla EK. Improved Survival after Resection of Liver and Lung Colorectal Metastases Compared with Liver-Only Metastases: A Study of 112 Patients with Limited Lung Metastatic Disease. Journal of the American College of Surgeons 2011;213:62-9. [DOI: 10.1016/j.jamcollsurg.2011.05.001] [Cited by in Crossref: 67] [Cited by in F6Publishing: 51] [Article Influence: 6.1] [Reference Citation Analysis]
2 Mostert B, Sieuwerts AM, Bolt-de Vries J, Kraan J, Lalmahomed Z, van Galen A, van der Spoel P, de Weerd V, Ramírez-Moreno R, Smid M, Verhoef C, IJzermans JN, Gratama JW, Sleijfer S, Foekens JA, Martens JW. mRNA expression profiles in circulating tumor cells of metastatic colorectal cancer patients. Mol Oncol 2015;9:920-32. [PMID: 25655581 DOI: 10.1016/j.molonc.2015.01.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
3 Rhim H, Lim HK. Radiofrequency ablation of hepatocellular carcinoma: pros and cons. Gut Liver 2010;4 Suppl 1:S113-8. [PMID: 21103289 DOI: 10.5009/gnl.2010.4.S1.S113] [Cited by in Crossref: 37] [Cited by in F6Publishing: 17] [Article Influence: 3.1] [Reference Citation Analysis]
4 Govaert KM, van Kessel CS, Lolkema M, Ruers TJ, Borel Rinkes IH. Does Radiofrequency Ablation Add to Chemotherapy for Unresectable Liver Metastases? Curr Colorectal Cancer Rep. 2012;8:130-137. [PMID: 22611343 DOI: 10.1007/s11888-012-0122-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
5 Vogl TJ, Farshid P, Naguib NN, Darvishi A, Bazrafshan B, Mbalisike E, Burkhard T, Zangos S. Thermal ablation of liver metastases from colorectal cancer: radiofrequency, microwave and laser ablation therapies. Radiol Med. 2014;119:451-461. [PMID: 24894923 DOI: 10.1007/s11547-014-0415-y] [Cited by in Crossref: 50] [Cited by in F6Publishing: 38] [Article Influence: 6.3] [Reference Citation Analysis]
6 Wang K, Liu W, Yan XL, Xing BC. Role of a liver-first approach for synchronous colorectal liver metastases. World J Gastroenterol 2016; 22(6): 2126-2132 [PMID: 26877617 DOI: 10.3748/wjg.v22.i6.2126] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
7 Nicosia L, Cuccia F, Mazzola R, Figlia V, Giaj-Levra N, Ricchetti F, Rigo M, Bonù M, Corradini S, Tolia M, Alongi F. Stereotactic body radiotherapy (SBRT) can delay polymetastatic conversion in patients affected by liver oligometastases. J Cancer Res Clin Oncol 2020;146:2351-8. [PMID: 32356176 DOI: 10.1007/s00432-020-03223-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
8 Cloyd JM, Aloia TA. Hammer versus Swiss Army knife: Developing a strategy for the management of bilobar colorectal liver metastases. Surgery. 2017;162:12-17. [PMID: 28109616 DOI: 10.1016/j.surg.2016.11.035] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
9 Stang A, Donati M, Weilert H, Oldhafer KJ. Impact of Systemic Therapy and Recurrence Pattern on Survival Outcome after Radiofrequency Ablation for Colorectal Liver Metastases. J Cancer 2016;7:1939-49. [PMID: 27877209 DOI: 10.7150/jca.15656] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
10 Gomez D, Morris-Stiff G, Toogood GJ, Lodge JP, Prasad KR. Interaction of tumour biology and tumour burden in determining outcome after hepatic resection for colorectal metastases. HPB (Oxford) 2010;12:84-93. [PMID: 20495651 DOI: 10.1111/j.1477-2574.2009.00127.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
11 Popescu I, Alexandrescu ST. Surgical options for initially unresectable colorectal liver metastases. HPB Surg 2012;2012:454026. [PMID: 23082042 DOI: 10.1155/2012/454026] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
12 Mateo R, Singh G, Jabbour N, Palmer S, Genyk Y, Roman L. Optimal cytoreduction after combined resection and radiofrequency ablation of hepatic metastases from recurrent malignant ovarian tumors. Gynecologic Oncology 2005;97:266-70. [DOI: 10.1016/j.ygyno.2004.12.038] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
13 Yan TD, Nunn DR, Morris DL. Recurrence after Complete Cryoablation of Colorectal Liver Metastases: Analysis of Prognostic Features. The American Surgeon 2006;72:382-90. [DOI: 10.1177/000313480607200503] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
14 Torzilli G, Procopio F, Botea F, Marconi M, Del Fabbro D, Donadon M, Palmisano A, Spinelli A, Montorsi M. One-stage ultrasonographically guided hepatectomy for multiple bilobar colorectal metastases: A feasible and effective alternative to the 2-stage approach. Surgery 2009;146:60-71. [DOI: 10.1016/j.surg.2009.02.017] [Cited by in Crossref: 101] [Cited by in F6Publishing: 88] [Article Influence: 7.8] [Reference Citation Analysis]
15 Chapman WC, Hoff PM, Strasberg SM. Selection of Patients for Resection of Hepatic Colorectal Metastases: Expert Consensus Statement by Charnsangavej et al. Ann Surg Oncol 2006;13:1269-70. [DOI: 10.1245/s10434-006-9024-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
16 Yamashita S, Chun YS, Kopetz SE, Vauthey JN. Biomarkers in colorectal liver metastases. Br J Surg 2018;105:618-27. [PMID: 29579319 DOI: 10.1002/bjs.10834] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 7.3] [Reference Citation Analysis]
17 Maekawa H, Fujikawa T, Tanaka A. Successful laparoscopic investigation and resection of solitary colonic metastasis from breast cancer (with video). BMJ Case Rep. 2012;2012. [PMID: 23152180 DOI: 10.1136/bcr-2012-007187] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
18 Zdenkowski N, Chen S, van der Westhuizen A, Ackland S. Curative strategies for liver metastases from colorectal cancer: a review. Oncologist. 2012;17:201-211. [PMID: 22234631 DOI: 10.1634/theoncologist.2011-0300] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
19 Hellingman T, Kuiper BI, Buffart LM, Meijerink MR, Versteeg KS, Swijnenburg RJ, van Delden OM, Haasbeek CJA, de Vries JJJ, van Waesberghe JHTM, Zonderhuis BM, van der Vliet HJ, Kazemier G. Survival Benefit of Repeat Local Treatment in Patients Suffering From Early Recurrence of Colorectal Cancer Liver Metastases. Clin Colorectal Cancer 2021:S1533-0028(21)00072-4. [PMID: 34462211 DOI: 10.1016/j.clcc.2021.07.007] [Reference Citation Analysis]
20 Franzese C, Comito T, Toska E, Tozzi A, Clerici E, De Rose F, Franceschini D, Navarria P, Reggiori G, Tomatis S, Scorsetti M. Predictive factors for survival of oligometastatic colorectal cancer treated with Stereotactic body radiation therapy. Radiother Oncol 2019;133:220-6. [PMID: 30414754 DOI: 10.1016/j.radonc.2018.10.024] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
21 Rupertus K, Dahlem C, Menger MD, Schilling MK, Kollmar O. Rapamycin inhibits hepatectomy-induced stimulation of metastatic tumor growth by reduction of angiogenesis, microvascular blood perfusion, and tumor cell proliferation. Ann Surg Oncol. 2009;16:2629-2637. [PMID: 19551445 DOI: 10.1245/s10434-009-0564-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
22 Durán Giménez-Rico H, García-Aguilar J, Warren RS, Iborra P, Guerrero V. [Liver metastases from colorectal cancer. Is the practice of surgery based on the best clinical evidence possible?]. Cir Esp 2005;78:75-85. [PMID: 16420801 DOI: 10.1016/s0009-739x(05)70894-0] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
23 Molla M, Fernandez-Plana J, Albiol S, Fondevila C, Vollmer I, Cases C, Garcia-Criado A, Capdevila J, Conill C, Fundora Y, Fernandez-Martos C, Pineda E. Limited Liver or Lung Colorectal Cancer Metastases. Systemic Treatment, Surgery, Ablation or SBRT. J Clin Med 2021;10:2131. [PMID: 34069240 DOI: 10.3390/jcm10102131] [Reference Citation Analysis]
24 Regimbeau JM, Cosse C, Kaiser G, Hubert C, Laurent C, Lapointe R, Isoniemi H, Adam R. Feasibility, safety and efficacy of two-stage hepatectomy for bilobar liver metastases of colorectal cancer: a LiverMetSurvey analysis. HPB (Oxford). 2017;19:396-405. [PMID: 28343889 DOI: 10.1016/j.hpb.2017.01.008] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 4.6] [Reference Citation Analysis]
25 Jaeck D, Pessaux P. Bilobar colorectal liver metastases: treatment options. Surg Oncol Clin N Am 2008;17:553-68, ix. [PMID: 18486883 DOI: 10.1016/j.soc.2008.02.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
26 Viganò L, Langella S, Ferrero A, Russolillo N, Sperti E, Capussotti L. Colorectal cancer with synchronous resectable liver metastases: monocentric management in a hepatobiliary referral center improves survival outcomes. Ann Surg Oncol 2013;20:938-45. [PMID: 23010733 DOI: 10.1245/s10434-012-2628-4] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
27 Mezhir JJ, Smith KD, Kimchi ET, Park JO, Lopez CA, Mauceri HJ, Beckett MA, Hellman S, Weichselbaum RR, Posner MC. Establishment of a syngeneic model of hepatic colorectal oligometastases. J Surg Res 2006;136:288-93. [PMID: 16930623 DOI: 10.1016/j.jss.2006.05.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
28 Maithel SK, Gönen M, Ito H, Dematteo RP, Allen PJ, Fong Y, Blumgart LH, Jarnagin WR, D’Angelica MI. Improving the clinical risk score: an analysis of molecular biomarkers in the era of modern chemotherapy for resectable hepatic colorectal cancer metastases. Surgery. 2012;151:162-170. [PMID: 21982065 DOI: 10.1016/j.surg.2011.07.020] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
29 Burdio F, Navarro A, Güemes A, Sousa R, Tejero E, Lozano R. Does thermal ablation promote liver metastases progression more than resection? Surgery 2006;140:479-80. [DOI: 10.1016/j.surg.2006.02.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
30 Loss M, Jung E, Scherer M, Farkas S, Schlitt H. Chirurgische Therapie von Lebermetastasen. Chirurg 2010;81:533-41. [DOI: 10.1007/s00104-010-1891-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
31 Minami Y, Kudo M. Radiofrequency ablation of liver metastases from colorectal cancer: a literature review. Gut Liver 2013;7:1-6. [PMID: 23422905 DOI: 10.5009/gnl.2013.7.1.1] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 4.5] [Reference Citation Analysis]
32 Tanaka K, Shimada H, Matsumoto C, Matsuo K, Takeda K, Nagano Y, Togo S. Impact of the degree of liver resection on survival for patients with multiple liver metastases from colorectal cancer. World J Surg. 2008;32:2057-2069. [PMID: 18454272 DOI: 10.1007/s00268-008-9610-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
33 Shiraiwa K, Suzuki Y, Uchida H, Iwashita Y, Tanaka R, Iwao M, Tada K, Hirashita T, Masuda T, Endo Y, Inomata M, Itoh H. Simultaneous quantification method for 5-FU, uracil, and tegafur using UPLC-MS/MS and clinical application in monitoring UFT/LV combination therapy after hepatectomy. Sci Rep 2021;11:3132. [PMID: 33542452 DOI: 10.1038/s41598-021-82908-8] [Reference Citation Analysis]
34 Carrasco J, Gizzi M, Pairet G, Lannoy V, Lefesvre P, Gigot JF, Hubert C, Jouret-Mourin A, Humblet Y, Canon JL, Sempoux C, Chapaux X, Danse E, Tinton N, Navez B, Van den Eynde M. Pathological responses after angiogenesis or EGFR inhibitors in metastatic colorectal cancer depend on the chemotherapy backbone. Br J Cancer 2015;113:1298-304. [PMID: 26461062 DOI: 10.1038/bjc.2015.321] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
35 Husain K, Coppola D, Yang CS, Malafa MP. Farnesyl dimethyl chromanol targets colon cancer stem cells and prevents colorectal cancer metastasis. Sci Rep 2021;11:2185. [PMID: 33500430 DOI: 10.1038/s41598-020-80911-z] [Reference Citation Analysis]
36 Rancoule C, Pacaut-Vassal C, Vallard A, Mery B, Trone JC, El Meddeb Hamrouni A, Magné N. [Reappraisal role of locoregional radiation therapy in metastatic cancers]. Bull Cancer 2017;104:86-91. [PMID: 27955816 DOI: 10.1016/j.bulcan.2016.11.008] [Reference Citation Analysis]
37 Martin RC, Husheck S, Scoggins CR, McMasters KM. Intraoperative magnetic resonance imaging for ablation of hepatic tumors. Surg Endosc 2006;20:1536-42. [PMID: 16897290 DOI: 10.1007/s00464-005-0496-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
38 Fowler KJ, Linehan DC, Menias CO. Colorectal liver metastases: state of the art imaging. Ann Surg Oncol. 2013;20:1185-1193. [PMID: 23115006 DOI: 10.1245/s10434-012-2730-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
39 Malik HZ, Gomez D, Wong V, Al-Mukthar A, Toogood GJ, Lodge JP, Prasad KR. Predictors of early disease recurrence following hepatic resection for colorectal cancer metastasis. Eur J Surg Oncol 2007;33:1003-9. [PMID: 17350218 DOI: 10.1016/j.ejso.2007.01.005] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 3.2] [Reference Citation Analysis]
40 Choi D, Lim HK, Joh JW, Kim SJ, Kim MJ, Rhim H, Kim YS, Yoo BC, Paik SW, Park CK. Combined hepatectomy and radiofrequency ablation for multifocal hepatocellular carcinomas: long-term follow-up results and prognostic factors. Ann Surg Oncol. 2007;14:3510-3518. [PMID: 17653800 DOI: 10.1245/s10434-007-9492-7] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 2.9] [Reference Citation Analysis]
41 Blazer DG, Kishi Y, Maru DM, Kopetz S, Chun YS, Overman MJ, Fogelman D, Eng C, Chang DZ, Wang H, Zorzi D, Ribero D, Ellis LM, Glover KY, Wolff RA, Curley SA, Abdalla EK, Vauthey J. Pathologic Response to Preoperative Chemotherapy: A New Outcome End Point After Resection of Hepatic Colorectal Metastases. JCO 2008;26:5344-51. [DOI: 10.1200/jco.2008.17.5299] [Cited by in Crossref: 420] [Cited by in F6Publishing: 152] [Article Influence: 30.0] [Reference Citation Analysis]
42 Koh SL, Ager EI, Christophi C. Liver regeneration and tumour stimulation: implications of the renin-angiotensin system. Liver Int 2010;30:1414-26. [PMID: 20633100 DOI: 10.1111/j.1478-3231.2010.02306.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
43 Assumpcao L, Choti MA, Gleisner AL, Schulick RD, Swartz M, Herman J, Gearhart SL, Pawlik TM. Patterns of recurrence following liver resection for colorectal metastases: effect of primary rectal tumor site. Arch Surg. 2008;143:743-749; discussion 749-750. [PMID: 18711033 DOI: 10.1001/archsurg.143.8.743] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 2.7] [Reference Citation Analysis]
44 Pawlik TM, Choti MA. Surgical therapy for colorectal metastases to the liver. J Gastrointest Surg. 2007;11:1057-1077. [PMID: 17530336 DOI: 10.1007/s11605-006-0061-3] [Cited by in Crossref: 151] [Cited by in F6Publishing: 136] [Article Influence: 10.1] [Reference Citation Analysis]
45 Torres-Jiménez J, Esteban-Villarrubia J, Ferreiro-Monteagudo R, Carrato A. Local Treatments in the Unresectable Patient with Colorectal Cancer Metastasis: A Review from the Point of View of the Medical Oncologist. Cancers (Basel) 2021;13:5938. [PMID: 34885047 DOI: 10.3390/cancers13235938] [Reference Citation Analysis]
46 Aigner F, Pratschke J, Schmelzle M. Oligometastatic Disease in Colorectal Cancer - How to Proceed?Visc Med. 2017;33:23-28. [PMID: 28612013 DOI: 10.1159/000454688] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
47 Agcaoglu O, Aliyev S, Karabulut K, El-Gazzaz G, Aucejo F, Pelley R, Siperstein AE, Berber E. Complementary use of resection and radiofrequency ablation for the treatment of colorectal liver metastases: an analysis of 395 patients. World J Surg 2013;37:1333-9. [PMID: 23460452 DOI: 10.1007/s00268-013-1981-1] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
48 Sasaki A, Nitta H, Otsuka K, Takahara T, Nishizuka S, Wakabayashi G. Ten-year experience of totally laparoscopic liver resection in a single institution. Br J Surg. 2009;96:274-279. [PMID: 19224518 DOI: 10.1002/bjs.6472] [Cited by in Crossref: 125] [Cited by in F6Publishing: 112] [Article Influence: 9.6] [Reference Citation Analysis]
49 Hashiguchi Y, Muro K, Saito Y, Ito Y, Ajioka Y, Hamaguchi T, Hasegawa K, Hotta K, Ishida H, Ishiguro M, Ishihara S, Kanemitsu Y, Kinugasa Y, Murofushi K, Nakajima TE, Oka S, Tanaka T, Taniguchi H, Tsuji A, Uehara K, Ueno H, Yamanaka T, Yamazaki K, Yoshida M, Yoshino T, Itabashi M, Sakamaki K, Sano K, Shimada Y, Tanaka S, Uetake H, Yamaguchi S, Yamaguchi N, Kobayashi H, Matsuda K, Kotake K, Sugihara K;  Japanese Society for Cancer of the Colon and Rectum. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol. 2020;25:1-42. [PMID: 31203527 DOI: 10.1007/s10147-019-01485-z] [Cited by in Crossref: 282] [Cited by in F6Publishing: 260] [Article Influence: 94.0] [Reference Citation Analysis]
50 Kollmar O, Rupertus K, Scheuer C, Nickels RM, Haberl GC, Tilton B, Menger MD, Schilling MK. CXCR4 and CXCR7 regulate angiogenesis and CT26.WT tumor growth independent from SDF-1. Int J Cancer. 2010;126:1302-1315. [PMID: 19821487 DOI: 10.1002/ijc.24956] [Cited by in Crossref: 9] [Cited by in F6Publishing: 30] [Article Influence: 0.8] [Reference Citation Analysis]
51 Knott EA, Ziemlewicz TJ, Lubner SJ, Swietlik JF, Weber SM, Zlevor AM, Longhurst C, Hinshaw JL, Lubner MG, Mulkerin DL, Abbott DE, Deming D, LoConte NK, Uboha N, Couillard AB, Wells SA, Laeseke PF, Alexander ML, Lee FT Jr. Microwave ablation for colorectal cancer metastasis to the liver: a single-center retrospective analysis. J Gastrointest Oncol 2021;12:1454-69. [PMID: 34532102 DOI: 10.21037/jgo-21-159] [Reference Citation Analysis]
52 Xu J, Qin X, Wang J, Zhang S, Zhong Y, Ren L, Wei Y, Zeng S, Wan D, Zheng S; Society of Surgery; Chinese Medical Association; Committee of Colorectal Cancer, Chinese Anti-cancer Association. Chinese guidelines for the diagnosis and comprehensive treatment of hepatic metastasis of colorectal cancer. J Cancer Res Clin Oncol. 2011;137:1379-1396. [PMID: 21796415 DOI: 10.1007/s00432-011-0999-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
53 Macedo FIB, Makarawo T. Colorectal hepatic metastasis: Evolving therapies. World J Hepatol 2014; 6(7): 453-463 [PMID: 25067997 DOI: 10.4254/wjh.v6.i7.453] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
54 Adileh M, Mor E, Assaf D, Benvenisti H, Laks S, Ben-Yaacov A, Schtrechman G, Hazzan D, Shacham-Shmueli E, Margalit O, Halpern N, Aderka D, Perelson D, Ariche A, Nissan A. Perioperative and Oncological Outcomes of Combined Hepatectomy with Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer. Ann Surg Oncol 2021;28:3320-9. [PMID: 32968959 DOI: 10.1245/s10434-020-09165-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
55 Abdalla EK, Vauthey J. Colorectal Metastases: Resect or Ablate? Ann Surg Oncol 2006;13:602-3. [DOI: 10.1245/aso.2006.09.920] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
56 Tanabe KK. The past 60 years in liver surgery. Cancer 2008;113:1888-96. [DOI: 10.1002/cncr.23652] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
57 de Jong MC, van Vledder MG, Ribero D, Hubert C, Gigot JF, Choti MA, Schulick RD, Capussotti L, Dejong CH, Pawlik TM. Therapeutic efficacy of combined intraoperative ablation and resection for colorectal liver metastases: an international, multi-institutional analysis. J Gastrointest Surg 2011;15:336-44. [PMID: 21108017 DOI: 10.1007/s11605-010-1391-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
58 Kulemann V, Schima W, Tamandl D, Kaczirek K, Gruenberger T, Wrba F, Weber M, Ba-Ssalamah A. Preoperative detection of colorectal liver metastases in fatty liver: MDCT or MRI? Eur J Radiol. 2011;79:e1-e6. [PMID: 20392584 DOI: 10.1016/j.ejrad.2010.03.004] [Cited by in Crossref: 59] [Cited by in F6Publishing: 56] [Article Influence: 4.9] [Reference Citation Analysis]
59 Helmberger T. [Interventional procedures for hepatic metastases]. Chirurg. 2010;81:542-550. [PMID: 20502849 DOI: 10.1007/s00104-010-1888-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
60 van der Pool AE, Lalmahomed ZS, de Wilt JH, Eggermont AM, Ijzermans JN, Verhoef C. Trends in treatment for synchronous colorectal liver metastases: Differences in outcome before and after 2000: Synchronous Colorectal Liver Metastases. J Surg Oncol 2010;102:413-8. [DOI: 10.1002/jso.21618] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
61 Sturesson C, Nilsson J, Eriksson S, Spelt L, Andersson R. Limiting factors for liver regeneration after a major hepatic resection for colorectal cancer metastases. HPB (Oxford). 2013;15:646-652. [PMID: 23458360 DOI: 10.1111/hpb.12040] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
62 Clarke CN, Choi H, Hou P, Davis CH, Ma J, Rashid A, Vauthey JN, Aloia TA. Using MRI to non-invasively and accurately quantify preoperative hepatic steatosis. HPB (Oxford) 2017;19:706-12. [PMID: 28528267 DOI: 10.1016/j.hpb.2017.04.009] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
63 Andres A, Majno P, Terraz S, Morel P, Roth A, Rubbia-Brandt L, Schiffer E, Ris F, Toso C. Management of patients with colorectal liver metastasis in eleven questions and answers. Expert Rev Anticancer Ther 2016;16:1277-90. [PMID: 27744725 DOI: 10.1080/14737140.2016.1249855] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
64 Takamoto T, Hashimoto T, Sano K, Maruyama Y, Inoue K, Ogata S, Takemura T, Kokudo N, Makuuchi M. Recovery of liver function after the cessation of preoperative chemotherapy for colorectal liver metastasis. Ann Surg Oncol 2010;17:2747-55. [PMID: 20425145 DOI: 10.1245/s10434-010-1074-4] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 3.6] [Reference Citation Analysis]
65 Aranda E, Abad A, Carrato A, Cervantes A, García-Foncillas J, García Alfonso P, García Carbonero R, Gómez España A, Tabernero JM, Díaz-Rubio E. Treatment recommendations for metastatic colorectal cancer. Clin Transl Oncol 2011;13:162-78. [PMID: 21421461 DOI: 10.1007/s12094-011-0636-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
66 Andreou A, Gloor S, Inglin J, Di Pietro Martinelli C, Banz V, Lachenmayer A, Kim-Fuchs C, Candinas D, Beldi G. Parenchymal-sparing hepatectomy for colorectal liver metastases reduces postoperative morbidity while maintaining equivalent oncologic outcomes compared to non-parenchymal-sparing resection. Surg Oncol 2021;38:101631. [PMID: 34298267 DOI: 10.1016/j.suronc.2021.101631] [Reference Citation Analysis]
67 Dijkstra M, Nieuwenhuizen S, Puijk RS, Timmer FEF, Geboers B, Schouten EAC, Opperman J, Scheffer HJ, de Vries JJJ, Versteeg KS, Lissenberg-Witte BI, van den Tol MP, Meijerink MR. Primary Tumor Sidedness, RAS and BRAF Mutations and MSI Status as Prognostic Factors in Patients with Colorectal Liver Metastases Treated with Surgery and Thermal Ablation: Results from the Amsterdam Colorectal Liver Met Registry (AmCORE). Biomedicines 2021;9:962. [PMID: 34440165 DOI: 10.3390/biomedicines9080962] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Birkett RT, O'donnell MT, Epstein AJ, Saur NM, Bleier JI, Paulson EC. Elective colon resection without curative intent in stage IV colon cancer. Surgical Oncology 2019;28:110-5. [DOI: 10.1016/j.suronc.2018.11.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
69 Procopio F, Marano S, Gentile D, Da Roit A, Basato S, Riva P, De Vita F, Torzilli G, Castoro C. Management of Liver Oligometastatic Esophageal Cancer: Overview and Critical Analysis of the Different Loco-Regional Treatments. Cancers (Basel) 2019;12:E20. [PMID: 31861604 DOI: 10.3390/cancers12010020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
70 Ito K, Takemura N, Inagaki F, Mihara F, Kurokawa T, Gohda Y, Kiyomatsu T, Yano H, Kokudo N. Hepatectomy for metachronous colorectal liver metastases following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastases: a report of three cases. World J Surg Oncol 2019;17:99. [PMID: 31196097 DOI: 10.1186/s12957-019-1646-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
71 Kuvshinoff B, Fong Y. Surgical therapy of liver metastases. Semin Oncol 2007;34:177-85. [PMID: 17560979 DOI: 10.1053/j.seminoncol.2007.03.003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]
72 Jaeck D, Oussoultzoglou E, Rosso E. Hepatectomy for colorectal metastases in the presence of extrahepatic disease. Surg Oncol Clin N Am 2007;16:507-23, viii. [PMID: 17606191 DOI: 10.1016/j.soc.2007.04.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
73 Huang KW, Lee PH, Kusano T, Reccia I, Jayant K, Habib N. Impact of cavitron ultrasonic surgical aspirator (CUSA) and bipolar radiofrequency device (Habib-4X) based hepatectomy for hepatocellular carcinoma on tumour recurrence and disease-free survival. Oncotarget 2017;8:93644-54. [PMID: 29212179 DOI: 10.18632/oncotarget.21271] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
74 Schullian P, Putzer D, Eberle G, Laimer G, Bale R. Simultaneous Stereotactic Radiofrequency Ablation of Multiple (≥ 4) Liver Tumors: Feasibility, Safety, and Efficacy. J Vasc Interv Radiol 2020;31:943-52. [PMID: 32414570 DOI: 10.1016/j.jvir.2019.12.794] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
75 Ammori JB, Kemeny NE. Regional hepatic chemotherapies in treatment of colorectal cancer metastases to the liver. Semin Oncol 2010;37:139-48. [PMID: 20494706 DOI: 10.1053/j.seminoncol.2010.03.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
76 Wang KW, Fan HY, Kong FM, Dong M. Analysis of prognostic factors for colorectal liver metastases. Shijie Huaren Xiaohua Zazhi 2011; 19(29): 3088-3093 [DOI: 10.11569/wcjd.v19.i29.3088] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
77 Shin H, Kim CW, Lee JL, Yoon YS, Park IJ, Lim SB, Yu CS, Kim JC. Solitary colorectal liver metastasis after curative intent surgery: prognostic factors affecting outcomes and survival. ANZ J Surg 2019;89:61-7. [PMID: 30484933 DOI: 10.1111/ans.14933] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
78 Nikfarjam M, Muralidharan V, Christophi C. Altered growth patterns of colorectal liver metastases after thermal ablation. Surgery. 2006;139:73-81. [PMID: 16364720 DOI: 10.1016/j.surg.2005.07.030] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 2.3] [Reference Citation Analysis]
79 Mbah NA, Scoggins C, McMasters K, Martin R. Impact of hepatectomy margin on survival following resection of colorectal metastasis: the role of adjuvant therapy and its effects. Eur J Surg Oncol. 2013;39:1394-1399. [PMID: 24084087 DOI: 10.1016/j.ejso.2013.09.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
80 Li HS, Li YF. Advances in treatment of liver metastases of colorectal cancer. Shijie Huaren Xiaohua Zazhi 2012; 20(36): 3754-3760 [DOI: 10.11569/wcjd.v20.i36.3754] [Reference Citation Analysis]
81 Perrodin SF, Renzulli MM, Maurer MH, Kim-Fuchs C, Candinas D, Beldi G, Lachenmayer A. CAN MICROWAVE ABLATION BE AN ALTERNATIVE TO RESECTION FOR THE TREATMENT OF NEUROENDOCRINE LIVER METASTASES? Endocr Pract 2020;26:378-87. [PMID: 31859556 DOI: 10.4158/EP-2019-0394] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
82 Bremers A, Ruers T. Prudent application of radiofrequency ablation in resectable colorectal liver metastasis. European Journal of Surgical Oncology (EJSO) 2007;33:752-6. [DOI: 10.1016/j.ejso.2007.02.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
83 Hill CR, Chagpar RB, Callender GG, Brown RE, Gilbert JE, Martin RC 2nd, McMasters KM, Scoggins CR. Recurrence following hepatectomy for metastatic colorectal cancer: development of a model that predicts patterns of recurrence and survival. Ann Surg Oncol. 2012;19:139-144. [PMID: 21751045 DOI: 10.1245/s10434-011-1921-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
84 Huh JW, Cho CK, Kim HR, Kim YJ. Impact of resection for primary colorectal cancer on outcomes in patients with synchronous colorectal liver metastases. J Gastrointest Surg 2010;14:1258-64. [PMID: 20544397 DOI: 10.1007/s11605-010-1250-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
85 Tanaka K, Shimada H, Nagano Y, Endo I, Sekido H, Togo S. Outcome after hepatic resection versus combined resection and microwave ablation for multiple bilobar colorectal metastases to the liver. Surgery. 2006;139:263-273. [PMID: 16455336 DOI: 10.1016/j.surg.2005.07.036] [Cited by in Crossref: 74] [Cited by in F6Publishing: 62] [Article Influence: 4.6] [Reference Citation Analysis]
86 Krieger PM, Tamandl D, Herberger B, Faybik P, Fleischmann E, Maresch J, Gruenberger T. Evaluation of chemotherapy-associated liver injury in patients with colorectal cancer liver metastases using indocyanine green clearance testing. Ann Surg Oncol. 2011;18:1644-1650. [PMID: 21207168 DOI: 10.1245/s10434-010-1494-1] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 3.7] [Reference Citation Analysis]
87 Yang D, Zhuang B, Lin M, Xu M, Lv M, Kuang M, Xie X, Xie X. Primary tumour location is an important prognostic factor in colorectal cancer liver metastases following radiofrequency ablation. Clin Radiol 2020;75:961.e1-9. [PMID: 32859384 DOI: 10.1016/j.crad.2020.07.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
88 Power DG, Lichtman SM. Chemotherapy for the Elderly Patient With Colorectal Cancer. The Cancer Journal 2010;16:241-52. [DOI: 10.1097/ppo.0b013e3181e07690] [Cited by in Crossref: 18] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
89 Peng S, Huang P, Yu H, Wen Y, Luo Y, Wang X, Zhou J, Qin S, Li T, Chen Y, Liu G, Huang M. Prognostic value of carcinoembryonic antigen level in patients with colorectal cancer liver metastasis treated with percutaneous microwave ablation under ultrasound guidance. Medicine (Baltimore) 2018;97:e0044. [PMID: 29517661 DOI: 10.1097/MD.0000000000010044] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
90 Lei P, Ruan Y, Tan L, Wei H, Chen T. Laparoscopic colorectal resection combined with simultaneous thermal ablation or surgical resection of liver metastasis: a retrospective comparative study. Int J Hyperthermia 2020;37:137-43. [PMID: 31986941 DOI: 10.1080/02656736.2020.1716086] [Reference Citation Analysis]
91 Chan A. Liver transplantation for unresectable colorectal liver metastasis. Hepatobiliary Surg Nutr 2013;2:162-4. [PMID: 24570935 DOI: 10.3978/j.issn.2304-3881.2013.05.01] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
92 Li L, Luo HS. G-Protein Signaling Protein-17 (RGS17) Is Upregulated and Promotes Tumor Growth and Migration in Human Colorectal Carcinoma. Oncol Res 2018;26:27-35. [PMID: 28337960 DOI: 10.3727/096504017X14900515946914] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
93 Nanashima A, Sumida Y, Abo T, Tobinaga S, Takeshita H, Hidaka S, Yasutake T, Nagayasu T, Mine M, Sawai T. A modified grading system for post-hepatectomy metastatic liver cancer originating from colorectal carcinoma. J Surg Oncol 2008;98:363-70. [DOI: 10.1002/jso.21114] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
94 Bae H, Lee H, Kim S, Han K, Rhee H, Kim DK, Kwon H, Hong H, Lim JS. Radiomics analysis of contrast-enhanced CT for classification of hepatic focal lesions in colorectal cancer patients: its limitations compared to radiologists. Eur Radiol 2021. [PMID: 33970307 DOI: 10.1007/s00330-021-07877-y] [Reference Citation Analysis]
95 Piltch A, Zhang F, Hayashi J. Culture and characterization of thymic epithelium from autoimmune NZB and NZB/W mice. Cell Immunol 1990;131:325-37. [PMID: 2242501 DOI: 10.1016/0008-8749(90)90258-s] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 0.7] [Reference Citation Analysis]
96 Maithel SK, D'Angelica MI. An update on randomized clinical trials in advanced and metastatic colorectal carcinoma. Surg Oncol Clin N Am 2010;19:163-81. [PMID: 19914565 DOI: 10.1016/j.soc.2009.09.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
97 Zalinski S, Bigourdan JM, Vauthey JN. [Does bevacizumab have a protective effect on hepatotoxicity induced by chemotherapy?]. J Chir (Paris) 2010;147 Suppl 1:S18-24. [PMID: 20172201 DOI: 10.1016/S0021-7697(10)70004-1] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
98 Shi Y, Wang Z, Chi J, Shi D, Wang T, Cui D, Lin Y, Zhai B. Long-term results of percutaneous microwave ablation for colorectal liver metastases. HPB (Oxford) 2021;23:37-45. [PMID: 32561175 DOI: 10.1016/j.hpb.2020.04.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
99 Ronnekleiv-Kelly SM, Kennedy GD. Management of stage IV rectal cancer: Palliative options. World J Gastroenterol 2011; 17(7): 835-847 [PMID: 21412493 DOI: 10.3748/wjg.v17.i7.835] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
100 Knowles B, Welsh FK, Chandrakumaran K, John TG, Rees M. Detailed liver-specific imaging prior to pre-operative chemotherapy for colorectal liver metastases reduces intra-hepatic recurrence and the need for a repeat hepatectomy. HPB (Oxford) 2012;14:298-309. [PMID: 22487067 DOI: 10.1111/j.1477-2574.2012.00447.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
101 Wray CJ, Lowy AM, Matthews JB, James LE, Mammen JM, Choe KA, Hanto DW, Ahmad SA. Intraoperative margin re-resection for colorectal liver metastases. J Surg Educ 2007;64:150-7. [PMID: 17574176 DOI: 10.1016/j.jsurg.2007.03.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
102 Ribero D, Viganò L, Amisano M, Capussotti L. Prognostic factors after resection of colorectal liver metastases: from morphology to biology. Future Oncol 2013;9:45-57. [PMID: 23252563 DOI: 10.2217/fon.12.159] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
103 Wolf PS, Park JO, Bao F, Allen PJ, DeMatteo RP, Fong Y, Jarnagin WR, Kingham TP, Gönen M, Kemeny N. Preoperative chemotherapy and the risk of hepatotoxicity and morbidity after liver resection for metastatic colorectal cancer: a single institution experience. J Am Coll Surg. 2013;216:41-49. [PMID: 23041049 DOI: 10.1016/j.jamcollsurg.2012.08.030] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 5.7] [Reference Citation Analysis]
104 Wiering B, Adang EM, van der Sijp JR, Roumen RM, de Jong KP, Comans EF, Pruim J, Dekker HM, Ruers TJ, Krabbe PF. Added value of positron emission tomography imaging in the surgical treatment of colorectal liver metastases. Nucl Med Commun. 2010;31:938-944. [PMID: 20856152 DOI: 10.1097/mnm.0b013e32833fa9ba] [Cited by in Crossref: 29] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
105 Kasivisvanathan R, Abbassi-Ghadi N, McLeod AD, Oliver A, Rao Baikady R, Jhanji S, Cone S, Wigmore T. Cardiopulmonary exercise testing for predicting postoperative morbidity in patients undergoing hepatic resection surgery. HPB (Oxford) 2015;17:637-43. [PMID: 25994624 DOI: 10.1111/hpb.12420] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
106 Bosma NA, Cheung WY, Thiessen M, Speers C, Renouf DJ, Tilley D, Tang PA, Ball CG, Dixon E, Lee-Ying RM. Real-World Outcomes of Oxaliplatin-Based Chemotherapy on R0 Resected Colonic Liver Metastasis. Clin Colorectal Cancer 2021;20:e201-9. [PMID: 34016533 DOI: 10.1016/j.clcc.2021.04.004] [Reference Citation Analysis]
107 Watanabe Y, Tamagawa H, Mizushima T, Taniguchi E, Kikkawa H, Sasaki M, Nakaba H. Colon liver metastasis complicated with tumor thrombus in the bile duct: A case report. Int J Surg Case Rep 2018;49:235-8. [PMID: 30056347 DOI: 10.1016/j.ijscr.2018.06.040] [Reference Citation Analysis]
108 Yamashita Y, Adachi E, Toh Y, Ohgaki K, Ikeda O, Oki E, Minami K, Sakaguchi Y, Tsujita E, Okamura T. Risk factors for early recurrence after curative hepatectomy for colorectal liver metastases. Surg Today 2011;41:526-32. [PMID: 21431486 DOI: 10.1007/s00595-010-4471-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
109 Andreou A, Brouquet A, Abdalla EK, Aloia TA, Curley SA, Vauthey JN. Repeat hepatectomy for recurrent colorectal liver metastases is associated with a high survival rate. HPB (Oxford). 2011;13:774-782. [PMID: 21999590 DOI: 10.1111/j.1477-2574.2011.00370.x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 49] [Article Influence: 5.1] [Reference Citation Analysis]
110 Mohan H, Nicholson P, Winter DC, O'Shea D, O'Toole D, Geoghegan J, Maguire D, Hoti E, Traynor O, Cantwell CP. Radiofrequency ablation for neuroendocrine liver metastases: a systematic review. J Vasc Interv Radiol. 2015;26:935-942.e1. [PMID: 25840836 DOI: 10.1016/j.jvir.2014.12.009] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 6.9] [Reference Citation Analysis]
111 Kaibori M, Iwamoto Y, Ishizaki M, Matsui K, Yoshioka K, Asano H, Kwon A. Predictors and outcome of early recurrence after resection of hepatic metastases from colorectal cancer. Langenbecks Arch Surg 2012;397:373-81. [DOI: 10.1007/s00423-011-0861-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
112 Yazici P, Akyuz M, Yigitbas H, Dural C, Okoh A, Aydin N, Berber E. A comparison of perioperative outcomes in elderly patients with malignant liver tumors undergoing laparoscopic liver resection versus radiofrequency ablation. Surg Endosc. 2017;31:1269-1274. [PMID: 27444839 DOI: 10.1007/s00464-016-5105-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
113 Homayounfar K, Liersch T, Niessner M, Meller J, Lorf T, Becker H, Ghadimi BM. Multimodal treatment options for bilobar colorectal liver metastases. Langenbecks Arch Surg 2010;395:633-41. [PMID: 20213463 DOI: 10.1007/s00423-010-0604-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
114 Tiong L, Maddern GJ. Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma. Br J Surg. 2011;98:1210-1224. [PMID: 21766289 DOI: 10.1002/bjs.7669] [Cited by in Crossref: 170] [Cited by in F6Publishing: 165] [Article Influence: 15.5] [Reference Citation Analysis]
115 Liersch T, Meller J, Bittrich M, Kulle B, Becker H, Goldenberg DM. Update of carcinoembryonic antigen radioimmunotherapy with (131)I-labetuzumab after salvage resection of colorectal liver metastases: comparison of outcome to a contemporaneous control group. Ann Surg Oncol 2007;14:2577-90. [PMID: 17570017 DOI: 10.1245/s10434-006-9328-x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 45] [Article Influence: 3.7] [Reference Citation Analysis]
116 Zalinski S, Mariette C, Farges O, SFCD-ACHBT evaluation committee : A. Alves, I. Baum-gaertner, C. Cabral, J. Carles, C. Diana, O. Dubreuil, D. Fuks, D. Goere, M. Karoui, J. Lefevre, P. Pessaux, G. Schmidt, O. Turrini, E. Vibert, J-C. Weber; French Society of Gastrointestinal Surgery (SFCD); Association of Hepatobiliary Surgery and Liver Transplantation (ACHBT). Management of patients with synchronous liver metastases of colorectal cancer. Clinical practice guidelines. Guidelines of the French society of gastrointestinal surgery (SFCD) and of the association of hepatobiliary surgery and liver transplantation (ACHBT). Short version. J Visc Surg. 2011;148:e171-e182. [PMID: 21703959 DOI: 10.1016/j.jviscsurg.2011.05.015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
117 Vauthey JN, Nordlinger B, Kopetz S, Poston G. Sequenced chemotherapy and surgery for potentially resectable colorectal liver metastases: a debate over goals of research and an approach while the jury remains out. Ann Surg Oncol. 2010;17:1983-1986. [PMID: 20232164 DOI: 10.1245/s10434-010-1007-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
118 Chavez MI, Gholami S, Kim BJ, Margonis GA, Ethun CG, Tsai S, Christians KK, Clarke C, Mogal H, Maithel SK, Pawlik TM, D'Angelica MI, Aloia TA, Eastwood D, Gamblin TC. Two-Stage Hepatectomy for Bilateral Colorectal Liver Metastases: A Multi-institutional Analysis. Ann Surg Oncol 2021;28:1457-65. [PMID: 33393036 DOI: 10.1245/s10434-020-09459-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
119 Liersch T, Becker H, Goldenberg DM. In Reply:. JCO 2006;24:2680-1. [DOI: 10.1200/jco.2006.05.8792] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
120 Mohammad WM, Martel G, Mimeault R, Fairfull-Smith RJ, Auer RC, Balaa FK. Evaluating agreement regarding the resectability of colorectal liver metastases: a national case-based survey of hepatic surgeons. HPB (Oxford). 2012;14:291-297. [PMID: 22487066 DOI: 10.1111/j.1477-2574.2012.00440.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
121 Padia SA, Johnson GE, Agopian VG, DiNorcia J, Srinivasa RN, Sayre J, Shin DS. Yttrium-90 radiation segmentectomy for hepatic metastases: A multi-institutional study of safety and efficacy. J Surg Oncol 2021;123:172-8. [PMID: 32944980 DOI: 10.1002/jso.26223] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
122 Adam R, Bhangui P, Poston G, Mirza D, Nuzzo G, Barroso E, Ijzermans J, Hubert C, Ruers T, Capussotti L, Ouellet JF, Laurent C, Cugat E, Colombo PE, Milicevic M. Is perioperative chemotherapy useful for solitary, metachronous, colorectal liver metastases? Ann Surg. 2010;252:774-787. [PMID: 21037433 DOI: 10.1097/sla.0b013e3181fcf3e3] [Cited by in Crossref: 127] [Cited by in F6Publishing: 52] [Article Influence: 10.6] [Reference Citation Analysis]
123 Razafindratsira T, Isambert M, Evrard S. Complications of intraoperative radiofrequency ablation of liver metastases. HPB (Oxford). 2011;13:15-23. [PMID: 21159099 DOI: 10.1111/j.1477-2574.2010.00243.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
124 Kawaguchi Y, Lillemoe HA, Vauthey JN. Dealing with an insufficient future liver remnant: Portal vein embolization and two-stage hepatectomy. J Surg Oncol 2019;119:594-603. [PMID: 30825223 DOI: 10.1002/jso.25430] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
125 Figueras J, Torras J, Valls C, Llado L, Ramos E, Marti-Ragué J, Serrano T, Fabregat J. Surgical resection of colorectal liver metastases in patients with expanded indications: a single-center experience with 501 patients. Dis Colon Rectum. 2007;50:478-488. [PMID: 17279302 DOI: 10.1007/s10350-006-0817-6] [Cited by in Crossref: 74] [Cited by in F6Publishing: 70] [Article Influence: 4.9] [Reference Citation Analysis]
126 Lipshitz J, Astrow AB, Xu Y. A unique and as yet unexplored subset of metastatic colorectal cancer: widespread lymph-node-only recurrence. J Gastrointest Cancer 2013;44:466-71. [PMID: 23247989 DOI: 10.1007/s12029-012-9470-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
127 Handgraaf HJM, Boogerd LSF, Höppener DJ, Peloso A, Sibinga Mulder BG, Hoogstins CES, Hartgrink HH, van de Velde CJH, Mieog JSD, Swijnenburg RJ, Putter H, Maestri M, Braat AE, Frangioni JV, Vahrmeijer AL. Long-term follow-up after near-infrared fluorescence-guided resection of colorectal liver metastases: A retrospective multicenter analysis. Eur J Surg Oncol 2017;43:1463-71. [PMID: 28528189 DOI: 10.1016/j.ejso.2017.04.016] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 5.6] [Reference Citation Analysis]
128 Schiffman SC, Kim KH, Tsung A, Marsh JW, Geller DA. Laparoscopic versus open liver resection for metastatic colorectal cancer: a metaanalysis of 610 patients. Surgery. 2015;157:211-222. [PMID: 25282529 DOI: 10.1016/j.surg.2014.08.036] [Cited by in Crossref: 93] [Cited by in F6Publishing: 68] [Article Influence: 11.6] [Reference Citation Analysis]
129 Khan AZ, Morris-Stiff G, Makuuchi M. Patterns of chemotherapy-induced hepatic injury and their implications for patients undergoing liver resection for colorectal liver metastases. J Hepatobiliary Pancreat Surg. 2009;16:137-144. [PMID: 19093069 DOI: 10.1007/s00534-008-0016-z] [Cited by in Crossref: 99] [Cited by in F6Publishing: 87] [Article Influence: 7.1] [Reference Citation Analysis]
130 Meriggi F, Bertocchi P, Zaniboni A. Management of potentially resectable colorectal cancer liver metastases. World J Gastrointest Surg 2013; 5(5): 138-145 [PMID: 23710291 DOI: 10.4240/wjgs.v5.i5.138] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
131 Fora A, Patta A, Attwood K, Wilding G, Fakih M. Intensive Radiographic and Biomarker Surveillance in Stage II and III Colorectal Cancer. Oncology 2012;82:41-7. [DOI: 10.1159/000333855] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
132 Parmar A, Chan KKW, Ko YJ. Metastatic colorectal cancer: therapeutic options for treating refractory disease. Curr Oncol 2019;26:S24-32. [PMID: 31819707 DOI: 10.3747/co.26.5575] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
133 Nijkamp MW, Hoogwater FJ, Steller EJ, Westendorp BF, van der Meulen TA, Leenders MW, Borel Rinkes IH, Kranenburg O. CD95 is a key mediator of invasion and accelerated outgrowth of mouse colorectal liver metastases following radiofrequency ablation. J Hepatol. 2010;53:1069-1077. [PMID: 20832890 DOI: 10.1016/j.jhep.2010.04.040] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 3.3] [Reference Citation Analysis]
134 Kawaguchi Y, Lillemoe HA, Vauthey JN. Gene mutation and surgical technique: Suggestion or more? Surg Oncol 2020;33:210-5. [PMID: 31351766 DOI: 10.1016/j.suronc.2019.07.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
135 Brouquet A, Nordlinger B. Neoadjuvant and adjuvant therapy in relation to surgery for colorectal liver metastases. Scandinavian Journal of Gastroenterology 2011;47:286-95. [DOI: 10.3109/00365521.2012.640826] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
136 McMasters KM. What's new in surgical oncology. J Am Coll Surg 2005;200:937-45. [PMID: 15922209 DOI: 10.1016/j.jamcollsurg.2005.03.008] [Reference Citation Analysis]
137 Kovacsovics-Bankowski M, Chisholm L, Vercellini J, Tucker CG, Montler R, Haley D, Newell P, Ma J, Tseng P, Wolf R, Vetto JT, Hammill C, Hansen P, Weinberg AD. Detailed characterization of tumor infiltrating lymphocytes in two distinct human solid malignancies show phenotypic similarities. J Immunother Cancer 2014;2:38. [PMID: 25436113 DOI: 10.1186/s40425-014-0038-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
138 Hashimoto M, Kobayashi T, Ishiyama K, Ide K, Ohira M, Tahara H, Kuroda S, Hamaoka M, Iwako H, Okimoto M, Ohdan H. Efficacy of repeat hepatectomy for recurrence following curative hepatectomy for colorectal liver metastases: A Retrospective Cohort Study of 128 patients. Int J Surg 2016;36:96-103. [PMID: 27741421 DOI: 10.1016/j.ijsu.2016.10.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
139 Wang E, Shibutani M, Nagahara H, Fukuoka T, Iseki Y, Okazaki Y, Kashiwagi S, Tanaka H, Maeda K. Prognostic value of the density of tumor-infiltrating lymphocytes in colorectal cancer liver metastases. Oncol Lett 2021;22:837. [PMID: 34712361 DOI: 10.3892/ol.2021.13098] [Reference Citation Analysis]
140 Pietrantonio F, Di Bartolomeo M, Cotsoglou C, Mennitto A, Berenato R, Morano F, Coppa J, Perrone F, Iacovelli R, Milione M, Alessi A, Vaiani M, Bossi I, Ricchini F, Scotti M, Caporale M, Bajetta E, de Braud F, Mazzaferro V. Perioperative Triplet Chemotherapy and Cetuximab in Patients With RAS Wild Type High Recurrence Risk or Borderline Resectable Colorectal Cancer Liver Metastases. Clinical Colorectal Cancer 2017;16:e191-8. [DOI: 10.1016/j.clcc.2016.09.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
141 Miklavčič D, Serša G, Brecelj E, Gehl J, Soden D, Bianchi G, Ruggieri P, Rossi CR, Campana LG, Jarm T. Electrochemotherapy: technological advancements for efficient electroporation-based treatment of internal tumors. Med Biol Eng Comput 2012;50:1213-25. [PMID: 23179413 DOI: 10.1007/s11517-012-0991-8] [Cited by in Crossref: 138] [Cited by in F6Publishing: 111] [Article Influence: 13.8] [Reference Citation Analysis]
142 Feng X, He P, Zeng C, Li YH, Das SK, Li B, Yang HF, Du Y. Novel insights into the role of Clostridium novyi-NT related combination bacteriolytic therapy in solid tumors. Oncol Lett 2021;21:110. [PMID: 33376543 DOI: 10.3892/ol.2020.12371] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
143 Alhumaid A, AlYousef Z, Bakhsh HA, AlGhamdi S, Aziz MA. Emerging paradigms in the treatment of liver metastases in colorectal cancer. Crit Rev Oncol Hematol. 2018;132:39-50. [PMID: 30447926 DOI: 10.1016/j.critrevonc.2018.09.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
144 Tang H, Li B, Zhang H, Dong J, Lu W. Comparison of Anatomical and Nonanatomical Hepatectomy for Colorectal Liver Metastasis: A Meta-Analysis of 5207 Patients. Sci Rep 2016;6:32304. [PMID: 27577197 DOI: 10.1038/srep32304] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
145 Nicholl MB, Bilchik AJ. Thermal ablation of hepatic malignancy: useful but still not optimal. Eur J Surg Oncol. 2008;34:318-323. [PMID: 18055158 DOI: 10.1016/j.ejso.2007.07.203] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
146 Han X, Wang R, Xu J, Chen Q, Liang C, Chen J, Zhao J, Chu J, Fan Q, Archibong E, Jiang L, Wang C, Liu Z. In situ thermal ablation of tumors in combination with nano-adjuvant and immune checkpoint blockade to inhibit cancer metastasis and recurrence. Biomaterials 2019;224:119490. [DOI: 10.1016/j.biomaterials.2019.119490] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
147 Figueras J. Changing strategies in surgical treatment of colorectal liver metastases: state of the art. Clin Transl Oncol 2005;7:229-31. [DOI: 10.1007/bf02710167] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
148 Bolaños-díaz R, Sanabria-montañez C, Farfán-tello C, Calderón-cahua M. Cost-effectiveness of Cetuximab as a treatment strategy for metastatic colon cancer in Peru: chemotherapy/Cetuximab versus chemotherapy alone. J Pharm Health Serv Res 2018;9:319-26. [DOI: 10.1111/jphs.12262] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
149 Tsukamoto S, Kinugasa Y, Yamaguchi T, Shiomi A. Survival after resection of liver and lung colorectal metastases in the era of modern multidisciplinary therapy. Int J Colorectal Dis 2014;29:81-7. [DOI: 10.1007/s00384-013-1752-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
150 Yang S, Alibhai SM, Kennedy ED, El-Sedfy A, Dixon M, Coburn N, Kiss A, Law CH. Optimal management of colorectal liver metastases in older patients: a decision analysis. HPB (Oxford) 2014;16:1031-42. [PMID: 24961482 DOI: 10.1111/hpb.12292] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
151 Mavros MN, Hyder O, Pulitano C, Aldrighetti L, Pawlik TM. Survival of patients operated for colorectal liver metastases and concomitant extra-hepatic disease: external validation of a prognostic model. J Surg Oncol. 2013;107:481-485. [PMID: 22952157 DOI: 10.1002/jso.23260] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
152 Bodingbauer M, Tamandl D, Schmid K, Plank C, Schima W, Gruenberger T. Size of surgical margin does not influence recurrence rates after curative liver resection for colorectal cancer liver metastases. Br J Surg. 2007;94:1133-1138. [PMID: 17514637 DOI: 10.1002/bjs.5762] [Cited by in Crossref: 78] [Cited by in F6Publishing: 68] [Article Influence: 5.2] [Reference Citation Analysis]
153 De Raffele E, Mirarchi M, Cuicchi D, Lecce F, Casadei R, Ricci C, Selva S, Minni F. Simultaneous colorectal and parenchymal-sparing liver resection for advanced colorectal carcinoma with synchronous liver metastases: Between conventional and mini-invasive approaches. World J Gastroenterol 2020; 26(42): 6529-6555 [PMID: 33268945 DOI: 10.3748/wjg.v26.i42.6529] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
154 Alemi F, Kwon E, Chiu J, Aoki H, Stewart L, Corvera CU. Laparoscopic treatment of liver tumours using a two-needle probe bipolar radiofrequency ablation device. HPB (Oxford) 2011;13:656-64. [PMID: 21843267 DOI: 10.1111/j.1477-2574.2011.00347.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
155 Han J, Lee KY, Kim NK, Min BS. Metachronous metastasis confined to isolated lymph node after curative treatment of colorectal cancer. Int J Colorectal Dis 2020;35:2089-97. [DOI: 10.1007/s00384-020-03695-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
156 Bower M, Wunderlich C, Brown R, Scoggins CR, Mcmasters KM, Martin RC. Obesity rather than neoadjuvant chemotherapy predicts steatohepatitis in patients with colorectal metastasis. The American Journal of Surgery 2013;205:685-90. [DOI: 10.1016/j.amjsurg.2012.07.034] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
157 Catalano OA, Coutinho AM, Sahani DV, Vangel MG, Gee MS, Hahn PF, Witzel T, Soricelli A, Salvatore M, Catana C, Mahmood U, Rosen BR, Gervais D. Colorectal cancer staging: comparison of whole-body PET/CT and PET/MR. Abdom Radiol 2017;42:1141-51. [DOI: 10.1007/s00261-016-0985-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
158 Kelly ME, Aalbers AGJ, Abdul Aziz N, Abecasis N, Abraham‐nordling M, Akiyoshi T, Alberda W, Albert M, Andric M, Angenete E, Antoniou A, Auer R, Austin KK, Aziz O, Baker RP, Bali M, Baseckas G, Bebington B, Bednarski BK, Beets GL, Berg PL, Beynon J, Biondo S, Boyle K, Bordeianou L, Bremers AB, Brunner M, Buchwald P, Bui A, Burgess A, Burger JWA, Burling D, Burns E, Campain N, Carvalhal S, Castro L, Caycedo‐marulanda A, Chan KKL, Chang GJ, Chew MH, Chong PC, Christensen HK, Clouston H, Codd M, Collins D, Colquhoun A, Corr A, Coscia M, Coyne PE, Creavin B, Croner RS, Damjanovic L, Daniels IR, Davies M, Davies RJ, Delaney CP, Denost Q, Deutsch C, Dietz D, Domingo S, Dozois EJ, Duff M, Eglinton T, Enrique‐navascues JM, Espin‐basany E, Evans MD, Fearnhead NS, Flatmark K, Fleming F, Frizelle FA, Gallego MA, Garcia‐granero E, Garcia‐sabrido JL, Gentilini L, George ML, Ghouti L, Giner F, Ginther N, Glynn R, Golda T, Griffiths B, Harris DA, Hagemans JAW, Hanchanale V, Harji DP, Helewa RM, Heriot AG, Hochman D, Hohenberger W, Holm T, Hompes R, Jenkins JT, Kaffenberger S, Kandaswamy GV, Kapur S, Kanemitsu Y, Kelley SR, Keller DS, Khan MS, Kiran RP, Kim H, Kim HJ, Koh CE, Kok NFM, Kokelaar R, Kontovounisios C, Kristensen HØ, Kroon HM, Kusters M, Lago V, Larsen SG, Larson DW, Law WL, Laurberg S, Lee PJ, Limbert M, Lydrup ML, Lyons A, Lynch AC, Mantyh C, Mathis KL, Margues CFS, Martling A, Meijerink WJHJ, Merkel S, Mehta AM, Mcarthur DR, Mcdermott FD, Mcgrath JS, Malde S, Mirnezami A, Monson JRT, Morton JR, Mullaney TG, Negoi I, Neto JWM, Nguyen B, Nielsen MB, Nieuwenhuijzen GAP, Nilsson PJ, O’connell PR, O’dwyer ST, Palmer G, Pappou E, Park J, Patsouras D, Pellino G, Peterson AC, Poggioli G, Proud D, Quinn M, Quyn A, Radwan RW, van Ramshorst GH, Rasheed S, Rasmussen PC, Regenbogen SE, Renehan A, Rocha R, Rochester M, Rohila J, Rothbarth J, Rottoli M, Roxburgh C, Rutten HJT, Ryan ÉJ, Safar B, Sagar PM, Sahai A, Saklani A, Sammour T, Sayyed R, Schizas AMP, Schwarzkopf E, Scripcariu V, Selvasekar C, Shaikh I, Hellawell G, Shida D, Simpson A, Smart NJ, Smart P, Smith JJ, Solbakken AM, Solomon MJ, Sørensen MM, Steele SR, Steffens D, Stitzenberg K, Stocchi L, Stylianides NA, Sumrien H, Sutton PA, Swartking T, Taylor C, Tekkis PP, Teras J, Thurairaja R, Toh EL, Tsarkov P, Tsukada Y, Tsukamoto S, Tuech JJ, Turner WH, Tuynman JB, Vasquez‐jimenez W, Verhoef C, Vizzielli G, Voogt ELK, Uehara K, Wakeman C, Warrier S, Wasmuth HH, Weber K, Weiser MR, Wheeler JMD, Wild J, Wilson M, de Wilt JHW, Wolthuis A, Yano H, Yip B, Yip J, Yoo RN, van Zoggel D, Winter DC; PelvEx Collaborative. Simultaneous pelvic exenteration and liver resection for primary rectal cancer with synchronous liver metastases: results from the PelvEx Collaborative. Colorectal Dis 2020;22:1258-62. [DOI: 10.1111/codi.15064] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
159 Passot G, Kim BJ, Glehen O, Mehran RJ, Kopetz SE, Goere D, Overman MJ, Pocard M, Marchal F, Conrad C, Aloia TA, Vauthey JN, Chun YS; BIG-RENAPE Working Group. Impact of RAS Mutations in Metastatic Colorectal Cancer After Potentially Curative Resection: Does Site of Metastases Matter? Ann Surg Oncol 2018;25:179-87. [PMID: 29071660 DOI: 10.1245/s10434-017-6141-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
160 Li CL, Tang DR, Ji J, Zang B, Chen C, Zhao JQ. Colorectal adenocarcinoma patients with M1a diseases gain more clinical benefits from palliative primary tumor resection than those with M1b diseases: A propensity score matching analysis. World J Clin Cases 2020; 8(15): 3230-3239 [PMID: 32874977 DOI: 10.12998/wjcc.v8.i15.3230] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
161 Fernandez FG, Ritter J, Goodwin JW, Linehan DC, Hawkins WG, Strasberg SM. Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases. J Am Coll Surg. 2005;200:845-853. [PMID: 15922194 DOI: 10.1016/j.jamcollsurg.2005.01.024] [Cited by in Crossref: 359] [Cited by in F6Publishing: 299] [Article Influence: 21.1] [Reference Citation Analysis]
162 Jiang W, Fang YJ, Wu XJ, Wang FL, Lu ZH, Zhang RX, Ding PR, Fan WH, Pan ZZ, De-Sen Wan. Intraoperative blood loss independently predicts survival and recurrence after resection of colorectal cancer liver metastasis. PLoS One 2013;8:e76125. [PMID: 24098431 DOI: 10.1371/journal.pone.0076125] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
163 Welten VM, Fields AC, Yoo J, Irani JL, Goldberg JE, Bleday R, Melnitchouk N. Survival Outcomes for Colorectal Cancer with Isolated Liver Metastases at Academic Versus Community Hospitals. J Gastrointest Surg 2021. [PMID: 34145493 DOI: 10.1007/s11605-021-05062-6] [Reference Citation Analysis]
164 van Amerongen MJ, van der Stok EP, Fütterer JJ, Jenniskens SF, Moelker A, Grünhagen DJ, Verhoef C, de Wilt JH. Short term and long term results of patients with colorectal liver metastases undergoing surgery with or without radiofrequency ablation. Eur J Surg Oncol 2016;42:523-30. [PMID: 26856957 DOI: 10.1016/j.ejso.2016.01.013] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
165 Cig Media Group Lp. Highlights from: The 2009 American Society of Clinical Oncology Gastrointestinal Cancers Symposium. Clin Colorectal Cancer 2009;8:72-6. [PMID: 19423499 DOI: 10.3816/CCC.2009.n.012] [Reference Citation Analysis]
166 Patel D, Townsend AR, Karapetis C, Beeke C, Padbury R, Roy A, Maddern G, Roder D, Price TJ. Is Survival for Patients with Resectable Lung Metastatic Colorectal Cancer Comparable to Those with Resectable Liver Disease? Results from the South Australian Metastatic Colorectal Registry. Ann Surg Oncol 2016;23:3616-22. [PMID: 27251133 DOI: 10.1245/s10434-016-5290-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
167 Ejaz A, Semenov E, Spolverato G, Kim Y, Tanner D, Hundt J, Pawlik TM. Synchronous primary colorectal and liver metastasis: impact of operative approach on clinical outcomes and hospital charges. HPB (Oxford) 2014;16:1117-26. [PMID: 24965845 DOI: 10.1111/hpb.12302] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
168 Miller G, Biernacki P, Kemeny NE, Gonen M, Downey R, Jarnagin WR, D’Angelica M, Fong Y, Blumgart LH, DeMatteo RP. Outcomes after resection of synchronous or metachronous hepatic and pulmonary colorectal metastases. J Am Coll Surg. 2007;205:231-238. [PMID: 17660069 DOI: 10.1016/j.jamcollsurg.2007.04.039] [Cited by in Crossref: 153] [Cited by in F6Publishing: 120] [Article Influence: 10.2] [Reference Citation Analysis]
169 Kuehl H, Rosenbaum-Krumme S, Veit-Haibach P, Stergar H, Forsting M, Bockisch A, Antoch G. Impact of whole-body imaging on treatment decision to radio-frequency ablation in patients with malignant liver tumors: comparison of [18F]fluorodeoxyglucose-PET/computed tomography, PET and computed tomography. Nucl Med Commun 2008;29:599-606. [PMID: 18528181 DOI: 10.1097/MNM.0b013e3282f8144d] [Cited by in Crossref: 18] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
170 Brown RE, Martin RC 2nd, Scoggins CR. Ablative therapies for colorectal liver metastases. Surg Oncol Clin N Am 2011;20:259-71, vii. [PMID: 21377582 DOI: 10.1016/j.soc.2010.11.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
171 Nanji S, Tsang ME, Wei X, Booth CM. Regional lymph node involvement in patients undergoing liver resection for colorectal cancer metastases. Eur J Surg Oncol 2017;43:322-9. [PMID: 28057391 DOI: 10.1016/j.ejso.2016.10.033] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
172 Hartmann S, Reimer T, Gerber B, Stachs A. Primary metastatic breast cancer: the impact of locoregional therapy. Breast Care (Basel) 2014;9:23-8. [PMID: 24803883 DOI: 10.1159/000360054] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
173 Hata N, Tokuda J, Hurwitz S, Morikawa S. MRI-compatible manipulator with remote-center-of-motion control. J Magn Reson Imaging 2008;27:1130-8. [PMID: 18407542 DOI: 10.1002/jmri.21314] [Cited by in Crossref: 35] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
174 Thillai K, Repana D, Korantzis I, Kane P, Prachalias A, Ross P. Clinical outcomes for patients with liver-limited metastatic colorectal cancer: Arguing the case for specialist hepatobiliary multidisciplinary assessment. Eur J Surg Oncol. 2016;42:1331-1336. [PMID: 27174600 DOI: 10.1016/j.ejso.2016.03.031] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
175 Abdalla EK. The Truth About Radiofrequency Ablation and Laparoscopic Liver Resection. Annals of Surgery 2011;253:841-2. [DOI: 10.1097/10.1097/sla.0b013e3182120b18] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
176 Cirocchi R, Trastulli S, Boselli C, Montedori A, Cavaliere D, Parisi A, Noya G, Abraha I. Radiofrequency ablation in the treatment of liver metastases from colorectal cancer. Cochrane Database Syst Rev. 2012;6:CD006317. [PMID: 22696357 DOI: 10.1002/14651858.cd006317.pub3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 38] [Article Influence: 2.7] [Reference Citation Analysis]
177 Poston GJ. Staging of advanced colorectal cancer. Surg Oncol Clin N Am 2008;17:503-17, viii. [PMID: 18486880 DOI: 10.1016/j.soc.2008.02.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
178 Eisele RM, Neumann U, Neuhaus P, Schumacher G. Open surgical is superior to percutaneous access for radiofrequency ablation of hepatic metastases. World J Surg. 2009;33:804-811. [PMID: 19184639 DOI: 10.1007/s00268-008-9905-1] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
179 Lang H. [Liver resection: Part I. Anatomy and operative planning]. Chirurg 2007;78:761-73; quiz 774. [PMID: 17673958 DOI: 10.1007/s00104-007-1392-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
180 Murthy R, Eng C, Krishnan S, Madoff DC, Habbu A, Canet S, Hicks ME. Hepatic yttrium-90 radioembolotherapy in metastatic colorectal cancer treated with cetuximab or bevacizumab. J Vasc Interv Radiol 2007;18:1588-91. [PMID: 18057297 DOI: 10.1016/j.jvir.2007.08.015] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
181 Connor AA, Burkes R, Gallinger S. Strategies in the Multidisciplinary Management of Synchronous Colorectal Cancer and Resectable Liver Metastases. Curr Colorectal Cancer Rep 2014;10:227-38. [DOI: 10.1007/s11888-014-0222-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
182 Tada K, Iwashita Y, Shiraiwa K, Uchida H, Oshima Y, Sato Y, Nakanuma H, Hirashita T, Masuda T, Endo Y, Takeuchi Y, Ohta M, Itoh H, Inomata M. Pharmacokinetic and toxicodynamic evaluation of 5-fluorouracil administration after major hepatectomy in a rat model. Cancer Chemother Pharmacol 2020;85:345-52. [PMID: 31605153 DOI: 10.1007/s00280-019-03969-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
183 Odisio BC, Yamashita S, Frota L, Huang SY, Kopetz SE, Ahrar K, Chun YS, Aloia TA, Hicks ME, Gupta S, Vauthey J. Planned Treatment of Advanced Metastatic Disease with Completion Ablation After Hepatic Resection. J Gastrointest Surg 2017;21:628-35. [DOI: 10.1007/s11605-016-3324-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
184 Leite D, Kater FR. Conversion treatment of hepatic metastases of colon adenocarcinoma by bevacizumab and FOLFOX. Anticancer Drugs 2011;22 Suppl 2:S1-7. [PMID: 21768791 DOI: 10.1097/01.cad.0000398726.60837.27] [Reference Citation Analysis]
185 Katayose Y, Unno M. Management of liver metastases from colorectal cancer. Clin J Gastroenterol 2010;3:128-35. [PMID: 26190118 DOI: 10.1007/s12328-010-0155-z] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
186 Kim M, Fisher DT, Powers CA, Gabriel EM, Korman AM, Sexton S, Gudkov AV, Skitzki JJ. Novel mouse models of hepatic artery infusion. J Surg Res 2017;219:25-32. [PMID: 29078890 DOI: 10.1016/j.jss.2017.05.083] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
187 Hubert C, Dahrenmoller C, Marique L, Jabbour N, Gianello P, Leclercq I. Hepatic regeneration in a rat model is impaired by chemotherapy agents used in metastatic colorectal cancer. European Journal of Surgical Oncology (EJSO) 2015;41:1471-8. [DOI: 10.1016/j.ejso.2015.08.152] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
188 Feng M, Suresh K, Schipper MJ, Bazzi L, Ben-Josef E, Matuszak MM, Parikh ND, Welling TH, Normolle D, Ten Haken RK, Lawrence TS. Individualized Adaptive Stereotactic Body Radiotherapy for Liver Tumors in Patients at High Risk for Liver Damage: A Phase 2 Clinical Trial. JAMA Oncol 2018;4:40-7. [PMID: 28796864 DOI: 10.1001/jamaoncol.2017.2303] [Cited by in Crossref: 70] [Cited by in F6Publishing: 61] [Article Influence: 23.3] [Reference Citation Analysis]
189 Mitchell D, Puckett Y, Nguyen QN. Literature Review of Current Management of Colorectal Liver Metastasis. Cureus. 2019;11:e3940. [PMID: 30937238 DOI: 10.7759/cureus.3940] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
190 Liu W, Yan XL, Wang K, Bao Q, Sun Y, Xing BC. The outcome of liver resection and lymphadenectomy for hilar lymph node involvement in colorectal cancer liver metastases. Int J Colorectal Dis 2014;29:737-45. [PMID: 24743847 DOI: 10.1007/s00384-014-1863-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
191 Shah SA, Bromberg R, Coates A, Rempel E, Simunovic M, Gallinger S. Survival after liver resection for metastatic colorectal carcinoma in a large population. J Am Coll Surg 2007;205:676-83. [PMID: 17964443 DOI: 10.1016/j.jamcollsurg.2007.06.283] [Cited by in Crossref: 82] [Cited by in F6Publishing: 71] [Article Influence: 5.5] [Reference Citation Analysis]
192 Viganò L, Torzilli G, Cimino M, Imai K, Vibert E, Donadon M, Castaing D, Adam R. Drop-out between the two liver resections of two-stage hepatectomy. Patient selection or loss of chance? European Journal of Surgical Oncology (EJSO) 2016;42:1385-93. [DOI: 10.1016/j.ejso.2016.03.020] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
193 Gervais DA, Goldberg SN, Brown DB, Soulen MC, Millward SF, Rajan DK; Interventional Oncology Task Force and Standards Division, Society of Interventional Radiology. Society of Interventional Radiology position statement on percutaneous radiofrequency ablation for the treatment of liver tumors. J Vasc Interv Radiol 2009;20:3-8. [PMID: 18948025 DOI: 10.1016/j.jvir.2008.09.007] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
194 Anderson BM, Lin YM, Lin EY, Cazoulat G, Gupta S, Kyle Jones A, Odisio BC, Brock KK. A novel use of biomechanical model-based deformable image registration (DIR) for assessing colorectal liver metastases ablation outcomes. Med Phys 2021. [PMID: 34342018 DOI: 10.1002/mp.15147] [Reference Citation Analysis]
195 Torino F, Bonmassar E, Bonmassar L, De Vecchis L, Barnabei A, Zuppi C, Capoluongo E, Aquino A. Circulating tumor cells in colorectal cancer patients. Cancer Treatment Reviews 2013;39:759-72. [DOI: 10.1016/j.ctrv.2012.12.007] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.3] [Reference Citation Analysis]
196 Dômont J, Pawlik TM, Boige V, Rose M, Weber J, Hoff PM, Brown TD, Zorzi D, Morat L, Pignon J, Rashid A, Jaeck D, Sabatier L, Elias D, Tursz T, Soria J, Vauthey J. Catalytic Subunit of Human Telomerase Reverse Transcriptase Is an Independent Predictor of Survival in Patients Undergoing Curative Resection of Hepatic Colorectal Metastases: A Multicenter Analysis. JCO 2005;23:3086-93. [DOI: 10.1200/jco.2005.06.944] [Cited by in Crossref: 50] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
197 Karanicolas PJ, Jarnagin WR, Gonen M, Tuorto S, Allen PJ, DeMatteo RP, D'Angelica MI, Fong Y. Long-term outcomes following tumor ablation for treatment of bilateral colorectal liver metastases. JAMA Surg. 2013;148:597-601. [PMID: 23699996 DOI: 10.1001/jamasurg.2013.1431] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 6.1] [Reference Citation Analysis]
198 Fraum TJ, Owen JW, Fowler KJ. Beyond Histologic Staging: Emerging Imaging Strategies in Colorectal Cancer with Special Focus on Magnetic Resonance Imaging. Clin Colon Rectal Surg 2016;29:205-15. [PMID: 27582645 DOI: 10.1055/s-0036-1584288] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
199 Lam VW, Laurence JM, Johnston E, Hollands MJ, Pleass HC, Richardson AJ. A systematic review of two-stage hepatectomy in patients with initially unresectable colorectal liver metastases. HPB (Oxford) 2013;15:483-91. [PMID: 23750490 DOI: 10.1111/j.1477-2574.2012.00607.x] [Cited by in Crossref: 119] [Cited by in F6Publishing: 102] [Article Influence: 11.9] [Reference Citation Analysis]
200 Zellweger M, Abdelnour-Berchtold E, Krueger T, Ris HB, Perentes JY, Gonzalez M. Surgical treatment of pulmonary metastasis in colorectal cancer patients: Current practice and results. Crit Rev Oncol Hematol 2018;127:105-16. [PMID: 29891107 DOI: 10.1016/j.critrevonc.2018.05.001] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 5.5] [Reference Citation Analysis]
201 Komeda K, Hayashi M, Kubo S, Nagano H, Nakai T, Kaibori M, Wada H, Takemura S, Kinoshita M, Koga C, Matsumoto M, Sakaguchi T, Inoue Y, Hirokawa F, Kwon AH, Uchiyama K. High survival in patients operated for small isolated liver metastases from gastric cancer: a multi-institutional study. World J Surg. 2014;38:2692-2697. [PMID: 24803345 DOI: 10.1007/s00268-014-2608-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
202 Evrard S. Limits of colorectal liver metastases resectability: how and why to overcome them? For progress in cancer research. Recent Results Cancer Res 2014;203:213-29. [PMID: 25103008 DOI: 10.1007/978-3-319-08060-4_15] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
203 Yan TD, Sim J, Black D, Niu R, Morris DL. Systematic review on safety and efficacy of repeat hepatectomy for recurrent liver metastases from colorectal carcinoma. Ann Surg Oncol. 2007;14:2069-2077. [PMID: 17440785 DOI: 10.1245/s10434-007-9388-6] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
204 Yang AD, Brouquet A, Vauthey JN. Extending limits of resection for metastatic colorectal cancer: Risk benefit ratio: Resectability of Colorectal Liver Metastases. J Surg Oncol 2010;102:996-1001. [DOI: 10.1002/jso.21701] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
205 Ahmad A, Chen SL, Kavanagh MA, Allegra DP, Bilchik AJ. Radiofrequency Ablation of Hepatic Metastases from Colorectal Cancer: Are Newer Generation Probes Better? The American Surgeon 2006;72:875-9. [DOI: 10.1177/000313480607201007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
206 Verberne CJ, Wiggers T, Vermeulen KM, de Jong KP. Detection of recurrences during follow-up after liver surgery for colorectal metastases: both carcinoembryonic antigen (CEA) and imaging are important. Ann Surg Oncol. 2013;20:457-463. [PMID: 22948771 DOI: 10.1245/s10434-012-2629-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
207 Pulitanò C, Castillo F, Aldrighetti L, Bodingbauer M, Parks RW, Ferla G, Wigmore SJ, Garden OJ. What defines 'cure' after liver resection for colorectal metastases? Results after 10 years of follow-up. HPB (Oxford) 2010;12:244-9. [PMID: 20590894 DOI: 10.1111/j.1477-2574.2010.00155.x] [Cited by in Crossref: 69] [Cited by in F6Publishing: 63] [Article Influence: 5.8] [Reference Citation Analysis]
208 de Baere T, Tselikas L, Pearson E, Yevitch S, Boige V, Malka D, Ducreux M, Goere D, Elias D, Nguyen F, Deschamps F. Interventional oncology for liver and lung metastases from colorectal cancer: The current state of the art. Diagnostic and Interventional Imaging 2015;96:647-54. [DOI: 10.1016/j.diii.2015.04.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
209 Saab R, Furman WL. Epidemiology and management options for colorectal cancer in children. Paediatr Drugs 2008;10:177-92. [PMID: 18454570 DOI: 10.2165/00148581-200810030-00006] [Cited by in Crossref: 33] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
210 Giglio MC, Logghe B, Garofalo E, Tomassini F, Vanlander A, Berardi G, Montalti R, Troisi RI. Laparoscopic Versus Open Thermal Ablation of Colorectal Liver Metastases: A Propensity Score-Based Analysis of Local Control of the Ablated Tumors. Ann Surg Oncol 2020;27:2370-80. [PMID: 32060758 DOI: 10.1245/s10434-020-08243-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
211 Weng M, Zhang Y, Zhou D, Yang Y, Tang Z, Zhao M, Quan Z, Gong W. Radiofrequency ablation versus resection for colorectal cancer liver metastases: a meta-analysis. PLoS One. 2012;7:e45493. [PMID: 23029051 DOI: 10.1371/journal.pone.0045493] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 4.9] [Reference Citation Analysis]
212 Mariathasan AB, Boye K, Dueland S, Flatmark K, Larsen SG. Metastases in locally advanced rectal cancer undergoing curatively intended treatment. Eur J Surg Oncol 2021;47:2377-83. [PMID: 34049768 DOI: 10.1016/j.ejso.2021.04.023] [Reference Citation Analysis]
213 Rompianesi G, Pegoraro F, Ceresa CD, Montalti R, Troisi RI. Artificial intelligence in the diagnosis and management of colorectal cancer liver metastases. World J Gastroenterol 2022; 28(1): 108-122 [DOI: 10.3748/wjg.v28.i1.108] [Reference Citation Analysis]
214 Correa-Gallego C, Gavane S, Grewal R, Cercek A, Klimstra DS, Gewirtz AN, Kingham TP, Fong Y, DeMatteo RP, Allen PJ, Jarnagin WR, Kemeny N, D'Angelica MI. Prospective evaluation of 18F-fluorodeoxyglucose positron emission tomography in patients receiving hepatic arterial and systemic chemotherapy for unresectable colorectal liver metastases. HPB (Oxford) 2015;17:644-50. [PMID: 26010778 DOI: 10.1111/hpb.12421] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
215 Shindoh J, Loyer EM, Kopetz S, Boonsirikamchai P, Maru DM, Chun YS, Zimmitti G, Curley SA, Charnsangavej C, Aloia TA, Vauthey JN. Optimal morphologic response to preoperative chemotherapy: an alternate outcome end point before resection of hepatic colorectal metastases. J Clin Oncol. 2012;30:4566-4572. [PMID: 23150701 DOI: 10.1200/jco.2012.45.2854] [Cited by in Crossref: 138] [Cited by in F6Publishing: 58] [Article Influence: 13.8] [Reference Citation Analysis]
216 Ng KK, Poon RT. Radiofrequency ablation for malignant liver tumor. Surg Oncol. 2005;14:41-52. [PMID: 15777889 DOI: 10.1016/j.suronc.2005.01.001] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 2.6] [Reference Citation Analysis]
217 Torzilli G, Nagino M, Tzeng CD, Kingham TP, Alatise OI, Ayandipo OO, Yamashita S, Arrington AK, Kim J, Chun YS, Vauthey JN. SSAT State-of-the-Art Conference: New Frontiers in Liver Surgery. J Gastrointest Surg 2017;21:175-85. [PMID: 27480411 DOI: 10.1007/s11605-016-3193-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
218 Boleslawski E, Dharancy S, Truant S, Pruvot FR. Surgical management of liver metastases from gastrointestinal endocrine tumors. Gastroenterol Clin Biol 2010;34:274-82. [PMID: 20347242 DOI: 10.1016/j.gcb.2010.02.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
219 Yin JM, Sun LB, Zheng JS, Wang XX, Chen DX, Li N. Copper chelation by trientine dihydrochloride inhibits liver RFA-induced inflammatory responses in vivo. Inflamm Res 2016;65:1009-20. [PMID: 27613237 DOI: 10.1007/s00011-016-0986-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
220 Saif MW. Secondary hepatic resection as a therapeutic goal in advanced colorectal cancer. World J Gastroenterol 2009; 15(31): 3855-3864 [PMID: 19701965 DOI: 10.3748/wjg.15.3855] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
221 Donadon M, Botea F, Del Fabbro D, Palmisano A, Montorsi M, Torzilli G. The surgical policy predicts the impact of contrast enhanced intraoperative ultrasound for colorectal liver metastases. European Journal of Radiology 2008;67:177-8. [DOI: 10.1016/j.ejrad.2007.09.039] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
222 Parmar KL, O'Reilly D, Valle JW, Braun M, Naish JH, Williams SR, Lloyd WK, Malcomson L, Cresswell K, Bamford C, Renehan AG. Prospective study of change in liver function and fat in patients with colorectal liver metastases undergoing preoperative chemotherapy: protocol for the CLiFF Study. BMJ Open 2020;10:e027630. [PMID: 32967864 DOI: 10.1136/bmjopen-2018-027630] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
223 Nijkamp M, van der Bilt J, Snoeren N, Hoogwater F, van Houdt W, Molenaar I, Kranenburg O, van Hillegersberg R, Borel Rinkes I. Prolonged portal triad clamping during liver surgery for colorectal liver metastases is associated with decreased time to hepatic tumour recurrence. European Journal of Surgical Oncology (EJSO) 2010;36:182-8. [DOI: 10.1016/j.ejso.2009.10.016] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
224 Berber E, Tsinberg M, Tellioglu G, Simpfendorfer CH, Siperstein AE. Resection versus laparoscopic radiofrequency thermal ablation of solitary colorectal liver metastasis. J Gastrointest Surg. 2008;12:1967-1972. [PMID: 18688683 DOI: 10.1007/s11605-008-0622-8] [Cited by in Crossref: 83] [Cited by in F6Publishing: 75] [Article Influence: 5.9] [Reference Citation Analysis]
225 Homayounfar K, Liersch T, Schuetze G, Niessner M, Goralczyk A, Meller J, Langer C, Ghadimi BM, Becker H, Lorf T. Two-stage hepatectomy (R0) with portal vein ligation--towards curing patients with extended bilobular colorectal liver metastases. Int J Colorectal Dis. 2009;24:409-418. [PMID: 19084973 DOI: 10.1007/s00384-008-0620-z] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 2.9] [Reference Citation Analysis]
226 Li GZ, Sloane JL, Lidsky ME, Beasley GM, Reddy SK, Scarborough JE, Tyler DS, Turley RS, Clary BM. Simultaneous Diaphragm and Liver Resection: A Propensity-Matched Analysis of Postoperative Morbidity. Journal of the American College of Surgeons 2013;216:402-11. [DOI: 10.1016/j.jamcollsurg.2012.11.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
227 Boutros C, Somasundar P, Garrean S, Saied A, Espat NJ. Microwave coagulation therapy for hepatic tumors: review of the literature and critical analysis. Surg Oncol. 2010;19:e22-e32. [PMID: 19268571 DOI: 10.1016/j.suronc.2009.02.001] [Cited by in Crossref: 85] [Cited by in F6Publishing: 77] [Article Influence: 6.5] [Reference Citation Analysis]
228 Lee BC, Lee HG, Park IJ, Kim SY, Kim KH, Lee JH, Kim CW, Lee JL, Yoon YS, Lim SB, Yu CS, Kim JC. The role of radiofrequency ablation for treatment of metachronous isolated hepatic metastasis from colorectal cancer. Medicine (Baltimore) 2016;95:e4999. [PMID: 27684857 DOI: 10.1097/MD.0000000000004999] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
229 Morris-Stiff G, Tan YM, Vauthey JN. Hepatic complications following preoperative chemotherapy with oxaliplatin or irinotecan for hepatic colorectal metastases. Eur J Surg Oncol. 2008;34:609-614. [PMID: 17764887 DOI: 10.1016/j.ejso.2007.07.007] [Cited by in Crossref: 81] [Cited by in F6Publishing: 72] [Article Influence: 5.4] [Reference Citation Analysis]
230 Lam M, Loree JM, Pereira AAL, Chun YS, Kopetz S. Accelerating Therapeutic Development through Innovative Trial Design in Colorectal Cancer. Curr Treat Options Oncol 2018;19:11. [PMID: 29488033 DOI: 10.1007/s11864-018-0524-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
231 Valls C, Ramos E, Leiva D, Ruiz S, Martinez L, Rafecas A. Safety and Efficacy of Ultrasound-Guided Radiofrequency Ablation of Recurrent Colorectal Cancer Liver Metastases after Hepatectomy. Scand J Surg. 2014;Epub ahead of print. [PMID: 25332220 DOI: 10.1177/1457496914553147] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
232 Glazer ES, Curley SA. The ongoing history of thermal therapy for cancer. Surg Oncol Clin N Am 2011;20:229-35, vii. [PMID: 21377580 DOI: 10.1016/j.soc.2010.11.001] [Cited by in Crossref: 36] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
233 Chen X, Du Z, Huang M, Wang D, Fong WP, Liang J, Fan L, Wang Y, Yang H, Chen Z, Hu M, Xu R, Li Y. Circulating PD-L1 is associated with T cell infiltration and predicts prognosis in patients with CRLM following hepatic resection. Cancer Immunol Immunother 2021. [PMID: 34322779 DOI: 10.1007/s00262-021-03021-3] [Reference Citation Analysis]
234 Ihnát P, Skácelíková E, Vávra P, Jonszta T, Ihnát Rudinská L, Tomášková H. Novel strategy in the treatment of liver metastases - Hepatic resection combined with stereotactic body radiotherapy. Asian J Surg 2020;43:902-6. [PMID: 31911035 DOI: 10.1016/j.asjsur.2019.11.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
235 Hemming AW. Heading in the right direction: improved outcome of surgery for advanced colorectal liver metastases. Ann Surg Oncol 2008;15:7-8. [PMID: 17973173 DOI: 10.1245/s10434-007-9620-4] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
236 Joosten J, Ruers T. Local radiofrequency ablation techniques for liver metastases of colorectal cancer. Crit Rev Oncol Hematol. 2007;62:153-163. [PMID: 17317204 DOI: 10.1016/j.critrevonc.2006.12.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
237 Chang CY, Kim HC, Park YS, Park JO, Choi DH, Park HC, Cho YB, Yun SH, Lee WY, Chun HK. The effect of postoperative pelvic irradiation after complete resection of metastatic rectal cancer. J Surg Oncol. 2012;105:244-248. [PMID: 21987401 DOI: 10.1002/jso.22109] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
238 Joosten J, Jager G, Oyen W, Wobbes T, Ruers T. Cryosurgery and radiofrequency ablation for unresectable colorectal liver metastases. European Journal of Surgical Oncology (EJSO) 2005;31:1152-9. [DOI: 10.1016/j.ejso.2005.07.010] [Cited by in Crossref: 64] [Cited by in F6Publishing: 55] [Article Influence: 3.8] [Reference Citation Analysis]
239 Fifis T, Malcontenti-Wilson C, Amijoyo J, Anggono B, Muralidharan V, Nikfarjam M, Christophi C. Changes in growth factor levels after thermal ablation in a murine model of colorectal liver metastases. HPB (Oxford) 2011;13:246-55. [PMID: 21418130 DOI: 10.1111/j.1477-2574.2010.00278.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
240 Mason MC, Tzeng CD, Tran Cao HS, Aloia TA, Newhook TE, Overman MJ, Kopetz SE, Vauthey JN, Chun YS. Preliminary Analysis of Liquid Biopsy after Hepatectomy for Colorectal Liver Metastases. J Am Coll Surg 2021;233:82-89.e1. [PMID: 33667566 DOI: 10.1016/j.jamcollsurg.2021.02.011] [Reference Citation Analysis]
241 Sun W, Ma XJ, Zhang F, Miao WL, Wang CR, Cai ZD. Surgical Treatment of Sacral Neurogenic Tumor: A 10-year Experience with 64 Cases. Orthop Surg 2016;8:162-70. [PMID: 27384724 DOI: 10.1111/os.12245] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
242 Donadon M, Vauthey JN, Loyer EM, Charnsangavej C, Abdalla EK. Portal thrombosis and steatosis after preoperativechemotherapy with FOLFIRI-bevacizumab for colorectal liver metastases. World J Gastroenterol 2006; 12(40): 6556-6558 [PMID: 17072991 DOI: 10.3748/wjg.v12.i40.6556] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
243 Chakedis J, Schmidt CR. Surgical Treatment of Metastatic Colorectal Cancer. Surg Oncol Clin N Am 2018;27:377-99. [PMID: 29496096 DOI: 10.1016/j.soc.2017.11.010] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
244 Neuwirth MG, Epstein AJ, Karakousis GC, Mamtani R, Paulson EC. Disparities in resection of hepatic metastases in colon cancer. J Gastrointest Oncol 2018;9:126-34. [PMID: 29564178 DOI: 10.21037/jgo.2017.11.03] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
245 Li CJ, Wang L, Tu XH, Song JX. Mechanism of thermochemotherapy with 5-fluorocytosine on human colon cancer cell line SW480 transfected cytosine deaminase gene. Shijie Huaren Xiaohua Zazhi 2004; 12(10): 2307-2311 [DOI: 10.11569/wcjd.v12.i10.2307] [Reference Citation Analysis]
246 Hokuto D, Nomi T, Yamato I, Yasuda S, Obara S, Yamada T, Kanehiro H, Nakajima Y. Hepatic artery injury during left hepatic trisectionectomy for colorectal liver metastasis treated by portal vein arterialization.Int J Surg Case Rep. 2015;13:119-124. [PMID: 26197094 DOI: 10.1016/j.ijscr.2015.07.004] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
247 Eltawil KM, Boame N, Mimeault R, Shabana W, Balaa FK, Jonker DJ, Asmis TR, Martel G. Patterns of recurrence following selective intraoperative radiofrequency ablation as an adjunct to hepatic resection for colorectal liver metastases. J Surg Oncol. 2014;110:734-738. [PMID: 24965163 DOI: 10.1002/jso.23689] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
248 Kemeny N, Kurilova I, Li J, Camacho JC, Sofocleous CT. Liver-Directed and Systemic Therapies for Colorectal Cancer Liver Metastases. Cardiovasc Intervent Radiol 2019;42:1240-54. [DOI: 10.1007/s00270-019-02284-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
249 Nam SJ, Cho JY, Lee HS, Choe G, Jang JJ, Yoon YS, Han HS, Kim H. Chemotherapy-associated hepatopathy in korean colorectal cancer liver metastasis patients: oxaliplatin-based chemotherapy and sinusoidal injury. Korean J Pathol 2012;46:22-9. [PMID: 23109974 DOI: 10.4132/KoreanJPathol.2012.46.1.22] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
250 Evrard S, Menetrier-Caux C, Biota C, Neaud V, Mathoulin-Pélissier S, Blay JY, Rosenbaum J. Cytokines pattern after surgical radiofrequency ablation of liver colorectal metastases. Gastroenterol Clin Biol 2007;31:141-5. [PMID: 17347620 DOI: 10.1016/s0399-8320(07)89344-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
251 Ruers TJ, Wiering B, van der Sijp JR, Roumen RM, de Jong KP, Comans EF, Pruim J, Dekker HM, Krabbe PF, Oyen WJ. Improved selection of patients for hepatic surgery of colorectal liver metastases with (18)F-FDG PET: a randomized study. J Nucl Med. 2009;50:1036-1041. [PMID: 19525451 DOI: 10.2967/jnumed.109.063040] [Cited by in Crossref: 124] [Cited by in F6Publishing: 100] [Article Influence: 9.5] [Reference Citation Analysis]
252 Newton PK, Mason J, Bethel K, Bazhenova L, Nieva J, Norton L, Kuhn P. Spreaders and sponges define metastasis in lung cancer: a Markov chain Monte Carlo mathematical model. Cancer Res 2013;73:2760-9. [PMID: 23447576 DOI: 10.1158/0008-5472.CAN-12-4488] [Cited by in Crossref: 59] [Cited by in F6Publishing: 28] [Article Influence: 6.6] [Reference Citation Analysis]
253 Sato M, Tateishi R, Yasunaga H, Horiguchi H, Yoshida H, Matsuda S, Koike K. Mortality and morbidity of hepatectomy, radiofrequency ablation, and embolization for hepatocellular carcinoma: a national survey of 54,145 patients. J Gastroenterol 2012;47:1125-33. [DOI: 10.1007/s00535-012-0569-0] [Cited by in Crossref: 72] [Cited by in F6Publishing: 68] [Article Influence: 7.2] [Reference Citation Analysis]
254 Poston G, Adam R, Vauthey JN. Downstaging or downsizing: time for a new staging system in advanced colorectal cancer? J Clin Oncol 2006;24:2702-6. [PMID: 16782909 DOI: 10.1200/JCO.2006.05.8404] [Cited by in Crossref: 31] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
255 Halpern AL, Fitz JG, Fujiwara Y, Yi J, Anderson AL, Zhu Y, Schulick RD, El Kasmi KC, Barnett CC Jr. Hepatic thermal injury promotes colorectal cancer engraftment in C57/black 6 mice. Am J Physiol Cell Physiol 2021;320:C142-51. [PMID: 33175574 DOI: 10.1152/ajpcell.00071.2020] [Reference Citation Analysis]
256 Adam R, Wicherts DA, de Haas RJ, Ciacio O, Lévi F, Paule B, Ducreux M, Azoulay D, Bismuth H, Castaing D. Patients With Initially Unresectable Colorectal Liver Metastases: Is There a Possibility of Cure? JCO 2009;27:1829-35. [DOI: 10.1200/jco.2008.19.9273] [Cited by in Crossref: 366] [Cited by in F6Publishing: 132] [Article Influence: 28.2] [Reference Citation Analysis]
257 Tasleem S, Bolger JC, Kelly ME, Boland MR, Bowden D, Sweeney KJ, Malone C. The role of liver resection in patients with metastatic breast cancer: a systematic review examining the survival impact. Ir J Med Sci 2018;187:1009-20. [PMID: 29392651 DOI: 10.1007/s11845-018-1746-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
258 Lencioni R, Crocetti L, Cioni D, Della Pina C, Bartolozzi C. Percutaneous radiofrequency ablation of hepatic colorectal metastases: technique, indications, results, and new promises. Invest Radiol. 2004;39:689-697. [PMID: 15486530 DOI: 10.1097/00004424-200411000-00007] [Cited by in Crossref: 125] [Cited by in F6Publishing: 94] [Article Influence: 7.4] [Reference Citation Analysis]
259 Jakab F. Surgical strategy of colorectal liver metastases treatment depending on clinical and pathological response to neoadjuvant chemo- and target therapy. Orvosi Hetilap 2010;151:1956-60. [DOI: 10.1556/oh.2010.28988] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
260 van der Bilt JD, Kranenburg O, Borren A, van Hillegersberg R, Borel Rinkes IH. Ageing and hepatic steatosis exacerbate ischemia/reperfusion-accelerated outgrowth of colorectal micrometastases. Ann Surg Oncol. 2008;15:1392-1398. [PMID: 18335279 DOI: 10.1245/s10434-007-9758-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
261 Nuzzo G, Giuliante F, Ardito F, Vellone M, Pozzo C, Cassano A, Giovannini I, Barone C. Liver resection for primarily unresectable colorectal metastases downsized by chemotherapy. J Gastrointest Surg. 2007;11:318-324. [PMID: 17458605 DOI: 10.1007/s11605-006-0070-2] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 2.7] [Reference Citation Analysis]
262 Lin YM, Paolucci I, Brock KK, Odisio BC. Image-Guided Ablation for Colorectal Liver Metastasis: Principles, Current Evidence, and the Path Forward. Cancers (Basel) 2021;13:3926. [PMID: 34439081 DOI: 10.3390/cancers13163926] [Reference Citation Analysis]
263 Jones S, O'Donovan P, Toub D. Radiofrequency ablation for treatment of symptomatic uterine fibroids. Obstet Gynecol Int 2012;2012:194839. [PMID: 21961009 DOI: 10.1155/2012/194839] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
264 Stintzing S, Einem JV, Fueweger C, Haidenberger A, Fedorov M, Muavcevic A. Long-term Survival in Patients Treated with a Robotic Radiosurgical Device for Liver Metastases. Cancer Res Treat 2019;51:187-93. [PMID: 29656632 DOI: 10.4143/crt.2017.594] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
265 Voroney JP, Brock KK, Eccles C, Haider M, Dawson LA. Prospective comparison of computed tomography and magnetic resonance imaging for liver cancer delineation using deformable image registration. Int J Radiat Oncol Biol Phys 2006;66:780-91. [PMID: 17011453 DOI: 10.1016/j.ijrobp.2006.05.035] [Cited by in Crossref: 46] [Cited by in F6Publishing: 33] [Article Influence: 2.9] [Reference Citation Analysis]
266 Diaz-nieto R, Fenwick S, Malik H, Poston G. Defining the Optimal Use of Ablation for Metastatic Colorectal Cancer to the Liver Without High-Level Evidence. Curr Treat Options in Oncol 2017;18. [DOI: 10.1007/s11864-017-0452-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
267 Loosen SH, Heise D, Dejong CH, Roy S, Tacke F, Trautwein C, Roderburg C, Luedde T, Neumann UP, Binnebösel M. Circulating Levels of Osteopontin Predict Patients' Outcome after Resection of Colorectal Liver Metastases. J Clin Med 2018;7:E390. [PMID: 30373147 DOI: 10.3390/jcm7110390] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
268 Eisele RM, Zhukowa J, Chopra S, Schmidt SC, Neumann U, Pratschke J, Schumacher G. Results of liver resection in combination with radiofrequency ablation for hepatic malignancies. Eur J Surg Oncol. 2010;36:269-274. [PMID: 19726155 DOI: 10.1016/j.ejso.2009.07.188] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
269 Nanji S, Cleary S, Ryan P, Guindi M, Selvarajah S, Al-Ali H, Grieg P, McGilvary I, Taylor B, Wei A. Up-front hepatic resection for metastatic colorectal cancer results in favorable long-term survival. Ann Surg Oncol. 2013;20:295-304. [PMID: 23054102 DOI: 10.1245/s10434-012-2424-1] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 3.7] [Reference Citation Analysis]
270 Settmacher U, Dittmar Y, Knösel T, Schöne U, Heise M, Jandt K, Altendorf-hofmann AK. Predictors of long-term survival in patients with colorectal liver metastases: a single center study and review of the literature. Int J Colorectal Dis 2011;26:967-81. [DOI: 10.1007/s00384-011-1195-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
271 Rule W, Timmerman R, Tong L, Abdulrahman R, Meyer J, Boike T, Schwarz RE, Weatherall P, Chinsoo Cho L. Phase I dose-escalation study of stereotactic body radiotherapy in patients with hepatic metastases. Ann Surg Oncol. 2011;18:1081-1087. [PMID: 21046264 DOI: 10.1245/s10434-010-1405-5] [Cited by in Crossref: 141] [Cited by in F6Publishing: 107] [Article Influence: 11.8] [Reference Citation Analysis]
272 Sindram D, McKillop IH, Martinie JB, Iannitti DA. Novel 3-D laparoscopic magnetic ultrasound image guidance for lesion targeting. HPB (Oxford) 2010;12:709-16. [PMID: 21083797 DOI: 10.1111/j.1477-2574.2010.00244.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
273 Yang S, Hongjinda S, Hanna SS, Gallinger S, Wei AC, Kiss A, Law C. Utility of preoperative imaging in evaluating colorectal liver metastases declines over time. HPB (Oxford) 2010;12:605-9. [PMID: 20961368 DOI: 10.1111/j.1477-2574.2010.00202.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
274 Lupinacci RM, Mello ES, Pinheiro RS, Marques G, Coelho FF, Kruger JA, Perini MV, Herman P. Intrahepatic lymphatic invasion but not vascular invasion is a major prognostic factor after resection of colorectal cancer liver metastases. World J Surg. 2014;38:2089-2096. [PMID: 24663482 DOI: 10.1007/s00268-014-2511-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
275 Park SJ, Ahn TS, Cho SW, Kim CJ, Jung DJ, Son MW, Bae SH, Shin EJ, Lee MS, Kim CH, Baek MJ. Stromal-cell-derived Factor 1-α Promotes Tumor Progression in Colorectal Cancer. J Korean Soc Coloproctol 2012;28:27-34. [PMID: 22413079 DOI: 10.3393/jksc.2012.28.1.27] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
276 Sperling J, Ziemann C, Gittler A, Benz-Weißer A, Menger MD, Kollmar O. Hepatic arterial infusion of temsirolimus inhibits tumor growth of colorectal rat liver metastases even after a growth stimulating procedure like liver resection. J Surg Res 2013;185:587-94. [PMID: 23845871 DOI: 10.1016/j.jss.2013.06.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
277 Pilgrim CHC, Thomson BN, Banting S, Phillips WA, Michael M. The developing clinical problem of chemotherapy-induced hepatic injury: Chemotherapy-induced hepatic injury. ANZ Journal of Surgery 2012;82:23-9. [DOI: 10.1111/j.1445-2197.2011.05789.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
278 Brouquet A, Andreou A, Vauthey JN. The management of solitary colorectal liver metastases. Surgeon 2011;9:265-72. [PMID: 21843821 DOI: 10.1016/j.surge.2010.12.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
279 King AJ, Breen DJ. Understanding the current status of image-guided ablation for metastatic colorectal disease. Abdom Imaging 2013;38:1234-44. [PMID: 23764908 DOI: 10.1007/s00261-013-0020-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
280 McKay A, Fradette K, Lipschitz J. Long-term outcomes following hepatic resection and radiofrequency ablation of colorectal liver metastases. HPB Surg 2009;2009:346863. [PMID: 20148084 DOI: 10.1155/2009/346863] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
281 Sandhu L, Fox A, Nhan C, Barnett H, McLeod RS, Gallinger S, Moulton CA. Assessing the management of hepatic colorectal cancer metastases: is treatment consistent in Ontario? HPB (Oxford) 2012;14:409-13. [PMID: 22568418 DOI: 10.1111/j.1477-2574.2012.00467.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
282 Kouri BE, Funaki BS, Ray CE, Abou-Alfa GK, Burke CT, Darcy MD, Fidelman N, Greene FL, Harrison SA, Kinney TB. ACR Appropriateness Criteria radiologic management of hepatic malignancy. J Am Coll Radiol. 2012;9:919-925. [PMID: 23206650 DOI: 10.1016/j.jacr.2012.09.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
283 de Baere T, Deschamps F, Briggs P, Dromain C, Boige V, Hechelhammer L, Abdel-rehim M, Aupérin A, Goere D, Elias D. Hepatic Malignancies: Percutaneous Radiofrequency Ablation during Percutaneous Portal or Hepatic Vein Occlusion. Radiology 2008;248:1056-66. [DOI: 10.1148/radiol.2483070222] [Cited by in Crossref: 46] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
284 Poston GJ, Figueras J, Giuliante F, Nuzzo G, Sobrero AF, Gigot JF, Nordlinger B, Adam R, Gruenberger T, Choti MA, Bilchik AJ, Van Cutsem EJ, Chiang JM, D'Angelica MI. Urgent need for a new staging system in advanced colorectal cancer. J Clin Oncol. 2008;26:4828-4833. [PMID: 18711170 DOI: 10.1200/jco.2008.17.6453] [Cited by in Crossref: 102] [Cited by in F6Publishing: 46] [Article Influence: 7.3] [Reference Citation Analysis]
285 Larssen L, Medhus AW, Korner H, Glomsaker T, Soberg T, Gleditsch D, Hovde O, Tholfsen JK, Skreden K, Nesbakken A. Long-term outcome of palliative treatment with self-expanding metal stents for malignant obstructions of the GI tract. Scand J Gastroenterol. 2012;47:1505-1514. [PMID: 23046494 DOI: 10.3109/00365521.2012.711854] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
286 Hodgson R, Sethi H, Ling AH, Lodge P. Combined hepatectomy and hepatic pedicle lymphadenectomy in colorectal liver metastases is justified. HPB (Oxford) 2017;19:525-9. [PMID: 28215513 DOI: 10.1016/j.hpb.2017.01.025] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
287 Torzilli G, Del Fabbro D, Palmisano A, Marconi M, Makuuchi M, Montorsi M. Salvage hepatic resection after incomplete interstitial therapy for primary and secondary liver tumours. Br J Surg. 2007;94:208-213. [PMID: 17149716 DOI: 10.1002/bjs.5603] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
288 Lang SA, Loss M, Benseler V, Glockzin G, Schlitt HJ. Long-term results after in-situ split (ISS) liver resection. Langenbecks Arch Surg 2015;400:361-9. [PMID: 25854503 DOI: 10.1007/s00423-015-1285-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
289 Okuno M, Goumard C, Kopetz S, Vega EA, Joechle K, Mizuno T, Omichi K, Tzeng CD, Chun YS, Vauthey J, Conrad C. RAS Mutation is Associated with Unsalvageable Recurrence Following Hepatectomy for Colorectal Cancer Liver Metastases. Ann Surg Oncol 2018;25:2457-66. [DOI: 10.1245/s10434-018-6517-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
290 Hasselgren K, Sandström P, Björnsson B. Role of associating liver partition and portal vein ligation for staged hepatectomy in colorectal liver metastases: A review. World J Gastroenterol 2015; 21(15): 4491-4498 [PMID: 25914457 DOI: 10.3748/wjg.v21.i15.4491] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
291 Battula N, Tsapralis D, Mayer D, Isaac J, Muiesan P, Sutcliffe RP, Bramhall S, Mirza D, Marudanayagam R. Repeat liver resection for recurrent colorectal metastases: a single-centre, 13-year experience. HPB (Oxford). 2014;16:157-163. [PMID: 23530978 DOI: 10.1111/hpb.12096] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
292 Ohkura Y, Shinohara H, Haruta S, Ueno M, Hashimoto M, Sakai Y, Udagawa H. Hepatectomy Offers Superior Survival Compared with Non-surgical Treatment for ≤ 3 Metastatic Tumors with Diameters < 3 cm from Gastric Cancer: A Retrospective Study. World J Surg 2015;39:2757-63. [PMID: 26148522 DOI: 10.1007/s00268-015-3151-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
293 Abdalla EK, Vauthey JN. Focus on treatment of large hepatocellular carcinoma. Ann Surg Oncol 2004;11:1035-6. [PMID: 15576831 DOI: 10.1245/ASO.2004.10.906] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
294 Reddy G, Dreher MR, Rossmann C, Wood BJ, Haemmerich D. Cytotoxicity of hepatocellular carcinoma cells to hyperthermic and ablative temperature exposures: in vitro studies and mathematical modelling. Int J Hyperthermia 2013;29:318-23. [PMID: 23738699 DOI: 10.3109/02656736.2013.792125] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
295 Rupertus K, Sperling J, Corsten M, Scheuer C, Nickels RM, Schilling MK, Menger MD, Kollmar O. Darbepoetin-α Enhances Hepatectomy-Associated Stimulation of Colorectal Liver Metastatic Growth. Annals of Surgery 2010;252:131-41. [DOI: 10.1097/sla.0b013e3181e33915] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
296 Guye ML, Schoellhammer HF, Chiu LW, Kim J, Lai LL, Singh G. Designing liver resections and pushing the envelope with resections for hepatic colorectal metastases. Indian J Surg Oncol 2013;4:349-55. [PMID: 24426756 DOI: 10.1007/s13193-013-0256-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
297 Liu YW, Lu CC, Chang CD, Lee KC, Chen HH, Yeh WS, Hu WH, Tsai KL, Yeh CH, Wee SY, Yin SM, Wang CC, Hung CH. Prognostic value of sarcopenia in patients with colorectal liver metastases undergoing hepatic resection. Sci Rep 2020;10:6459. [PMID: 32296122 DOI: 10.1038/s41598-020-63644-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
298 Liu F, Wang X, Liu H, Wang Y, Liu X, Hao X, Li H. LncRNA BX357664 inhibits cell proliferation and invasion and promotes cell apoptosis in human colorectal cancer cells. Oncol Lett 2018;15:8237-44. [PMID: 29844809 DOI: 10.3892/ol.2018.8435] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
299 Einama T, Abe H, Shichi S, Matsui H, Kanazawa R, Shibuya K, Suzuki T, Matsuzawa F, Hashimoto T, Kohei N, Homma S, Kawamura H, Taketomi A. Long-term survival and prognosis associated with conversion surgery in patients with metastatic gastric cancer. Mol Clin Oncol 2017;6:163-6. [PMID: 28357085 DOI: 10.3892/mco.2017.1128] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
300 Gruenberger T, Gruenberger B, Becherer A, Kettenbach J, Dieckmann K, Schima W. Interdisciplinary management of colorectal cancer liver metastases. Eur Surg 2006;38:107-11. [DOI: 10.1007/s10353-006-0229-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
301 Lupinacci RM, Mello ES, Coelho FF, Kruger JA, Perini MV, Pinheiro RS, Fonseca GM, Cecconello I, Herman P. Prognostic implication of mucinous histology in resected colorectal cancer liver metastases. Surgery. 2014;155:1062-1068. [PMID: 24856126 DOI: 10.1016/j.surg.2014.01.011] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
302 Gavriilidis P, Roberts KJ, de'Angelis N, Aldrighetti L, Sutcliffe RP. Recurrence and survival following microwave, radiofrequency ablation, and hepatic resection of colorectal liver metastases: A systematic review and network meta-analysis. Hepatobiliary Pancreat Dis Int 2021;20:307-14. [PMID: 34127382 DOI: 10.1016/j.hbpd.2021.05.004] [Reference Citation Analysis]
303 Kianmanesh R, O'Toole D, Sauvanet A, Ruszniewski P, Belghiti J. [Surgical treatment of gastric, enteric pancreatic endocrine tumors. Part 2. treatment of hepatic metastases]. J Chir (Paris). 2005;142:208-219. [PMID: 16335893 DOI: 10.1016/s0021-7697(05)80906-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
304 Ganapathi S, Roberts G, Mogford S, Bahlmann B, Ateleanu B, Kumar N. Epidural analgesia provides effective pain relief in patients undergoing open liver surgery. Br J Pain. 2015;9:78-85. [PMID: 26516562 DOI: 10.1177/2049463714525140] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
305 Maithel SK, Ginsberg MS, D’Amico F, DeMatteo RP, Allen PJ, Fong Y, Blumgart LH, Jarnagin WR, D’Angelica MI. Natural history of patients with subcentimeter pulmonary nodules undergoing hepatic resection for metastatic colorectal cancer. J Am Coll Surg. 2010;210:31-38. [PMID: 20123329 DOI: 10.1016/j.jamcollsurg.2009.09.032] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 3.3] [Reference Citation Analysis]
306 Schiffman SC, Bower M, Brown RE, Martin RC, McMasters KM, Scoggins CR. Hepatectomy is superior to thermal ablation for patients with a solitary colorectal liver metastasis. J Gastrointest Surg. 2010;14:1881-1886; discussion 1886-1887. [PMID: 20859701 DOI: 10.1007/s11605-010-1339-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
307 Shimada H, Tanaka K, Endou I, Ichikawa Y. Treatment for colorectal liver metastases: a review. Langenbecks Arch Surg. 2009;394:973-983. [PMID: 19582473 DOI: 10.1007/s00423-009-0530-8] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 3.1] [Reference Citation Analysis]
308 Sugarbaker PH. Colorectal Cancer Metastases. Surgical Oncology Clinics of North America 2013;22:289-98. [DOI: 10.1016/j.soc.2012.12.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
309 Wicherts D, de Haas R, Adam R. Bringing unresectable liver disease to resection with curative intent. European Journal of Surgical Oncology (EJSO) 2007;33:S42-51. [DOI: 10.1016/j.ejso.2007.09.017] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 3.1] [Reference Citation Analysis]
310 Carpizo DR, Are C, Jarnagin W, Dematteo R, Fong Y, Gönen M, Blumgart L, D’angelica M. Liver Resection for Metastatic Colorectal Cancer in Patients with Concurrent Extrahepatic Disease: Results in 127 Patients Treated at a Single Center. Ann Surg Oncol 2009;16:2138-46. [DOI: 10.1245/s10434-009-0521-6] [Cited by in Crossref: 106] [Cited by in F6Publishing: 75] [Article Influence: 8.2] [Reference Citation Analysis]
311 Szymanski D, Durczynski A, Strzelczyk J. Two-staged surgery for metastatic liver tumor in morbidly obese individual-left hemihepatectomy following placement of laparoscopic adjustable gastric band. Obes Surg 2011;21:267-71. [PMID: 20180038 DOI: 10.1007/s11695-010-0097-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
312 Rong Z, Martel G, Vandenbroucke-Menu F, Adam R, Lapointe R. Impact of peri-operative bevacizumab on survival in patients with resected colorectal liver metastases: an analysis of the LiverMetSurvey. HPB (Oxford) 2014;16:342-9. [PMID: 24641317 DOI: 10.1111/hpb.12138] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
313 Mcloughlin JM, Jensen EH, Malafa M. Resection of Colorectal Liver Metastases: Current Perspectives. Cancer Control 2017;13:32-41. [DOI: 10.1177/107327480601300105] [Cited by in Crossref: 56] [Cited by in F6Publishing: 49] [Article Influence: 11.2] [Reference Citation Analysis]
314 Kuo IM, Huang SF, Chiang JM, Yeh CY, Chan KM, Chen JS, Yu MC. Clinical features and prognosis in hepatectomy for colorectal cancer with centrally located liver metastasis. World J Surg Oncol. 2015;13:92. [PMID: 25889950 DOI: 10.1186/s12957-015-0497-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
315 Han Y, Yan D, Xu F, Li X, Cai JQ. Radiofrequency Ablation versus Liver Resection for Colorectal Cancer Liver Metastasis: An Updated Systematic Review and Meta-analysis. Chin Med J (Engl) 2016;129:2983-90. [PMID: 27958231 DOI: 10.4103/0366-6999.195470] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
316 Chow AK, Cheng NS, Lam CS, Ng L, Wong SK, Wan TM, Man JH, Cheung AH, Yau TC, Poon JT, Law WL, Pang RW. Preclinical analysis of the anti-tumor and anti-metastatic effects of Raf265 on colon cancer cells and CD26(+) cancer stem cells in colorectal carcinoma. Mol Cancer. 2015;14:80. [PMID: 25884645 DOI: 10.1186/s12943-015-0352-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
317 Page AJ, Cosgrove DC, Herman JM, Pawlik TM. Advances in understanding of colorectal liver metastasis and implications for the clinic. Expert Review of Gastroenterology & Hepatology 2014;9:245-59. [DOI: 10.1586/17474124.2014.940897] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
318 van Duijnhoven FH, Jansen MC, Junggeburt JM, van Hillegersberg R, Rijken AM, van Coevorden F, van der Sijp JR, van Gulik TM, Slooter GD, Klaase JM. Factors influencing the local failure rate of radiofrequency ablation of colorectal liver metastases. Ann Surg Oncol. 2006;13:651-658. [PMID: 16538411 DOI: 10.1245/aso.2006.08.014] [Cited by in Crossref: 91] [Cited by in F6Publishing: 32] [Article Influence: 5.7] [Reference Citation Analysis]
319 Adair RA, Young AL, Cockbain AJ, Malde D, Prasad KR, Lodge JP, Toogood GJ. Repeat hepatic resection for colorectal liver metastases. Br J Surg. 2012;99:1278-1283. [PMID: 22864889 DOI: 10.1002/bjs.8845] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
320 Prasanna T, Wong R, Price T, Shapiro J, Tie J, Wong HL, Nott L, Roder D, Lee M, Kosmider S, Jalali A, Burge M, Padbury R, Maddern G, Carruthers S, Moore J, Sorich M, Karapetis CS, Gibbs P, Yip D. Metastasectomy and BRAF mutation; an analysis of survival outcome in metastatic colorectal cancer. Curr Probl Cancer 2021;45:100637. [PMID: 32826083 DOI: 10.1016/j.currproblcancer.2020.100637] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
321 Yamashita S, Sheth RA, Niekamp AS, Aloia TA, Chun YS, Lee JE, Vauthey JN, Conrad C. Comprehensive Complication Index Predicts Cancer-specific Survival After Resection of Colorectal Metastases Independent of RAS Mutational Status. Ann Surg. 2017;266:1045-1054. [PMID: 27735824 DOI: 10.1097/sla.0000000000002018] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 4.4] [Reference Citation Analysis]
322 Liu G, Zhu J, Yu M, Cai C, Zhou Y, Yu M, Fu Z, Gong Y, Yang B, Li Y, Zhou Q, Lin Q, Ye H, Ye L, Zhao X, Li Z, Chen R, Han F, Tang C, Zeng B. Glutamate dehydrogenase is a novel prognostic marker and predicts metastases in colorectal cancer patients. J Transl Med 2015;13:144. [PMID: 25947346 DOI: 10.1186/s12967-015-0500-6] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 5.9] [Reference Citation Analysis]
323 Ward MA, Gayet B, Tabchouri N, Moisan F, Donatelli G, Stättner S, Fuks D. Technical advances and future perspectives in liver surgery. Eur Surg 2018;50:137-41. [DOI: 10.1007/s10353-018-0530-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
324 Schoellhammer HF, Goldner B, Merchant SJ, Kessler J, Fong Y, Gagandeep S. Colorectal liver metastases: making the unresectable resectable using irreversible electroporation for microscopic positive margins - a case report. BMC Cancer 2015;15:271. [PMID: 25886376 DOI: 10.1186/s12885-015-1279-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
325 Lam VWT, Pang T, Laurence JM, Johnston E, Hollands MJ, Pleass HCC, Richardson AJ. A Systematic Review of Repeat Hepatectomy for Recurrent Colorectal Liver Metastases. J Gastrointest Surg 2013;17:1312-21. [DOI: 10.1007/s11605-013-2186-5] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 3.8] [Reference Citation Analysis]
326 Neeff HP, Drognitz O, Klock A, Illerhaus G, Opitz OG, Hopt UT, Makowiec F. Impact of preoperative targeted therapy on postoperative complications after resection of colorectal liver metastases. Int J Colorectal Dis. 2012;27:635-645. [PMID: 22139030 DOI: 10.1007/s00384-011-1360-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
327 Vaughan A, Dietz JR, Moley JF, Debenedetti MK, Aft RL, Gillanders WE, Eberlein TJ, Ritter J, Margenthaler JA. Metastatic disease to the breast: the Washington University experience. World J Surg Oncol 2007;5:74. [PMID: 17615059 DOI: 10.1186/1477-7819-5-74] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
328 She WH, Chan ACY, Ma KW, Dai WC, Chok KSH, Cheung TT, Lo CM. Anterior Approach to Major Resection for Colorectal Liver Metastasis. J Gastrointest Surg 2018;22:1928-38. [PMID: 29959643 DOI: 10.1007/s11605-018-3840-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
329 Krasnick BA, Sindram D, Simo K, Goss R, Bharadwaj J, Howk K, Herdina KA, Hammill CW. Tumor Ablation Using 3-Dimensional Electromagnetic-Guided Ultrasound Versus Standard Ultrasound in a Porcine Model. Surg Innov 2019;26:420-6. [DOI: 10.1177/1553350619825717] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
330 Reinacher-Schick AC, Bechstein WO. [Colorectal liver metastases. Neoadjuvant chemotherapy: aspects of medical and surgical oncology]. Internist (Berl) 2007;48:51-8. [PMID: 17160665 DOI: 10.1007/s00108-006-1770-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
331 Hammill CW, Billingsley KG, Cassera MA, Wolf RF, Ujiki MB, Hansen PD. Outcome after laparoscopic radiofrequency ablation of technically resectable colorectal liver metastases. Ann Surg Oncol. 2011;18:1947-1954. [PMID: 21399885 DOI: 10.1245/s10434-010-1535-9] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 4.7] [Reference Citation Analysis]
332 Hattori N, Kanemitsu Y, Komori K, Shimizu Y, Sano T, Senda Y, Mitsudomi T, Fukui T. Outcomes after hepatic and pulmonary metastasectomies compared with pulmonary metastasectomy alone in patients with colorectal cancer metastasis to liver and lungs. World J Surg 2013;37:1315-21. [PMID: 23435701 DOI: 10.1007/s00268-013-1954-4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
333 Yoon HM, Kim JH, Shin YM, Won HJ, Kim PN. Percutaneous radiofrequency ablation using internally cooled wet electrodes for treatment of colorectal liver metastases. Clin Radiol. 2012;67:122-127. [PMID: 21906730 DOI: 10.1016/j.crad.2011.08.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
334 Kato H, Ono H, Hamamoto Y, Ishikawa H. Interaction between Medical Treatment and Minimally Invasive Surgical Treatment for the Malignancies of the Digestive Tract. Digestion 2018;97:13-9. [PMID: 29393164 DOI: 10.1159/000484033] [Reference Citation Analysis]
335 Di Martino M, Rompianesi G, Mora-Guzmán I, Martín-Pérez E, Montalti R, Troisi RI. Systematic review and meta-analysis of local ablative therapies for resectable colorectal liver metastases. Eur J Surg Oncol 2020;46:772-81. [PMID: 31862133 DOI: 10.1016/j.ejso.2019.12.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
336 Hao W, Binbin J, Wei Y, Kun Y. Can Radiofrequency Ablation Replace Liver Resection for Solitary Colorectal Liver Metastasis? A Systemic Review and Meta-Analysis. Front Oncol 2020;10:561669. [PMID: 33312946 DOI: 10.3389/fonc.2020.561669] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
337 Kelly M, Spolverato G, Lê G, Mavros M, Doyle F, Pawlik T, Winter D. Synchronous colorectal liver metastasis: A network meta-analysis review comparing classical, combined, and liver-first surgical strategies: Synchronous Colorectal Liver Metastasis. J Surg Oncol 2015;111:341-51. [DOI: 10.1002/jso.23819] [Cited by in Crossref: 88] [Cited by in F6Publishing: 62] [Article Influence: 11.0] [Reference Citation Analysis]
338 Andreou A, Aloia TA, Brouquet A, Dickson PV, Zimmitti G, Maru DM, Kopetz S, Loyer EM, Curley SA, Abdalla EK, Vauthey JN. Margin status remains an important determinant of survival after surgical resection of colorectal liver metastases in the era of modern chemotherapy. Ann Surg 2013;257:1079-88. [PMID: 23426338 DOI: 10.1097/SLA.0b013e318283a4d1] [Cited by in Crossref: 125] [Cited by in F6Publishing: 56] [Article Influence: 13.9] [Reference Citation Analysis]
339 Abdalla EK. Portal vein embolization (prior to major hepatectomy) effects on regeneration, resectability, and outcome. J Surg Oncol. 2010;102:960-967. [PMID: 21165999 DOI: 10.1002/jso.21654] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 5.2] [Reference Citation Analysis]
340 Van der Bilt JD, Soeters ME, Duyverman AM, Nijkamp MW, Witteveen PO, van Diest PJ, Kranenburg O, Borel Rinkes IH. Perinecrotic hypoxia contributes to ischemia/reperfusion-accelerated outgrowth of colorectal micrometastases. Am J Pathol. 2007;170:1379-1388. [PMID: 17392176 DOI: 10.2353/ajpath.2007.061028] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 2.5] [Reference Citation Analysis]
341 Ng KK, Poon RT. Role of radiofrequency ablation for liver malignancies. Surgical Practice 2005;9:94-103. [DOI: 10.1111/j.1744-1633.2005.00265.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
342 Viganò L, Russolillo N, Ferrero A, Langella S, Sperti E, Capussotti L. Evolution of long-term outcome of liver resection for colorectal metastases: analysis of actual 5-year survival rates over two decades. Ann Surg Oncol. 2012;19:2035-2044. [PMID: 22219066 DOI: 10.1245/s10434-011-2186-1] [Cited by in Crossref: 78] [Cited by in F6Publishing: 73] [Article Influence: 7.8] [Reference Citation Analysis]
343 Mulier S, Ni Y, Jamart J, Ruers T, Marchal G, Michel L. Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg. 2005;242:158-171. [PMID: 16041205 DOI: 10.1097/01.sla.0000171032.99149.fe] [Cited by in Crossref: 503] [Cited by in F6Publishing: 448] [Article Influence: 29.6] [Reference Citation Analysis]
344 Makishima H, Yasuda S, Isozaki Y, Kasuya G, Okada N, Miyazaki M, Mohamad O, Matsufuji N, Yamada S, Tsuji H, Kamada T; Liver Cancer Working Group. Single fraction carbon ion radiotherapy for colorectal cancer liver metastasis: A dose escalation study. Cancer Sci 2019;110:303-9. [PMID: 30417485 DOI: 10.1111/cas.13872] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
345 Tsikitis VL, Malireddy K, Green EA, Christensen B, Whelan R, Hyder J, Marcello P, Larach S, Lauter D, Sargent DJ, Nelson H. Postoperative surveillance recommendations for early stage colon cancer based on results from the clinical outcomes of surgical therapy trial. J Clin Oncol. 2009;27:3671-3676. [PMID: 19564531 DOI: 10.1200/jco.2008.20.7050] [Cited by in Crossref: 75] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
346 Miyake H, Murono K, Kawai K, Nozawa H, Maki H, Hasegawa K, Nakajima J, Ishihara S. Impact of Surgical Resection on Metachronous Metastases of Colorectal Cancer According to Tumor Doubling Time. In Vivo 2020;34:3367-74. [PMID: 33144444 DOI: 10.21873/invivo.12175] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
347 de Geus-Oei LF, Ruers TJ, Punt CJ, Leer JW, Corstens FH, Oyen WJ. FDG-PET in colorectal cancer. Cancer Imaging 2006;6:S71-81. [PMID: 17114081 DOI: 10.1102/1470-7330.2006.9014] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
348 Sharma S, Camci C, Jabbour N. Management of hepatic metastasis from colorectal cancers: an update. J Hepatobiliary Pancreat Surg 2008;15:570-80. [PMID: 18987925 DOI: 10.1007/s00534-008-1350-x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 3.9] [Reference Citation Analysis]
349 Torzilli G, Viganò L, Cimino M, Imai K, Vibert E, Donadon M, Mansour D, Castaing D, Adam R. Is Enhanced One-Stage Hepatectomy a Safe and Feasible Alternative to the Two-Stage Hepatectomy in the Setting of Multiple Bilobar Colorectal Liver Metastases? A Comparative Analysis between Two Pioneering Centers. Dig Surg 2018;35:323-32. [PMID: 29439275 DOI: 10.1159/000486210] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 5.8] [Reference Citation Analysis]
350 Pawlik TM, Schulick RD, Choti MA. Expanding criteria for resectability of colorectal liver metastases. Oncologist. 2008;13:51-64. [PMID: 18245012 DOI: 10.1634/theoncologist.2007-0142] [Cited by in Crossref: 290] [Cited by in F6Publishing: 263] [Article Influence: 20.7] [Reference Citation Analysis]
351 Nierkens S, den Brok MH, Ruers TJ, Adema GJ. Radiofrequency Ablation in Cancer Therapy: Tuning in to in situ Tumor Vaccines. In: Keisari Y, editor. Tumor Ablation. Dordrecht: Springer Netherlands; 2013. pp. 39-59. [DOI: 10.1007/978-94-007-4694-7_3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
352 Akiyama T, Miyamoto Y, Imai K, Yamashita Y, Nomoto D, Daitoku N, Sakamoto Y, Kiyozumi Y, Tokunaga R, Eto K, Harada K, Hiyoshi Y, Iwatsuki M, Nagai Y, Iwagami S, Baba Y, Yoshida N, Baba H. Fibrosis-4 Index, a Noninvasive Fibrosis Marker, Predicts Survival Outcomes After Hepatectomy for Colorectal Cancer Liver Metastases. Ann Surg Oncol 2020;27:3534-41. [PMID: 32648180 DOI: 10.1245/s10434-020-08828-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
353 Huddy JR, Thomas RL, Worthington TR, Karanjia ND. Liver metastases from esophageal carcinoma: is there a role for surgical resection? Dis Esophagus. 2015;28:483-487. [PMID: 24898890 DOI: 10.1111/dote.12233] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.5] [Reference Citation Analysis]
354 Dijkstra M, Nieuwenhuizen S, Puijk RS, Timmer FEF, Geboers B, Schouten EAC, Opperman J, Scheffer HJ, Vries JJJ, Swijnenburg RJ, Versteeg KS, Lissenberg-Witte BI, van den Tol MP, Meijerink MR. Thermal Ablation Compared to Partial Hepatectomy for Recurrent Colorectal Liver Metastases: An Amsterdam Colorectal Liver Met Registry (AmCORE) Based Study. Cancers (Basel) 2021;13:2769. [PMID: 34199556 DOI: 10.3390/cancers13112769] [Reference Citation Analysis]
355 Suppiah A, White T, Roy-choudhury S, Breen D, Cast J, Maraveyas A, Hartley J, Monson J. Long-Term Results of Percutaneous Radiofrequency Ablation of Unresectable Colorectal Hepatic Metastases: Final Outcomes. Dig Surg 2007;24:358-60. [DOI: 10.1159/000107717] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
356 Ruers TJ, Joosten JJ, Wiering B, Langenhoff BS, Dekker HM, Wobbes T, Oyen WJ, Krabbe PF, Punt CJ. Comparison between local ablative therapy and chemotherapy for non-resectable colorectal liver metastases: a prospective study. Ann Surg Oncol. 2007;14:1161-1169. [PMID: 17195903 DOI: 10.1245/s10434-006-9312-5] [Cited by in Crossref: 42] [Cited by in F6Publishing: 31] [Article Influence: 2.6] [Reference Citation Analysis]
357 Law WL, Fan JK, Poon JT, Choi H, Lo OS. Laparoscopic bowel resection in the setting of metastatic colorectal cancer. Ann Surg Oncol. 2008;15:1424-1428. [PMID: 18253800 DOI: 10.1245/s10434-008-9820-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
358 She WH, Chan ACY, Poon RTP, Cheung TT, Chok KSH, Chan SC, Lo CM. Defining an optimal surgical strategy for synchronous colorectal liver metastases: staged versus simultaneous resection?: Staged or simultaneous resection for colorectal liver metastases? ANZ J Surg 2015;85:829-33. [DOI: 10.1111/ans.12739] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
359 Takeda A, Kunieda E, Ohashi T, Aoki Y, Koike N, Takeda T. Stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer and other primary cancers in comparison with primary lung cancer. Radiother Oncol. 2011;101:255-259. [PMID: 21641064 DOI: 10.1016/j.radonc.2011.05.033] [Cited by in Crossref: 101] [Cited by in F6Publishing: 107] [Article Influence: 10.1] [Reference Citation Analysis]
360 Bu ZD, Ji JF. Explanations of the NCCN clinical practice guidelines 2008 on colon cancer. Shijie Huaren Xiaohua Zazhi 2009; 17(4): 343-346 [DOI: 10.11569/wcjd.v17.i4.343] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
361 Hino H, Kagawa H, Kinugasa Y, Shiomi A, Yamaguchi T, Yamakawa Y, Numata M, Sugiura T, Uesaka K. Long-term survival with surgery for metachronous retroperitoneal lymph node and pancreatic metastases after curative resection of rectal cancer: a case report. Surg Case Rep 2016;2:49. [PMID: 27225417 DOI: 10.1186/s40792-016-0177-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
362 John SK, Robinson SM, Rehman S, Harrison B, Vallance A, French JJ, Jaques BC, Charnley RM, Manas DM, White SA. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study. Dig Surg. 2013;30:293-301. [PMID: 23969407 DOI: 10.1159/000354310] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 4.4] [Reference Citation Analysis]
363 Chirica M, Leconte M, Oberlin O, Dousset B. [Surgical treatment of liver metastasis in patients with colorectal cancer]. Presse Med 2012;41:58-67. [PMID: 22138292 DOI: 10.1016/j.lpm.2011.10.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
364 Donadon M, Botea F, Belliappa V, Montorsi M, Torzilli G. Experience With More Than 500 Minimally Invasive Hepatic Procedures: A Serious Note Of Caution. Annals of Surgery 2009;249:1064-5. [DOI: 10.1097/sla.0b013e3181a8836c] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
365 Kocman B, Mikulić D, Jadrijevic S, Poljak M, Kocman I, Gašparov S, Kanižaj TF, Cvrlje VČ. Long-Term Survival After Living-Donor Liver Transplantation for Unresectable Colorectal Metastases to the Liver: Case Report. Transplantation Proceedings 2011;43:4013-5. [DOI: 10.1016/j.transproceed.2011.09.065] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
366 Abdel-Misih SR, Schmidt CR, Bloomston PM. Update and review of the multidisciplinary management of stage IV colorectal cancer with liver metastases. World J Surg Oncol 2009;7:72. [PMID: 19788748 DOI: 10.1186/1477-7819-7-72] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
367 Spelt L, Hermansson L, Tingstedt B, Andersson R. Influence of preoperative chemotherapy on the intraoperative and postoperative course of liver resection for colorectal cancer metastases. World J Surg. 2012;36:157-163. [PMID: 22086255 DOI: 10.1007/s00268-011-1342-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
368 Mathai VK, Aung SY, Wong V, Dunn C, Shapiro J, Jalali A, Wong R, Lee M, Tie J, Ananda S, Kosmider S, Lim SH, Caird S, Burge M, Dean A, Gibbs P, Nott L. Treatment and Outcomes of Oligometastatic Colorectal Cancer Limited to Lymph Node Metastases. Clin Colorectal Cancer 2021:S1533-0028(21)00063-3. [PMID: 34289941 DOI: 10.1016/j.clcc.2021.06.003] [Reference Citation Analysis]
369 Antoniou A, Lovegrove RE, Tilney HS, Heriot AG, John TG, Rees M, Tekkis PP, Welsh FK. Meta-analysis of clinical outcome after first and second liver resection for colorectal metastases. Surgery. 2007;141:9-18. [PMID: 17188163 DOI: 10.1016/j.surg.2006.07.045] [Cited by in Crossref: 65] [Cited by in F6Publishing: 54] [Article Influence: 4.1] [Reference Citation Analysis]
370 de Cuba EMV, Kwakman R, van Egmond M, Bosch LJW, Bonjer HJ, Meijer GA, te Velde EA. Understanding molecular mechanisms in peritoneal dissemination of colorectal cancer: Future possibilities for personalised treatment by use of biomarkers. Virchows Arch 2012;461:231-43. [DOI: 10.1007/s00428-012-1287-y] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 3.9] [Reference Citation Analysis]
371 Scheffer HJ, Vroomen LG, Nielsen K, van Tilborg AA, Comans EF, van Kuijk C, van der Meijs BB, van den Bergh J, van den Tol PM, Meijerink MR. Colorectal liver metastatic disease: efficacy of irreversible electroporation--a single-arm phase II clinical trial (COLDFIRE-2 trial). BMC Cancer 2015;15:772. [PMID: 26497813 DOI: 10.1186/s12885-015-1736-5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
372 Nishioka Y, Kawaguchi Y, Kothari AN, Odisio BC, Vauthey JN. Prognostic and Therapeutic Implications of Tumor Biology, Including Gene Alterations, in Colorectal Liver Metastases. J Gastrointest Surg 2021;25:1591-600. [PMID: 33742360 DOI: 10.1007/s11605-021-04962-x] [Reference Citation Analysis]
373 Kianmanesh R, Scaringi S, Sabate JM, Castel B, Pons-Kerjean N, Coffin B, Hay JM, Flamant Y, Msika S. Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis of colorectal origin with or without liver metastases. Ann Surg. 2007;245:597-603. [PMID: 17414609 DOI: 10.1097/01.sla.0000255561.87771.11] [Cited by in Crossref: 120] [Cited by in F6Publishing: 112] [Article Influence: 8.0] [Reference Citation Analysis]
374 Stang A, Fischbach R, Teichmann W, Bokemeyer C, Braumann D. A systematic review on the clinical benefit and role of radiofrequency ablation as treatment of colorectal liver metastases. Eur J Cancer. 2009;45:1748-1756. [PMID: 19356924 DOI: 10.1016/j.ejca.2009.03.012] [Cited by in Crossref: 100] [Cited by in F6Publishing: 84] [Article Influence: 7.7] [Reference Citation Analysis]
375 Valadão M. Abordagem reversa: novo paradigma no tratamento da metástase hepática sincrônica de câncer colorretal. Rev Col Bras Cir 2010;37:314-5. [DOI: 10.1590/s0100-69912010000500001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
376 Spangenberg HC, Mohr L, Blum HE. [Regional therapy of liver tumors]. Internist (Berl). 2007;48:40-45. [PMID: 17160664 DOI: 10.1007/s00108-006-1771-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
377 Mueller GR, Wolf RF, Hansen PD, Gregory KW, Prahl SA. Hemostasis after liver resection improves after single application of albumin and argon beam coagulation. J Gastrointest Surg 2010;14:1764-9. [PMID: 20607437 DOI: 10.1007/s11605-010-1262-3] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
378 Wu YZ, Li B, Wang T, Wang SJ, Zhou YM. Radiofrequency ablation vs hepatic resection for solitary colorectal liver metastasis: A meta-analysis. World J Gastroenterol 2011; 17(36): 4143-4148 [PMID: 22039331 DOI: 10.3748/wjg.v17.i36.4143] [Cited by in CrossRef: 42] [Cited by in F6Publishing: 40] [Article Influence: 3.8] [Reference Citation Analysis]
379 Witt JS, Rosenberg SA, Bassetti MF. MRI-guided adaptive radiotherapy for liver tumours: visualising the future. Lancet Oncol 2020;21:e74-82. [PMID: 32007208 DOI: 10.1016/S1470-2045(20)30034-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 10.5] [Reference Citation Analysis]
380 Nielsen K, Scheffer HJ, Volders JH, van der Vorst MJ, van Tilborg AA, Comans EF, de Lange-de Klerk ES, Sietses C, Meijer S, Meijerink MR, van den Tol MP. Radiofrequency Ablation to Improve Survival After Conversion Chemotherapy for Colorectal Liver Metastases. World J Surg 2016;40:1951-8. [PMID: 27220509 DOI: 10.1007/s00268-016-3554-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
381 Fischman AM, Ward TJ, Horn JC, Kim E, Patel RS, Nowakowski FS, Lookstein RA. Portal vein embolization before right hepatectomy or extended right hepatectomy using sodium tetradecyl sulfate foam: technique and initial results. J Vasc Interv Radiol 2014;25:1045-53. [PMID: 24657089 DOI: 10.1016/j.jvir.2014.01.034] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
382 Bergenfeldt M, Jensen BV, Skjoldbye B, Nielsen D. Liver resection and local ablation of breast cancer liver metastases--a systematic review. Eur J Surg Oncol. 2011;37:549-557. [PMID: 21605957 DOI: 10.1016/j.ejso.2011.04.013] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 3.4] [Reference Citation Analysis]
383 Gomez D, Sangha VK, Morris-Stiff G, Malik HZ, Guthrie AJ, Toogood GJ, Lodge JP, Prasad KR. Outcomes of intensive surveillance after resection of hepatic colorectal metastases. Br J Surg. 2010;97:1552-1560. [PMID: 20632325 DOI: 10.1002/bjs.7136] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
384 Vauthey JN. Colorectal liver metastases: treat effectively up front and consider the borderline resectable. J Clin Oncol. 2007;25:4524-4525. [PMID: 17925547 DOI: 10.1200/jco.2007.13.1136] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
385 Power DG, Kemeny NE. Role of adjuvant therapy after resection of colorectal cancer liver metastases. J Clin Oncol. 2010;28:2300-2309. [PMID: 20368552 DOI: 10.1200/jco.2009.26.9340] [Cited by in Crossref: 53] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
386 Eisele RM, Neuhaus P, Schumacher G. Radiofrequency Ablation of Liver Tumors Using a Novel Bipolar Device. Journal of Laparoendoscopic & Advanced Surgical Techniques 2008;18:857-63. [DOI: 10.1089/lap.2008.0260] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
387 Kawaguchi Y, De Bellis M, Panettieri E, Duwe G, Vauthey JN. Debate: Improvements in Systemic Therapies for Liver Metastases Will Increase the Role of Locoregional Treatments. Surg Oncol Clin N Am 2021;30:205-18. [PMID: 33220806 DOI: 10.1016/j.soc.2020.08.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
388 Jensen CT, Wagner-Bartak NA, Vu LN, Liu X, Raval B, Martinez D, Wei W, Cheng Y, Samei E, Gupta S. Detection of Colorectal Hepatic Metastases Is Superior at Standard Radiation Dose CT versus Reduced Dose CT. Radiology 2019;290:400-9. [PMID: 30480489 DOI: 10.1148/radiol.2018181657] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 6.5] [Reference Citation Analysis]
389 Araujo RL, Riechelmann RP, Fong Y. Patient selection for the surgical treatment of resectable colorectal liver metastases. J Surg Oncol. 2017;115:213-220. [PMID: 27778357 DOI: 10.1002/jso.24482] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
390 Mohammad WM, Balaa FK. Surgical management of colorectal liver metastases. Clin Colon Rectal Surg. 2009;22:225-232. [PMID: 21037813 DOI: 10.1055/s-0029-1242462.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
391 Hu H, Feng W, Qian X, Yu L, Chen Y, Li Y. Emerging Nanomedicine‐Enabled/Enhanced Nanodynamic Therapies beyond Traditional Photodynamics. Adv Mater 2021;33:2005062. [DOI: 10.1002/adma.202005062] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
392 Fioole B, Jansen MC, van Duijnhoven FH, van Hillegersberg R, van Gulik TM, Borel Rinkes IH. Combining partial liver resection and local ablation of liver tumours: a preliminary Dutch experience. World J Surg Oncol 2006;4:46. [PMID: 16846515 DOI: 10.1186/1477-7819-4-46] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
393 Srouji RM, Narayan RR, Boerner T, Buisman FE, Seier K, Gonen M, Balachandran VP, Drebin JA, Jarnagin WR, Kingham TP, Wei A, Kemeny NE, D'Angelica MI. Extrahepatic recurrence rates in patients receiving adjuvant hepatic artery infusion and systemic chemotherapy after complete resection of colorectal liver metastases. J Surg Oncol 2020;122:1536-42. [PMID: 32976666 DOI: 10.1002/jso.26221] [Reference Citation Analysis]
394 Acciuffi S, Meyer F, Bauschke A, Croner R, Settmacher U, Altendorf-Hofmann A. Solitary colorectal liver metastasis: overview of treatment strategies and role of prognostic factors. J Cancer Res Clin Oncol 2021. [PMID: 34914005 DOI: 10.1007/s00432-021-03880-4] [Reference Citation Analysis]
395 Dieudonné A, Garin E, Laffont S, Rolland Y, Lebtahi R, Leguludec D, Gardin I. Clinical feasibility of fast 3-dimensional dosimetry of the liver for treatment planning of hepatocellular carcinoma with 90Y-microspheres. J Nucl Med 2011;52:1930-7. [PMID: 22068894 DOI: 10.2967/jnumed.111.095232] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 4.5] [Reference Citation Analysis]
396 Wiering B, Ruers TJM, Krabbe PFM, Dekker HM, Oyen WJG. Comparison of Multiphase CT, FDG-PET and Intra-Operative Ultrasound in Patients with Colorectal Liver Metastases Selected for Surgery. Ann Surg Oncol 2007;14:818-26. [DOI: 10.1245/s10434-006-9259-6] [Cited by in Crossref: 53] [Cited by in F6Publishing: 42] [Article Influence: 3.3] [Reference Citation Analysis]
397 Germer CT. [Hepatic metastases: an interdisciplinary therapy approach is desirable]. Chirurg 2010;81:505-6. [PMID: 20502848 DOI: 10.1007/s00104-010-1948-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
398 Kurokohchi K, Watanabe S, Yoneyama H, Deguchi A, Masaki T, Himoto T, Miyoshi H, Mohammad HS, Kitanaka A, Taminato T, Kuriyama S. A combination therapy of ethanol injection and radiofrequency ablation under general anesthesia for the treatment of hepatocellular carcinoma. World J Gastroenterol 2008; 14(13): 2037-2043 [PMID: 18395903 DOI: 10.3748/wjg.14.2037] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
399 Yang PC, Lin BR, Chen YC, Lin YL, Lai HS, Huang KW, Liang JT. Local Control by Radiofrequency Thermal Ablation Increased Overall Survival in Patients With Refractory Liver Metastases of Colorectal Cancer. Medicine (Baltimore) 2016;95:e3338. [PMID: 27057913 DOI: 10.1097/MD.0000000000003338] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
400 Pawlik TM, Gleisner AL, Bauer TW, Adams RB, Reddy SK, Clary BM, Martin RC, Scoggins CR, Tanabe KK, Michaelson JS, Kooby DA, Staley CA, Schulick RD, Vauthey J, Abdalla EK, Curley SA, Choti MA, Elias D. Liver-Directed Surgery for Metastatic Squamous Cell Carcinoma to the Liver: Results of a Multi-Center Analysis. Ann Surg Oncol 2007;14:2807-16. [DOI: 10.1245/s10434-007-9467-8] [Cited by in Crossref: 62] [Cited by in F6Publishing: 40] [Article Influence: 4.1] [Reference Citation Analysis]
401 Kalra N, Kang M, Duseja AK, Bhatia A, Singh V, Dhiman RK, Rajwanshi A, Chawla YK, Khandelwal N. Comparison of radiofrequency ablation alone & in combination with percutaneous ethanol injection for management of hepatocellular carcinoma. Indian J Med Res 2017;146:S30-7. [PMID: 29578192 DOI: 10.4103/ijmr.IJMR_1812_15] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
402 Carpizo DR, D’angelica M. Liver Resection for Metastatic Colorectal Cancer in the Presence of Extrahepatic Disease. Ann Surg Oncol 2009;16:2411-21. [DOI: 10.1245/s10434-009-0493-6] [Cited by in Crossref: 36] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
403 Sirohi B, Shrikhande SV, Perakath B, Raghunandharao D, Julka PK, Lele V, Chaturvedi A, Nandakumar A, Ramadwar M, Bhatia V, Mittal R, Kaur T, Shukla DK, Rath GK. Indian Council of Medical Research consensus document for the management of colorectal cancer. Indian J Med Paediatr Oncol 2014;35:192-6. [PMID: 25336788 DOI: 10.4103/0971-5851.142031] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
404 Nanashima A, Takeshita H, Abo T, Tou K, Tanaka K, Fukuda D, Kunizaki M, Hidaka S, Sawai T. Recent advances and significance of intra-arterial infusion chemotherapy in non-resectable colorectal liver metastasis. J Gastrointest Oncol 2013;4:164-72. [PMID: 23730512 DOI: 10.3978/j.issn.2078-6891.2013.005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
405 Garrean S, Hering J, Saied A, Helton WS, Espat NJ. Radiofrequency ablation of primary and metastatic liver tumors: a critical review of the literature. Am J Surg. 2008;195:508-520. [PMID: 18361927 DOI: 10.1016/j.amjsurg.2007.06.024] [Cited by in Crossref: 92] [Cited by in F6Publishing: 78] [Article Influence: 6.6] [Reference Citation Analysis]
406 Alexander ES, Soulen MC. Liver Metastases From Noncolorectal Malignancies (Neuroendocrine Tumor, Sarcoma, Melanoma, Breast). The Cancer Journal 2016;22:381-6. [DOI: 10.1097/ppo.0000000000000232] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
407 Fahy BN, Jarnagin WR. Evolving techniques in the treatment of liver colorectal metastases: role of laparoscopy, radiofrequency ablation, microwave coagulation, hepatic arterial chemotherapy, indications and contraindications for resection, role of transplantation, and timing of chemotherapy. Surg Clin North Am. 2006;86:1005-1022. [PMID: 16905421 DOI: 10.1016/j.suc.2006.06.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
408 Serrablo A, Paliogiannis P, Pulighe F, Moro SS, Borrego-estella V, Attene F, Scognamillo F, Hörndler C. Impact of novel histopathological factors on the outcomes of liver surgery for colorectal cancer metastases. European Journal of Surgical Oncology (EJSO) 2016;42:1268-77. [DOI: 10.1016/j.ejso.2016.02.013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
409 Zhao L, Wang Q, Zhao SD, Zhou J, Jiang KW, Ye YJ, Wang S, Shen ZL. Genetic mutations associated with sensitivity to neoadjuvant chemotherapy in metastatic colon cancer: A case report and review of literature. World J Clin Cases 2021; 9(24): 7099-7109 [PMID: 34540965 DOI: 10.12998/wjcc.v9.i24.7099] [Reference Citation Analysis]
410 Frich L, Bjørnland K, Pettersen S, Clausen OP, Gladhaug IP. Increased activity of matrix metalloproteinase 2 and 9 after hepatic radiofrequency ablation. J Surg Res. 2006;135:297-304. [PMID: 16934296 DOI: 10.1016/j.jss.2006.05.010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
411 Bliggenstorfer JT, Ofshteyn A, Bingmer K, Ginesi M, Steinhagen E, Stein SL. Predictors of curative-intent oncologic management among patients with stage IV rectal cancer. Am J Surg 2021:S0002-9610(21)00404-9. [PMID: 34311948 DOI: 10.1016/j.amjsurg.2021.07.024] [Reference Citation Analysis]
412 Stättner S, Jones RP, Yip VS, Buchanan K, Poston GJ, Malik HZ, Fenwick SW. Microwave ablation with or without resection for colorectal liver metastases. Eur J Surg Oncol. 2013;39:844-849. [PMID: 23769976 DOI: 10.1016/j.ejso.2013.04.005] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 4.3] [Reference Citation Analysis]
413 Lin WX, Fifis T, Malcontenti-Wilson C, Nikfarjam M, Muralidharan V, Nguyen L, Christophi C. Induction of Th1Immune responses following laser ablation in a murine model of colorectal liver metastases. J Transl Med 2011;9:83. [PMID: 21619693 DOI: 10.1186/1479-5876-9-83] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
414 Orcutt ST, Massarweh NN, Li LT, Artinyan A, Richardson PA, Albo D, Anaya DA. Patterns of Care for Colorectal Liver Metastasis Within an Integrated Health System: Secular Trends and Outcomes. Ann Surg Oncol 2017;24:23-30. [PMID: 27342829 DOI: 10.1245/s10434-016-5351-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
415 Shady W, Petre EN, Vakiani E, Ziv E, Gonen M, Brown KT, Kemeny NE, Solomon SB, Solit DB, Sofocleous CT. Kras mutation is a marker of worse oncologic outcomes after percutaneous radiofrequency ablation of colorectal liver metastases. Oncotarget 2017;8:66117-27. [PMID: 29029497 DOI: 10.18632/oncotarget.19806] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 6.6] [Reference Citation Analysis]
416 Inagaki NF, Inagaki FF, Kokudo N, Miyajima A. Use of mouse liver mesothelial cells to prevent postoperative adhesion and promote liver regeneration after hepatectomy. J Hepatol 2015;62:1141-7. [PMID: 25514558 DOI: 10.1016/j.jhep.2014.12.010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
417 Mizuno T, Cloyd JM, Vicente D, Omichi K, Chun YS, Kopetz SE, Maru D, Conrad C, Tzeng CD, Wei SH, Aloia TA, Vauthey JN. SMAD4 gene mutation predicts poor prognosis in patients undergoing resection for colorectal liver metastases. Eur J Surg Oncol. 2018;44:684-692. [PMID: 29551247 DOI: 10.1016/j.ejso.2018.02.247] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 7.8] [Reference Citation Analysis]
418 Zacharias AJ, Jayakrishnan TT, Rajeev R, Rilling WS, Thomas JP, George B, Johnston FM, Gamblin TC, Turaga KK. Comparative Effectiveness of Hepatic Artery Based Therapies for Unresectable Colorectal Liver Metastases: A Meta-Analysis. PLoS One. 2015;10:e0139940. [PMID: 26448327 DOI: 10.1371/journal.pone.0139940] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
419 Tsoulfas G, Pramateftakis MG. Management of rectal cancer and liver metastatic disease: which comes first? Int J Surg Oncol. 2012;2012:196908. [PMID: 22778934 DOI: 10.1155/2012/196908] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
420 Pereira PL. Actual role of radiofrequency ablation of liver metastases. Eur Radiol 2007;17:2062-70. [PMID: 17429644 DOI: 10.1007/s00330-007-0587-0] [Cited by in Crossref: 73] [Cited by in F6Publishing: 57] [Article Influence: 4.9] [Reference Citation Analysis]
421 Yang R, Cheung MC, Hurley J, Byrne MM, Huang Y, Zimmers TA, Koniaris LG. A comprehensive evaluation of outcomes for inflammatory breast cancer. Breast Cancer Res Treat 2009;117:631-41. [DOI: 10.1007/s10549-009-0312-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
422 Adam R, Hoti E, Bredt LC. [Oncosurgical strategies for metastatic liver cancer]. Cir Esp 2011;89:10-9. [PMID: 21176894 DOI: 10.1016/j.ciresp.2010.10.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
423 Osada S, Imai H, Tomita H, Tokuyama Y, Okumura N, Matsuhashi N, Sakashita F, Nonaka K. Serum cytokine levels in response to hepatic cryoablation. J Surg Oncol. 2007;95:491-498. [PMID: 17219394 DOI: 10.1002/jso.20712] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 2.6] [Reference Citation Analysis]
424 Cheung TT, Ng KK, Chok KS, Chan SC, Poon RT, Lo CM, Fan ST. Combined resection and radiofrequency ablation for multifocal hepatocellular carcinoma: Prognosis and outcomes. World J Gastroenterol 2010; 16(24): 3056-3062 [PMID: 20572310 DOI: 10.3748/wjg.v16.i24.3056] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.5] [Reference Citation Analysis]
425 Gomez D, Malik HZ, Bonney GK, Wong V, Toogood GJ, Lodge JP, Prasad KR. Steatosis predicts postoperative morbidity following hepatic resection for colorectal metastasis. Br J Surg. 2007;94:1395-1402. [PMID: 17607707 DOI: 10.1002/bjs.5820] [Cited by in Crossref: 90] [Cited by in F6Publishing: 83] [Article Influence: 6.0] [Reference Citation Analysis]
426 Ali ND, Donohue K, Zandieh S, Chen C, Moore D, Poplin E, Shah MM, Nosher J, Gui B, Jabbour SK, Spencer K, Carpizo DR. Conditional Survival Analysis of Metastatic Colorectal Cancer Patients Living ≥24 Months: A Single Institutional Study. Am J Clin Oncol 2019;42:512-8. [PMID: 30973370 DOI: 10.1097/COC.0000000000000535] [Reference Citation Analysis]
427 Banz VM, Baechtold M, Weber S, Peterhans M, Inderbitzin D, Candinas D. Computer planned, image-guided combined resection and ablation for bilobar colorectal liver metastases. World J Gastroenterol 2014; 20(40): 14992-14996 [PMID: 25356061 DOI: 10.3748/wjg.v20.i40.14992] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
428 Abdalla EK, Adam R, Bilchik AJ, Jaeck D, Vauthey JN, Mahvi D. Improving resectability of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol. 2006;13:1271-1280. [PMID: 16955381 DOI: 10.1245/s10434-006-9045-5] [Cited by in Crossref: 354] [Cited by in F6Publishing: 294] [Article Influence: 22.1] [Reference Citation Analysis]
429 Worni M, Mantyh CR, Akushevich I, Pietrobon R, Clary BM. Is there a role for simultaneous hepatic and colorectal resections? A contemporary view from NSQIP. J Gastrointest Surg 2012;16:2074-85. [PMID: 22972010 DOI: 10.1007/s11605-012-1990-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
430 Araujo RLC, Milani JM, Armentano DP, Moreira RB, Pinto GSF, de Castro LA, Lucchesi FR. Disappearing colorectal liver metastases: Strategies for the management of patients achieving a radiographic complete response after systemic chemotherapy. J Surg Oncol. 2020;121:848-856. [PMID: 31773747 DOI: 10.1002/jso.25784] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
431 Skof E, Rebersek M, Hlebanja Z, Ocvirk J. Capecitabine plus Irinotecan (XELIRI regimen) compared to 5-FU/LV plus Irinotecan (FOLFIRI regimen) as neoadjuvant treatment for patients with unresectable liver-only metastases of metastatic colorectal cancer: a randomised prospective phase II trial. BMC Cancer 2009;9:120. [PMID: 19386096 DOI: 10.1186/1471-2407-9-120] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 3.5] [Reference Citation Analysis]
432 Mentha G, Majno P, Terraz S, Rubbia-brandt L, Gervaz P, Andres A, Allal A, Morel P, Roth A. Treatment strategies for the management of advanced colorectal liver metastases detected synchronously with the primary tumour. European Journal of Surgical Oncology (EJSO) 2007;33:S76-83. [DOI: 10.1016/j.ejso.2007.09.016] [Cited by in Crossref: 65] [Cited by in F6Publishing: 52] [Article Influence: 4.3] [Reference Citation Analysis]
433 Pawlik TM, Cosgrove D. The role of peri-operative chemotherapy for resectable colorectal liver metastasis: what does the evidence support? J Gastrointest Surg. 2011;15:410-415. [PMID: 21253876 DOI: 10.1007/s11605-011-1423-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
434 Pellini B, Pejovic N, Feng W, Earland N, Harris PK, Usmani A, Szymanski JJ, Qaium F, Mudd J, Petty M, Jiang Y, Singh A, Maher CA, Henke LE, Park H, Ciorba MA, Kim H, Mutch MG, Pedersen KS, Tan BR, Hawkins WG, Fields RC, Chaudhuri AA. ctDNA MRD Detection and Personalized Oncogenomic Analysis in Oligometastatic Colorectal Cancer From Plasma and Urine. JCO Precis Oncol 2021;5:PO. [PMID: 34250420 DOI: 10.1200/PO.20.00276] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
435 Takahashi S, Konishi M, Kinoshita T, Gotohda N, Kato Y, Saito N, Sugito M, Yoshino T. Predictors for early recurrence after hepatectomy for initially unresectable colorectal liver metastasis. J Gastrointest Surg. 2013;17:939-948. [PMID: 23400510 DOI: 10.1007/s11605-013-2162-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
436 Shamimi-Noori S, Gonsalves CF, Shaw CM. Metastatic Liver Disease: Indications for Locoregional Therapy and Supporting Data.Semin Intervent Radiol. 2017;34:145-166. [PMID: 28579683 DOI: 10.1055/s-0037-1602712] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
437 Holt PR, Kozuch P, Mewar S. Colon cancer and the elderly: from screening to treatment in management of GI disease in the elderly. Best Pract Res Clin Gastroenterol. 2009;23:889-907. [PMID: 19942166 DOI: 10.1016/j.bpg.2009.10.010] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
438 Weiss MJ, Ito H, Araujo RL, Zabor EC, Gonen M, D'Angelica MI, Allen PJ, DeMatteo RP, Fong Y, Blumgart LH, Jarnagin WR. Hepatic pedicle clamping during hepatic resection for colorectal liver metastases: no impact on survival or hepatic recurrence. Ann Surg Oncol 2013;20:285-94. [PMID: 22868921 DOI: 10.1245/s10434-012-2583-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
439 Narita M, Oussoultzoglou E, Jaeck D, Fuchschuber P, Rosso E, Pessaux P, Marzano E, Bachellier P. Two-stage hepatectomy for multiple bilobar colorectal liver metastases. Br J Surg. 2011;98:1463-1475. [PMID: 21710481 DOI: 10.1002/bjs.7580] [Cited by in Crossref: 97] [Cited by in F6Publishing: 85] [Article Influence: 8.8] [Reference Citation Analysis]
440 Tatsubayashi T, Tanizawa Y, Miki Y, Tokunaga M, Bando E, Kawamura T, Sugiura T, Kinugasa Y, Uesaka K, Terashima M. Treatment outcomes of hepatectomy for liver metastases of gastric cancer diagnosed using contrast-enhanced magnetic resonance imaging. Gastric Cancer. 2017;20:387-393. [PMID: 27155874 DOI: 10.1007/s10120-016-0611-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 4.7] [Reference Citation Analysis]
441 Terayama M, Ito K, Takemura N, Inagaki F, Mihara F, Kokudo N. Preserving inferior right hepatic vein enabled bisegmentectomy 7 and 8 without venous congestion: a case report. Surg Case Rep 2021;7:101. [PMID: 33881648 DOI: 10.1186/s40792-021-01184-w] [Reference Citation Analysis]
442 Laeseke PF, Sampson LA, Haemmerich D, Brace CL, Fine JP, Frey TM, Winter TC 3rd, Lee FT Jr. Multiple-electrode radiofrequency ablation: simultaneous production of separate zones of coagulation in an in vivo porcine liver model. J Vasc Interv Radiol 2005;16:1727-35. [PMID: 16371542 DOI: 10.1097/01.rvi.000018362.17771.b0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
443 Jones TJ, Murphy AE, Tameron A, Hussain LR, Grannan K, Guend H, Dunki-Jacobs EM, Lee DY. Trends and Outcomes of Synchronous Resection of Colorectal Metastasis in the Modern Era-Analysis of Targeted Hepatic NSQIP Database. J Surg Res. 2019;238:35-40. [PMID: 30735964 DOI: 10.1016/j.jss.2019.01.021] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
444 Casado-saenz E, Feliu J, Gomez-españa MA, Sanchez-gastaldo A, Garcia-carbonero R. SEOM Clinical guidelines for the treatment of advanced colorectal cancer 2013. Clin Transl Oncol 2013;15:996-1003. [DOI: 10.1007/s12094-013-1082-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
445 Suzuki Y, Yamaguchi T, Matsumoto H, Nakano D, Honda G, Shinoura N, Karasawa K, Takahashi K. Prognostic factors and treatment effects in patients with curatively resected brain metastasis from colorectal cancer. Dis Colon Rectum. 2014;57:56-63. [PMID: 24316946 DOI: 10.1097/01.dcr.0000436998.30504.98] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
446 Adams RB, Haller DG, Roh MS. Improving resectability of hepatic colorectal metastases: expert consensus statement by Abdalla et al. Ann Surg Oncol. 2006;13:1281-1283. [PMID: 16964448 DOI: 10.1245/s10434-006-9149-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
447 Biasco G, Derenzini E, Grazi G, Ercolani G, Ravaioli M, Pantaleo M, Brandi G. Treatment of hepatic metastases from colorectal cancer: Many doubts, some certainties. Cancer Treatment Reviews 2006;32:214-28. [DOI: 10.1016/j.ctrv.2005.12.011] [Cited by in Crossref: 70] [Cited by in F6Publishing: 63] [Article Influence: 4.4] [Reference Citation Analysis]
448 Yeo S, Kim DY, Kim TH, Jung KH, Hong YS, Kim SY, Park JW, Choi HS, Oh JH. Curative chemoradiotherapy for isolated retroperitoneal lymph node recurrence of colorectal cancer. Radiotherapy and Oncology 2010;97:307-11. [DOI: 10.1016/j.radonc.2010.05.021] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
449 Casaril A, Abu Hilal M, Harb A, Campagnaro T, Mansueto G, Nicoli N. The safety of radiofrequency thermal ablation in the treatment of liver malignancies. Eur J Surg Oncol. 2008;34:668-672. [PMID: 17681717 DOI: 10.1016/j.ejso.2007.05.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
450 Kopetz S, Chang GJ, Overman MJ, Eng C, Sargent DJ, Larson DW, Grothey A, Vauthey JN, Nagorney DM, McWilliams RR. Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol. 2009;27:3677-3683. [PMID: 19470929 DOI: 10.1200/jco.2008.20.5278] [Cited by in Crossref: 819] [Cited by in F6Publishing: 381] [Article Influence: 63.0] [Reference Citation Analysis]
451 Nielsen K, van Tilborg AA, Meijerink MR, Macintosh MO, Zonderhuis BM, de Lange ES, Comans EF, Meijer S, van den Tol MP. Incidence and treatment of local site recurrences following RFA of colorectal liver metastases. World J Surg 2013;37:1340-7. [PMID: 23494086 DOI: 10.1007/s00268-013-1997-6] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
452 Martin RC, Scoggins CR, Mc Masters KM. A phase II study of radiofrequency ablation of unresectable metastatic colorectal cancer with hepatic arterial infusion pump chemotherapy. J Surg Oncol 2006;93:387-93. [DOI: 10.1002/jso.20463] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
453 Mills S, Stamos MJ. Metastatic Colorectal Cancer. In: Steele SR, Maykel JA, Champagne BJ, Orangio GR, editors. Complexities in Colorectal Surgery. New York: Springer; 2014. pp. 91-104. [DOI: 10.1007/978-1-4614-9022-7_6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
454 Saied A, Katz SC, Espat NJ. Regional hepatic therapies: an important component in the management of colorectal cancer liver metastases. Hepatobiliary Surg Nutr 2013;2:97-107. [PMID: 24570923 DOI: 10.3978/j.issn.2304-3881.2012.12.07] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
455 Ramos FJ, Tabernero J. Cetuximab and chemotherapy for patients with unresectable CRC liver metastasis: are we changing the natural course of the disease? Onkologie 2007;30:602-4. [PMID: 18063871 DOI: 10.1159/000110799] [Reference Citation Analysis]
456 Kawaguchi Y, Vauthey JN. The Landmark Series: Randomized Control Trials Examining Perioperative Chemotherapy and Postoperative Adjuvant Chemotherapy for Resectable Colorectal Liver Metastasis. Ann Surg Oncol 2020;27:4263-70. [PMID: 32803551 DOI: 10.1245/s10434-020-08777-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
457 Lee KH, Kim HO, Yoo CH, Son BH, Park YL, Cho YK, Kim H, Han WK. Comparison of radiofrequency ablation and resection for hepatic metastasis from colorectal cancer. Korean J Gastroenterol. 2012;59:218-223. [PMID: 22460570 DOI: 10.4166/kjg.2012.59.3.218] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
458 Abdalla EK, Bauer TW, Chun YS, D’Angelica M, Kooby DA, Jarnagin WR. Locoregional surgical and interventional therapies for advanced colorectal cancer liver metastases: expert consensus statements. HPB (Oxford). 2013;15:119-130. [PMID: 23297723 DOI: 10.1111/j.1477-2574.2012.00597.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 54] [Article Influence: 6.4] [Reference Citation Analysis]
459 Gold JS, Are C, Kornprat P, Jarnagin WR, Gönen M, Fong Y, Dematteo RP, Blumgart LH, D'angelica M. Increased Use of Parenchymal-Sparing Surgery for Bilateral Liver Metastases From Colorectal Cancer Is Associated With Improved Mortality Without Change in Oncologic Outcome: Trends in Treatment Over Time in 440 Patients. Annals of Surgery 2008;247:109-17. [DOI: 10.1097/sla.0b013e3181557e47] [Cited by in Crossref: 172] [Cited by in F6Publishing: 70] [Article Influence: 12.3] [Reference Citation Analysis]
460 Snoeren N, Voest EE, Bergman AM, Dalesio O, Verheul HM, Tollenaar RA, van der Sijp JR, Schouten SB, Rinkes IH, van Hillegersberg R. A randomized two arm phase III study in patients post radical resection of liver metastases of colorectal cancer to investigate bevacizumab in combination with capecitabine plus oxaliplatin (CAPOX) vs CAPOX alone as adjuvant treatment. BMC Cancer. 2010;10:545. [PMID: 20937118 DOI: 10.1186/1471-2407-10-545] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
461 Topal B, Hompes D, Aerts R, Fieuws S, Thijs M, Penninckx F. Morbidity and mortality of laparoscopic vs. open radiofrequency ablation for hepatic malignancies. European Journal of Surgical Oncology (EJSO) 2007;33:603-7. [DOI: 10.1016/j.ejso.2007.02.031] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
462 Quan D, Gallinger S, Nhan C, Auer RA, Biagi JJ, Fletcher GG, Law CH, Moulton CE, Ruo L, Wei AC, Mcleod RS. The role of liver resection for colorectal cancer metastases in an era of multimodality treatment: A systematic review. Surgery 2012;151:860-70. [DOI: 10.1016/j.surg.2011.12.018] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 6.1] [Reference Citation Analysis]
463 Vogl TJ, Jost A, Nour-Eldin NA, Mack MG, Zangos S, Naguib NN. Repeated transarterial chemoembolisation using different chemotherapeutic drug combinations followed by MR-guided laser-induced thermotherapy in patients with liver metastases of colorectal carcinoma. Br J Cancer 2012;106:1274-9. [PMID: 22382689 DOI: 10.1038/bjc.2012.69] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
464 Hallet J, Sa Cunha A, Adam R, Goéré D, Bachellier P, Azoulay D, Ayav A, Grégoire E, Navarro F, Pessaux P; French Colorectal Liver Metastases Working Group, Association Française de Chirurgie (AFC). Factors influencing recurrence following initial hepatectomy for colorectal liver metastases. Br J Surg 2016;103:1366-76. [PMID: 27306949 DOI: 10.1002/bjs.10191] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 6.3] [Reference Citation Analysis]
465 Evrard S. [Intraoperative radiofrequency ablation of liver metastases: age of reason]. Bull Cancer 2010;97:91-6. [PMID: 20007068 DOI: 10.1684/bdc.2009.1018] [Reference Citation Analysis]
466 Ito K, Govindarajan A, Ito H, Fong Y. Surgical treatment of hepatic colorectal metastasis: evolving role in the setting of improving systemic therapies and ablative treatments in the 21st century. Cancer J. 2010;16:103-110. [PMID: 20404606 DOI: 10.1097/ppo.0b013e3181d7e8e5] [Cited by in Crossref: 55] [Cited by in F6Publishing: 26] [Article Influence: 4.6] [Reference Citation Analysis]
467 Liu Z, Ahmed M, Weinstein Y, Yi M, Mahajan RL, Goldberg SN. Characterization of the RF ablation-induced “oven effect”: the importance of background tissue thermal conductivity on tissue heating. Int J Hyperthermia. 2006;22:327-342. [PMID: 16754353 DOI: 10.1080/02656730600609122] [Cited by in Crossref: 78] [Cited by in F6Publishing: 64] [Article Influence: 4.9] [Reference Citation Analysis]
468 Evrard S. In favour of One-Stage Strategy (OSS). European Journal of Surgical Oncology (EJSO) 2015;41:1568-9. [DOI: 10.1016/j.ejso.2015.09.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
469 Lim C, Broqueres-You D, Brouland JP, Merkulova-Rainon T, Faussat AM, Hilal R, Rouquie D, Eveno C, Audollent R, Levy BI. Hepatic ischemia-reperfusion increases circulating bone marrow-derived progenitor cells and tumor growth in a mouse model of colorectal liver metastases. J Surg Res. 2013;184:888-897. [PMID: 23726239 DOI: 10.1016/j.jss.2013.04.069] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
470 Gallinger S, Biagi JJ, Fletcher GG, Nhan C, Ruo L, McLeod RS. Liver resection for colorectal cancer metastases. Curr Oncol. 2013;20:e255-e265. [PMID: 23737695 DOI: 10.3747/co.20.1341] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 4.3] [Reference Citation Analysis]
471 Hoffmann RT, Paprottka P, Jakobs TF, Trumm CG, Reiser MF. Arterial therapies of non-colorectal cancer metastases to the liver (from chemoembolization to radioembolization). Abdom Imaging 2011;36:671-6. [DOI: 10.1007/s00261-011-9753-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
472 Cardinal J, Klune JR, Chory E, Jeyabalan G, Kanzius JS, Nalesnik M, Geller DA. Noninvasive radiofrequency ablation of cancer targeted by gold nanoparticles. Surgery 2008;144:125-32. [PMID: 18656617 DOI: 10.1016/j.surg.2008.03.036] [Cited by in Crossref: 140] [Cited by in F6Publishing: 111] [Article Influence: 10.0] [Reference Citation Analysis]
473 Samim M, El-Haddad GE, Molenaar IQ, Prevoo W, van den Bosch MA, Alavi A, Lam MG. [18F]Fluorodeoxyglucose PET for Interventional Oncology in Liver Malignancy. PET Clin 2014;9:469-95, vi. [PMID: 26050948 DOI: 10.1016/j.cpet.2014.07.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
474 Viana EF, Herman P, Coelho FF, Taka TA, D'Albuquerque LA, Cecconello I. The role of hilar lymphadenectomy in patients subjected to hepatectomy due to colorectal metastasis. Arq Gastroenterol 2011;48:217-9. [PMID: 21952709 DOI: 10.1590/s0004-28032011000300012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
475 Qiu J, Chen S, Wu H. Long-term outcomes after hepatic resection combined with radiofrequency ablation for initially unresectable multiple and bilobar liver malignancies. J Surg Res. 2014;188:14-20. [PMID: 24387841 DOI: 10.1016/j.jss.2013.11.1120] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
476 Andreou A, Brouquet A, Bharathy KG, Perrier ND, Abdalla EK, Curley SA, Glanemann M, Seehofer D, Neuhaus P, Vauthey JN, Aloia TA. Liver resection for liver metastases from nondigestive endocrine cancer: extrahepatic disease burden defines outcome. Surgery 2012;151:851-9. [PMID: 22306838 DOI: 10.1016/j.surg.2011.12.025] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
477 Quesada R, Moreno A, Poves I, Berjano E, Grande L, Burdío F. The impact of radiofrequency-assisted transection on local hepatic recurrence after resection of colorectal liver metastases. Surgical Oncology 2017;26:229-35. [DOI: 10.1016/j.suronc.2017.04.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
478 Hirokawa F, Komeda K, Asakuma M, Shimizu T, Kagota S, Tomioka A, Uchiyama K. Is Surgical Treatment Effective or Contraindicated in Patients with Colorectal Cancer Liver Metastases Exhibiting Extrahepatic Metastasis? J Gastrointest Surg 2021. [PMID: 34506021 DOI: 10.1007/s11605-021-05122-x] [Reference Citation Analysis]
479 Wang Y, Wang ZQ, Wang FH, Yuan YF, Li BK, Ding PR, Chen G, Wu XJ, Lu ZH, Pan ZZ. The Role of Adjuvant Chemotherapy for Colorectal Liver Metastasectomy after Pre-Operative Chemotherapy: Is the Treatment Worthwhile? J Cancer. 2017;8:1179-1186. [PMID: 28607592 DOI: 10.7150/jca.18091] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
480 Solazzo SA, Liu Z, Lobo SM, Ahmed M, Hines-Peralta AU, Lenkinski RE, Goldberg SN. Radiofrequency ablation: importance of background tissue electrical conductivity--an agar phantom and computer modeling study. Radiology. 2005;236:495-502. [PMID: 16040906 DOI: 10.1148/radiol.2362040965] [Cited by in Crossref: 87] [Cited by in F6Publishing: 68] [Article Influence: 5.1] [Reference Citation Analysis]
481 Nuzzo G, Giuliante F, Ardito F, Vellone M, Giovannini I. Hanging Maneuver in Right Hepatectomy for Recurrent Metastases with Diaphragmatic Infiltration after Radiofrequency Ablation: A New Indication. The American Surgeon 2007;73:884-7. [DOI: 10.1177/000313480707300911] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
482 Krmpot AJ, Janjetovic KD, Misirkic MS, Vucicevic LM, Pantelic DV, Vasiljevic DM, Popadic DM, Jelenkovic BM, Trajkovic VS. Protective effect of autophagy in laser-induced glioma cell death in vitro. Lasers Surg Med 2010;42:338-47. [PMID: 20432283 DOI: 10.1002/lsm.20911] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
483 Joharatnam-Hogan N, Khan K. Thermal ablation in colorectal liver metastases-the paradox of equipoise. Hepatobiliary Surg Nutr 2021;10:276-8. [PMID: 33898577 DOI: 10.21037/hbsn-21-1] [Reference Citation Analysis]
484 Kim J, Mori T, Chen SL, Amersi FF, Martinez SR, Kuo C, Turner RR, Ye X, Bilchik AJ, Morton DL. Chemokine receptor CXCR4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcome. Ann Surg. 2006;244:113-120. [PMID: 16794396 DOI: 10.1097/01.sla.0000217690.65909.9c] [Cited by in Crossref: 125] [Cited by in F6Publishing: 118] [Article Influence: 7.8] [Reference Citation Analysis]
485 Xu H, Schmidt R, Hamm CA, Schobert IT, He Y, Böning G, Jonczyk M, Hamm B, Gebauer B, Savic LJ. Comparison of intrahepatic progression patterns of hepatocellular carcinoma and colorectal liver metastases following CT-guided high dose-rate brachytherapy. Ther Adv Med Oncol 2021;13:17588359211042304. [PMID: 34539817 DOI: 10.1177/17588359211042304] [Reference Citation Analysis]
486 Cai GX, Cai SJ. Multi-modality treatment of colorectal liver metastases. World J Gastroenterol 2012; 18(1): 16-24 [PMID: 22228966 DOI: 10.3748/wjg.v18.i1.16] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
487 Nikfarjam M, Malcontenti-Wilson C, Christophi C. Focal hyperthermia produces progressive tumor necrosis independent of the initial thermal effects. J Gastrointest Surg. 2005;9:410-417. [PMID: 15749605 DOI: 10.1016/j.gassur.2004.07.008] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 1.7] [Reference Citation Analysis]
488 Hemming AW, Reed AI, Fujita S, Zendejas I, Howard RJ, Kim RD. Role for extending hepatic resection using an aggressive approach to liver surgery. J Am Coll Surg 2008;206:870-5; discussion 875-8. [PMID: 18471713 DOI: 10.1016/j.jamcollsurg.2007.12.036] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
489 Pepple PT, Gerber DA. Laparoscopic-assisted ablation of hepatic tumors: a review. Semin Intervent Radiol. 2014;31:125-128. [PMID: 25053864 DOI: 10.1055/s-0034-1373787] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
490 Shady W, Petre EN, Gonen M, Erinjeri JP, Brown KT, Covey AM, Alago W, Durack JC, Maybody M, Brody LA, Siegelbaum RH, D'Angelica MI, Jarnagin WR, Solomon SB, Kemeny NE, Sofocleous CT. Percutaneous Radiofrequency Ablation of Colorectal Cancer Liver Metastases: Factors Affecting Outcomes--A 10-year Experience at a Single Center. Radiology. 2016;278:601-611. [PMID: 26267832 DOI: 10.1148/radiol.2015142489] [Cited by in Crossref: 165] [Cited by in F6Publishing: 163] [Article Influence: 23.6] [Reference Citation Analysis]
491 Xie M, Zhu J, He X, Yang Z, Chen X, Lan P, Lian L. Liver Metastasis from Colorectal Cancer in the Elderly: Is Surgery Justified? Dig Dis Sci. 2015;60:3525-3535. [PMID: 26173502 DOI: 10.1007/s10620-015-3789-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
492 García-Carbonero R, Gómez España MA, Casado Sáenz E, Alonso Orduña V, Cervantes Ruipérez A, Gallego Plazas J, García Alfonso P, Juez Martel I, González Flores E, Lomas Garrido M, Isla Casado D; SEOM (Spanish Society for Medical Oncology). SEOM clinical guidelines for the treatment of advanced colorectal cancer. Clin Transl Oncol 2010;12:729-34. [PMID: 20974564 DOI: 10.1007/s12094-010-0587-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
493 Mateva G, Handzhiev S, Kostadinova I. The Role of 18F-FDG PET/CT in Evaluating the Efficacy of Radiofrequency Ablation in Metastatic and Primary Liver Tumors: Preliminary Results. Mol Imaging Radionucl Ther 2021;30:1-7. [PMID: 33586401 DOI: 10.4274/mirt.galenos.2020.63634] [Reference Citation Analysis]
494 Murawa D, Spychała A, Lewandowski A, Nowaczyk P. Laparoscopic thermoablation of colorectal cancer metastases to the liver - new experience of the centre. Contemp Oncol (Pozn) 2012;16:179-83. [PMID: 23788874 DOI: 10.5114/wo.2012.28801] [Reference Citation Analysis]
495 Pérez-Santiago L, Dorcaratto D, Garcés-Albir M, Muñoz-Forner E, Huerta Álvaro M, Roselló Keranën S, Sabater L. The actual management of colorectal liver metastases. Minerva Chir 2020;75:328-44. [PMID: 32773753 DOI: 10.23736/S0026-4733.20.08436-9] [Reference Citation Analysis]
496 Chaudhry S, Fields RC, Grierson PM, Lim KH. Combined Systemic and Hepatic Artery Infusion Pump Chemo-Therapy as a Liver-Directed Therapy for Colorectal Liver Metastasis-Review of Literature and Case Discussion. Cancers (Basel) 2021;13:1283. [PMID: 33805846 DOI: 10.3390/cancers13061283] [Reference Citation Analysis]
497 Wada Y, Takami Y, Tateishi M, Ryu T, Mikagi K, Saitsu H. Efficacy of surgical treatment using microwave coagulo-necrotic therapy for unresectable multiple colorectal liver metastases. Onco Targets Ther 2016;9:937-43. [PMID: 26955286 DOI: 10.2147/OTT.S97824] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
498 Mazzoni G, Napoli A, Mandetta S, Miccini M, Cassini D, Gregori M, Colace L, Tocchi A. Intra-operative ultrasound for detection of liver metastases from colorectal cancer. Liver Int. 2008;28:88-94. [PMID: 17971094 DOI: 10.1111/j.1478-3231.2007.01583.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
499 Dijkstra M, Nieuwenhuizen S, Puijk RS, Geboers B, Timmer FEF, Schouten EAC, Scheffer HJ, de Vries JJJ, Ket JCF, Versteeg KS, Meijerink MR, van den Tol MP. The Role of Neoadjuvant Chemotherapy in Repeat Local Treatment of Recurrent Colorectal Liver Metastases: A Systematic Review and Meta-Analysis. Cancers (Basel) 2021;13:378. [PMID: 33561088 DOI: 10.3390/cancers13030378] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
500 Pawlik TM, Choti MA. Shifting from clinical to biologic indicators of prognosis after resection of hepatic colorectal metastases. Curr Oncol Rep 2007;9:193-201. [DOI: 10.1007/s11912-007-0021-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
501 He N, Jin QN, Wang D, Yang YM, Liu YL, Wang GB, Tao KX. Radiofrequency ablation vs. hepatic resection for resectable colorectal liver metastases. J Huazhong Univ Sci Technolog Med Sci. 2016;36:514-518. [PMID: 27465325 DOI: 10.1007/s11596-016-1617-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
502 Yan X, Ning ZY, Wang P, Zhuang LP, Xu LT, Zhu ZF, Sheng J, Shen YH, Hua YQ, Meng ZQ. Combined ablation-chemotherapy versus chemotherapy alone for pancreatic cancer with liver metastasis: a propensity score matching study. Expert Rev Gastroenterol Hepatol 2021;15:1047-56. [PMID: 33356652 DOI: 10.1080/17474124.2021.1869937] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
503 Wang Y, Lin HC, Huang MY, Shao Q, Wang ZQ, Wang FH, Yuan YF, Li BK, Wang DS, Ding PR, Chen G, Wu XJ, Lu ZH, Li LR, Pan ZZ, Sun P, Yan SM, Wan DS, Xu RH, Li YH. The Immunoscore system predicts prognosis after liver metastasectomy in colorectal cancer liver metastases. Cancer Immunol Immunother 2018;67:435-44. [PMID: 29204700 DOI: 10.1007/s00262-017-2094-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 4.8] [Reference Citation Analysis]
504 de Jong KP, Wertenbroek MW. Liver Resection Combined with Local Ablation: Where Are the Limits? Dig Surg 2011;28:127-33. [DOI: 10.1159/000323823] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
505 Tanaka K, Shimada H, Ueda M, Matsuo K, Endo I, Togo S. Role of hepatectomy in treating multiple bilobar colorectal cancer metastases. Surgery 2008;143:259-70. [DOI: 10.1016/j.surg.2007.08.015] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
506 Feliberti EC, Wagman LD. Radiofrequency Ablation of Liver Metastases from Colorectal Carcinoma. Cancer Control 2017;13:48-51. [DOI: 10.1177/107327480601300107] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
507 Choti MA. Chemotherapy-Associated Hepatotoxicity: Do We Need to Be Concerned? Ann Surg Oncol 2009;16:2391-4. [DOI: 10.1245/s10434-009-0512-7] [Cited by in Crossref: 38] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
508 Franko J. Therapeutic efficacy of systemic therapy for colorectal peritoneal carcinomatosis: Surgeon's perspective. Pleura Peritoneum 2018;3:20180102. [PMID: 30911652 DOI: 10.1515/pp-2018-0102] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
509 Ranieri G, Laface C, Laforgia M, De Summa S, Porcelli M, Macina F, Ammendola M, Molinari P, Lauletta G, Di Palo A, Rubini G, Ferrari C, Gadaleta CD. Bevacizumab Plus FOLFOX-4 Combined With Deep Electro-Hyperthermia as First-line Therapy in Metastatic Colon Cancer: A Pilot Study. Front Oncol 2020;10:590707. [PMID: 33224885 DOI: 10.3389/fonc.2020.590707] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
510 Gotohda N, Nomura S, Doi M, Karasawa K, Ohki T, Shimizu Y, Inaba Y, Takeda A, Takaki H, Anai H, Ikeda M, Sugimoto M, Akimoto T. Clinical impact of radiofrequency ablation and stereotactic body radiation therapy for colorectal liver metastasis as local therapies for elderly, vulnerable patients. JGH Open 2020;4:722-8. [PMID: 32782962 DOI: 10.1002/jgh3.12325] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
511 Hompes D, Prevoo W, Ruers T. Radiofrequency ablation as a treatment tool for liver metastases of colorectal origin. Cancer Imaging 2011;11:23-30. [PMID: 21435988 DOI: 10.1102/1470-7330.2011.0004] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
512 Kulaylat MN, Gibbs JF. Thermoablation of colorectal liver metastasis. J Surg Oncol 2010;101:699-705. [PMID: 20512946 DOI: 10.1002/jso.21504] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
513 Lee SD, Han HS, Cho JY, Yoon YS, Hwang DW, Jung K, Yoon CJ, Kwon Y, Kim JH. Safety and efficacy of laparoscopic radiofrequency ablation for hepatic malignancies. J Korean Surg Soc 2012;83:36-42. [PMID: 22792532 DOI: 10.4174/jkss.2012.83.1.36] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
514 Schüle S, Dittmar Y, Knösel T, Krieg P, Albrecht R, Settmacher U, Altendorf-Hofmann A. Long-term results and prognostic factors after resection of hepatic and pulmonary metastases of colorectal cancer. Int J Colorectal Dis 2013;28:537-45. [PMID: 22885838 DOI: 10.1007/s00384-012-1553-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
515 Kawaguchi Y, Kopetz S, Tran Cao HS, Panettieri E, De Bellis M, Nishioka Y, Hwang H, Wang X, Tzeng CD, Chun YS, Aloia TA, Hasegawa K, Guglielmi A, Giuliante F, Vauthey JN. Contour prognostic model for predicting survival after resection of colorectal liver metastases: development and multicentre validation study using largest diameter and number of metastases with RAS mutation status. Br J Surg 2021;108:968-75. [PMID: 33829254 DOI: 10.1093/bjs/znab086] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
516 Gillams A, Goldberg N, Ahmed M, Bale R, Breen D, Callstrom M, Chen MH, Choi BI, de Baere T, Dupuy D. Thermal ablation of colorectal liver metastases: a position paper by an international panel of ablation experts, The Interventional Oncology Sans Frontières meeting 2013. Eur Radiol. 2015;25:3438-3454. [PMID: 25994193 DOI: 10.1007/s00330-015-3779-z] [Cited by in Crossref: 138] [Cited by in F6Publishing: 130] [Article Influence: 19.7] [Reference Citation Analysis]
517 Hur H, Ko YT, Min BS, Kim KS, Choi JS, Sohn SK, Cho CH, Ko HK, Lee JT, Kim NK. Comparative study of resection and radiofrequency ablation in the treatment of solitary colorectal liver metastases. Am J Surg. 2009;197:728-736. [PMID: 18789428 DOI: 10.1016/j.amjsurg.2008.04.013] [Cited by in Crossref: 146] [Cited by in F6Publishing: 128] [Article Influence: 10.4] [Reference Citation Analysis]
518 Okuno M, Kawaguchi Y, De Bellis M, Vega EA, Huang SY, Ahrar K, Gupta S, Vauthey J, Odisio BC. A new sequential treatment strategy for multiple colorectal liver metastases: Planned incomplete resection and postoperative completion ablation for intentionally-untreated tumors under guidance of cross-sectional imaging. European Journal of Surgical Oncology 2021;47:311-6. [DOI: 10.1016/j.ejso.2020.08.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
519 Kuehl H, Stattaus J, Hertel S, Hunold P, Kaiser G, Bockisch A, Forsting M. Mid-term outcome of positron emission tomography/computed tomography-assisted radiofrequency ablation in primary and secondary liver tumours--a single-centre experience. Clin Oncol (R Coll Radiol). 2008;20:234-240. [PMID: 18155453 DOI: 10.1016/j.clon.2007.11.011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
520 Freitas PS, Janicas C, Veiga J, Matos AP, Herédia V, Ramalho M. Imaging evaluation of the liver in oncology patients: A comparison of techniques. World J Hepatol 2021; 13(12): 1936-1955 [DOI: 10.4254/wjh.v13.i12.1936] [Reference Citation Analysis]
521 Arru M, Aldrighetti L, Castoldi R, Di Palo S, Orsenigo E, Stella M, Pulitanò C, Gavazzi F, Ferla G, Di Carlo V, Staudacher C. Analysis of Prognostic Factors Influencing Long-term Survival After Hepatic Resection for Metastatic Colorectal Cancer. World J Surg 2008;32:93-103. [DOI: 10.1007/s00268-007-9285-y] [Cited by in Crossref: 81] [Cited by in F6Publishing: 74] [Article Influence: 5.4] [Reference Citation Analysis]
522 Nishioka Y, Odisio BC, Velasco JD, Ninan E, Huang SY, Mahvash A, Tzeng CD, Tran Cao HS, Gupta S, Vauthey JN. Fast-track two-stage hepatectomy by concurrent portal vein embolization at first-stage hepatectomy in hybrid interventional radiology / operating suite. Surg Oncol 2021;39:101648. [PMID: 34438236 DOI: 10.1016/j.suronc.2021.101648] [Reference Citation Analysis]
523 Hallet J, Beyfuss K, Memeo R, Karanicolas PJ, Marescaux J, Pessaux P. Short and long-term outcomes of laparoscopic compared to open liver resection for colorectal liver metastases. Hepatobiliary Surg Nutr 2016;5:300-10. [PMID: 27500142 DOI: 10.21037/hbsn.2016.02.01] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
524 De Raffele E, Mirarchi M, Cuicchi D, Lecce F, Ricci C, Casadei R, Cola B, Minni F. Simultaneous curative resection of double colorectal carcinoma with synchronous bilobar liver metastases. World J Gastrointest Oncol 2018; 10(10): 293-316 [PMID: 30364774 DOI: 10.4251/wjgo.v10.i10.293] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
525 Bartolini I, Ringressi MN, Melli F, Risaliti M, Brugia M, Mini E, Batignani G, Bechi P, Boni L, Taddei A. Analysis of Prognostic Factors for Resected Synchronous and Metachronous Liver Metastases from Colorectal Cancer. Gastroenterol Res Pract. 2018;2018:5353727. [PMID: 30116264 DOI: 10.1155/2018/5353727] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
526 Ghanbarian M, Afgar A, Yadegarazari R, Najafi R, Teimoori-Toolabi L. Through oxaliplatin resistance induction in colorectal cancer cells, increasing ABCB1 level accompanies decreasing level of miR-302c-5p, miR-3664-5p and miR-129-5p. Biomed Pharmacother 2018;108:1070-80. [PMID: 30372807 DOI: 10.1016/j.biopha.2018.09.112] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
527 Jones RT, French JJ, Scott J, Manas DM, Charnley RM. Radiofrequency ablation resulting in left lobe hypertrophy and improved resectability. Case Rep Gastroenterol 2011;5:132-5. [PMID: 21512619 DOI: 10.1159/000326959] [Reference Citation Analysis]
528 Ichihara H, Hino M, Umebayashi M, Matsumoto Y, Ueoka R. Intravenous injection of hybrid liposomes suppresses the liver metastases in xenograft mouse models of colorectal cancer in vivo. Eur J Med Chem 2012;57:143-8. [PMID: 23059544 DOI: 10.1016/j.ejmech.2012.08.040] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
529 Wei AC, Sandhu L, Devitt KS, Gagliardi AR, Kennedy ED, Urbach DR, Gallinger S, Baxter NN. Practice patterns for the management of hepatic metastases from colorectal cancer: a mixed methods analysis. Ann Surg Oncol 2013;20:1567-74. [PMID: 23124860 DOI: 10.1245/s10434-012-2698-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
530 Meijerink MR, van Waesberghe JH, van der Weide L, van den Tol P, Meijer S, van Kuijk C. Total-liver-volume perfusion CT using 3-D image fusion to improve detection and characterization of liver metastases. Eur Radiol. 2008;18:2345-2354. [PMID: 18491094 DOI: 10.1007/s00330-008-0996-8] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 3.9] [Reference Citation Analysis]
531 Zeng X, Ward SE, Zhou J, Cheng ASL. Liver Immune Microenvironment and Metastasis from Colorectal Cancer-Pathogenesis and Therapeutic Perspectives. Cancers (Basel) 2021;13:2418. [PMID: 34067719 DOI: 10.3390/cancers13102418] [Reference Citation Analysis]
532 Lang H, Baumgart J, Heinrich S, Tripke V, Passalaqua M, Maderer A, Galle PR, Roth W, Kloth M, Moehler M. Extended Molecular Profiling Improves Stratification and Prediction of Survival After Resection of Colorectal Liver Metastases. Ann Surg. 2019;270:799-805. [PMID: 31634180 DOI: 10.1097/sla.0000000000003527] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 9.5] [Reference Citation Analysis]
533 Madurska MJ, Poyade M, Eason D, Rea P, Watson AJ. Development of a Patient-Specific 3D-Printed Liver Model for Preoperative Planning. Surg Innov 2017;24:145-50. [PMID: 28134003 DOI: 10.1177/1553350616689414] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]
534 Chan KM, Wu TH, Wang YC, Lee CF, Wu TJ, Chou HS, Lee WC, Chiang JM, Chen JS. Clinical relevance of oncologic prognostic factors in the decision-making of pre-hepatectomy chemotherapy for colorectal cancer hepatic metastasis: the priority of hepatectomy. World J Surg Oncol 2018;16:24. [PMID: 29415722 DOI: 10.1186/s12957-018-1322-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
535 Govaert KM, Nijkamp MW, Emmink BL, Steller EJA, Minchinton AI, Kranenburg O, Borel Rinkes IHM. Effects of tirapazamine on experimental colorectal liver metastases after radiofrequency ablation1. British Journal of Surgery 2012;99:567-75. [DOI: 10.1002/bjs.8668] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
536 Leblanc F, Fonck M, Brunet R, Becouarn Y, Mathoulin-Pélissier S, Evrard S. Comparison of hepatic recurrences after resection or intraoperative radiofrequency ablation indicated by size and topographical characteristics of the metastases. Eur J Surg Oncol. 2008;34:185-190. [PMID: 17998155 DOI: 10.1016/j.ejso.2007.09.028] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 1.7] [Reference Citation Analysis]
537 Hata S, Imamura H, Aoki T, Hashimoto T, Akahane M, Hasegawa K, Bekku Y, Sugawara Y, Makuuchi M, Kokudo N. Value of visual inspection, bimanual palpation, and intraoperative ultrasonography during hepatic resection for liver metastases of colorectal carcinoma. World J Surg 2011;35:2779-87. [PMID: 21959929 DOI: 10.1007/s00268-011-1264-7] [Cited by in Crossref: 34] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
538 Kishi Y, Kopetz S, Chun YS, Palavecino M, Abdalla EK, Vauthey JN. Blood neutrophil-to-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy. Ann Surg Oncol. 2009;16:614-622. [PMID: 19130139 DOI: 10.1245/s10434-008-0267-6] [Cited by in Crossref: 229] [Cited by in F6Publishing: 229] [Article Influence: 17.6] [Reference Citation Analysis]
539 Chua TC, Saxena A, Chu F, Zhao J, Morris DL. Predictors of cure after hepatic resection of colorectal liver metastases: An analysis of actual 5- and 10-year survivors: Long-Term Survivors of Colorectal Liver Metastases. J Surg Oncol 2011;103:796-800. [DOI: 10.1002/jso.21864] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 3.2] [Reference Citation Analysis]
540 Kennedy TJ, Cassera MA, Khajanchee YS, Diwan TS, Hammill CW, Hansen PD. Laparoscopic radiofrequency ablation for the management of colorectal liver metastases: 10-year experience. J Surg Oncol 2013;107:324-8. [PMID: 22996143 DOI: 10.1002/jso.23268] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
541 Mann C, Neal C, Pattenden C, Metcalfe M, Garcea G, Dennison A, Berry D. Major resection of hepatic colorectal liver metastases in elderly patients – An aggressive approach is justified. European Journal of Surgical Oncology (EJSO) 2008;34:428-32. [DOI: 10.1016/j.ejso.2007.03.013] [Cited by in Crossref: 53] [Cited by in F6Publishing: 42] [Article Influence: 3.8] [Reference Citation Analysis]
542 Chiappa A, Makuuchi M, Lygidakis NJ, Zbar AP, Chong G, Bertani E, Sitzler PJ, Biffi R, Pace U, Bianchi PP. The management of colorectal liver metastases: Expanding the role of hepatic resection in the age of multimodal therapy. Crit Rev Oncol Hematol. 2009;72:65-75. [PMID: 19147371 DOI: 10.1016/j.critrevonc.2008.11.003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
543 Misiakos EP, Karidis NP, Kouraklis G. Current treatment for colorectal liver metastases. World J Gastroenterol 2011; 17(36): 4067-4075 [PMID: 22039320 DOI: 10.3748/wjg.v17.i36.4067] [Cited by in CrossRef: 102] [Cited by in F6Publishing: 95] [Article Influence: 9.3] [Reference Citation Analysis]
544 Sonoda H, Shimizu T, Takebayashi K, Ohta H, Murakami K, Shiomi H, Naka S, Hanaoka J, Tani T. Minimally invasive surgery using the open magnetic resonance imaging system combined with video-assisted thoracoscopic surgery for synchronous hepatic and pulmonary metastases from colorectal cancer: report of four cases. Surg Today 2015;45:652-8. [PMID: 25096001 DOI: 10.1007/s00595-014-1002-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
545 Kim CW, Lee JL, Yoon YS, Park IJ, Lim SB, Yu CS, Kim TW, Kim JC. Resection after preoperative chemotherapy versus synchronous liver resection of colorectal cancer liver metastases: A propensity score matching analysis. Medicine (Baltimore) 2017;96:e6174. [PMID: 28207557 DOI: 10.1097/MD.0000000000006174] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
546 Hou RM, Chu F, Zhao J, Morris DL. The effects of surgical margin and edge cryotherapy after liver resection for colorectal cancer metastases. HPB (Oxford) 2007;9:201-7. [PMID: 18333223 DOI: 10.1080/13651820701275113] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
547 Meijerink MR, van den Tol P, van Tilborg AA, van Waesberghe JH, Meijer S, van Kuijk C. Radiofrequency ablation of large size liver tumours using novel plan-parallel expandable bipolar electrodes: initial clinical experience. Eur J Radiol 2011;77:167-71. [PMID: 19616911 DOI: 10.1016/j.ejrad.2009.06.025] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
548 Bonastre J, De Baère T, Elias D, Evrard S, Rouanet P, Bazin C, Giovannini M, Delpero JR, De Pouvourville G, Marchal F. Cost of radiofrequency ablation in the treatment of hepatic malignancies. Gastroenterol Clin Biol 2007;31:828-35. [PMID: 18166861 DOI: 10.1016/s0399-8320(07)73973-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
549 Ito F, Ku AW, Bucsek MJ, Muhitch JB, Vardam-Kaur T, Kim M, Fisher DT, Camoriano M, Khoury T, Skitzki JJ, Gollnick SO, Evans SS. Immune Adjuvant Activity of Pre-Resectional Radiofrequency Ablation Protects against Local and Systemic Recurrence in Aggressive Murine Colorectal Cancer. PLoS One. 2015;10:e0143370. [PMID: 26599402 DOI: 10.1371/journal.pone.0143370] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
550 Ruers T, Punt C, Van Coevorden F, Pierie JP, Borel-Rinkes I, Ledermann JA, Poston G, Bechstein W, Lentz MA, Mauer M. Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004). Ann Oncol. 2012;23:2619-2626. [PMID: 22431703 DOI: 10.1093/annonc/mds053] [Cited by in Crossref: 241] [Cited by in F6Publishing: 207] [Article Influence: 24.1] [Reference Citation Analysis]
551 Huh JW, Koh YS, Kim HR, Cho CK, Kim YJ. Comparison of laparoscopic and open colorectal resections for patients undergoing simultaneous R0 resection for liver metastases. Surg Endosc 2011;25:193-8. [PMID: 20549242 DOI: 10.1007/s00464-010-1158-z] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 3.3] [Reference Citation Analysis]
552 Styczen H, Nagelmeier I, Beissbarth T, Nietert M, Homayounfar K, Sprenger T, Boczek U, Stanek K, Kitz J, Wolff HA, Ghadimi BM, Middel P, Liersch T, Rüschoff J, Conradi LC. HER-2 and HER-3 expression in liver metastases of patients with colorectal cancer. Oncotarget 2015;6:15065-76. [PMID: 25915155 DOI: 10.18632/oncotarget.3527] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
553 Yamashita S, Odisio BC, Huang SY, Kopetz SE, Ahrar K, Chun YS, Conrad C, Aloia TA, Gupta S, Harmoush S, Hicks ME, Vauthey JN. Embryonic origin of primary colon cancer predicts survival in patients undergoing ablation for colorectal liver metastases. Eur J Surg Oncol 2017;43:1040-9. [PMID: 28187878 DOI: 10.1016/j.ejso.2017.01.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
554 Ryan P, Nanji S, Pollett A, Moore M, Moulton C, Gallinger S, Guindi M. Chemotherapy-induced Liver Injury in Metastatic Colorectal Cancer: Semiquantitative Histologic Analysis of 334 Resected Liver Specimens Shows That Vascular Injury but not Steatohepatitis Is Associated With Preoperative Chemotherapy. American Journal of Surgical Pathology 2010;34:784-91. [DOI: 10.1097/pas.0b013e3181dc242c] [Cited by in Crossref: 65] [Cited by in F6Publishing: 27] [Article Influence: 5.4] [Reference Citation Analysis]
555 Muratore A, Ribero D, Zimmitti G, Mellano A, Langella S, Capussotti L. Resection margin and recurrence-free survival after liver resection of colorectal metastases. Ann Surg Oncol. 2010;17:1324-1329. [PMID: 19847565 DOI: 10.1245/s10434-009-0770-4] [Cited by in Crossref: 102] [Cited by in F6Publishing: 90] [Article Influence: 7.8] [Reference Citation Analysis]
556 Jones NB, Wakely PE Jr, Klemanski DL, Al-Saif O, Young G, Frankel WL, Martin EW, Bloomston M. Cytopathologic evaluation of the in situ margin in patients undergoing hepatectomy. Cancer Cytopathol 2012;120:410-5. [PMID: 22605571 DOI: 10.1002/cncy.21204] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
557 Zakaria S, Donohue JH, Que FG, Farnell MB, Schleck CD, Ilstrup DM, Nagorney DM. Hepatic resection for colorectal metastases: value for risk scoring systems? Ann Surg 2007;246:183-91. [PMID: 17667495 DOI: 10.1097/SLA.0b013e3180603039] [Cited by in Crossref: 190] [Cited by in F6Publishing: 75] [Article Influence: 12.7] [Reference Citation Analysis]
558 Ng KM, Chua TC, Saxena A, Zhao J, Chu F, Morris DL. Two decades of experience with hepatic cryotherapy for advanced colorectal metastases. Ann Surg Oncol. 2012;19:1276-1283. [PMID: 21913018 DOI: 10.1245/s10434-011-2025-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
559 Smith JJ, D’Angelica MI. Surgical management of hepatic metastases of colorectal cancer. Hematol Oncol Clin North Am. 2015;29:61-84. [PMID: 25475573 DOI: 10.1016/j.hoc.2014.09.003] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 5.7] [Reference Citation Analysis]
560 Saxena A, Chua TC, Chu FC, Ng KM, Herle P, Morris DL. Impact of treatment modality and number of lesions on recurrence and survival outcomes after treatment of colorectal cancer liver metastases. J Gastrointest Oncol 2014;5:46-56. [PMID: 24490042 DOI: 10.3978/j.issn.2078-6891.2013.055] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
561 Zhang J, Gong Z, Gong Y, Guo W. Development and validation of nomograms for prediction of overall survival and cancer-specific survival of patients with Stage IV colorectal cancer. Jpn J Clin Oncol. 2019;49:438-446. [PMID: 30924498 DOI: 10.1093/jjco/hyz035] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
562 Hoffmann R, Jakobs TF, Reiser MF. Identification of Candidates and Selection Criteria. In: Bilbao JI, Reiser MF, editors. Liver Radioembolization with 90Y Microspheres. Berlin: Springer Berlin Heidelberg; 2008. pp. 11-4. [DOI: 10.1007/978-3-540-35423-9_2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
563 Guenette JP, Dupuy DE. Radiofrequency ablation of colorectal hepatic metastases. J Surg Oncol. 2010;102:978-987. [PMID: 21166002 DOI: 10.1002/jso.21658] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
564 Lazorthes F, Navarro F, Ychou M, Delpero JR, Rougier P;  ANAES. [Therapeutic management of hepatic metastases from colorectal cancers]. Gastroenterol Clin Biol. 2003;27 Spec No 2:B7. [PMID: 12637870 DOI: 10.1055/s-2005-916282] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 2.5] [Reference Citation Analysis]
565 Goiffon RJ, O'Shea A, Harisinghani MG. Advances in radiological staging of colorectal cancer. Clin Radiol 2021:S0009-9260(21)00310-X. [PMID: 34243943 DOI: 10.1016/j.crad.2021.06.005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
566 Luo M, Chen SL, Chen J, Yan H, Qiu Z, Chen G, Lu L, Zhang F. Resection vs. ablation for lesions characterized as resectable-ablative within the colorectal liver oligometastases criteria: a propensity score matching from retrospective study. PeerJ 2020;8:e8398. [PMID: 32025372 DOI: 10.7717/peerj.8398] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
567 Morris-Stiff G, White A, Gomez D, Toogood G, Lodge JP, Prasad KR. Thrombotic complications following liver resection for colorectal metastases are preventable. HPB (Oxford). 2008;10:311-314. [PMID: 18982144 DOI: 10.1080/13651820802074431] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
568 Au KP, Chok KSH, Chan ACY, Dai WC, Cheung TT, Lo CM. Impact of Hepatitis B Carrier Status on the Outcomes of Surgical Treatment of Colorectal Liver Metastases. World J Surg 2018;42:2642-50. [PMID: 29352337 DOI: 10.1007/s00268-018-4483-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
569 Wang DS, Yang H, Liu XY, Chen ZG, Wang Y, Fong WP, Hu MT, Zheng YC, Zheng Y, Li BK, Yuan YF, Chen G, Pan ZZ, Song L, Li YH, Xu RH. Dynamic monitoring of circulating tumor DNA to predict prognosis and efficacy of adjuvant chemotherapy after resection of colorectal liver metastases. Theranostics 2021;11:7018-28. [PMID: 34093868 DOI: 10.7150/thno.59644] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
570 Kaczirek K, Muckhoff P, Koelblinger C, Tamandl D, Bodingbauer M, Gruenberger T. Laparoscopic hepatectomy: an alternative to open surgery for colorectal liver metastases? Eur Surg 2012;44:164-7. [DOI: 10.1007/s10353-012-0087-6] [Reference Citation Analysis]
571 Chandra R, Karalis JD, Liu C, Murimwa GZ, Voth Park J, Heid CA, Reznik SI, Huang E, Minna JD, Brekken RA. The Colorectal Cancer Tumor Microenvironment and Its Impact on Liver and Lung Metastasis. Cancers (Basel) 2021;13:6206. [PMID: 34944826 DOI: 10.3390/cancers13246206] [Reference Citation Analysis]
572 Brouquet A, Benoist S. [Hepatectomy for colorectal liver metastases after neoadjuvant chemotherapy]. Bull Cancer 2011;98:11-8. [PMID: 21300602 DOI: 10.1684/bdc.2010.1284] [Reference Citation Analysis]
573 Tan KK, Hong CC, Zhang J, Liu JZ, Sim R. Surgery for perforated colorectal malignancy in an Asian population: an institution’s experience over 5 years. Int J Colorectal Dis. 2010;25:989-995. [PMID: 20390285 DOI: 10.1007/s00384-010-0945-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
574 Nakai N, Yamaguchi T, Kinugasa Y, Shiomi A, Kagawa H, Yamakawa Y, Numata M, Furutani A. Long-term outcomes after resection of para-aortic lymph node metastasis from left-sided colon and rectal cancer. Int J Colorectal Dis 2017;32:999-1007. [PMID: 28382511 DOI: 10.1007/s00384-017-2806-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
575 Morris-stiff G, Marangoni G, Hakeem A, Farida SG, Gomez D, Toogood GJ, Lodge JPA, Raj Prasad K. Redefining major hepatic resection for colorectal liver metastases: Analysis of 1111 liver resections. International Journal of Surgery 2016;25:172-7. [DOI: 10.1016/j.ijsu.2015.07.711] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
576 Lencioni R, Crocetti L. Radiofrequency Ablation of Liver Cancer. Techniques in Vascular and Interventional Radiology 2007;10:38-46. [DOI: 10.1053/j.tvir.2007.08.006] [Cited by in Crossref: 71] [Cited by in F6Publishing: 52] [Article Influence: 4.7] [Reference Citation Analysis]
577 Quénet F, Pissas M, Gil H, Roca L, Carrère S, Sgarbura O, Rouanet P, de Forges H, Khellaf L, Deshayes E, Ychou M, Bibeau F. Two-stage hepatectomy for colorectal liver metastases: Pathologic response to preoperative chemotherapy is associated with second-stage completion and longer survival. Surgery 2019;165:703-11. [DOI: 10.1016/j.surg.2018.10.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
578 Ichikawa N, Kamiyama T, Yokoo H, Homma S, Maeda Y, Shinohara T, Tsuruga Y, Kazui K, Iijima H, Yoshida T, Taketomi A. Preoperative chemotherapy in colorectal cancer patients with synchronous liver metastasis. Mol Clin Oncol 2020;12:374-83. [PMID: 32190322 DOI: 10.3892/mco.2020.1992] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
579 Lencioni R, Della Pina C, Crocetti L, Cioni D. Percutaneous Ablation of Hepatocellular Carcinoma. In: Stroszczynski C, editor. Minimally Invasive Tumor Therapies. Berlin: Springer Berlin Heidelberg; 2006. pp. 91-105. [DOI: 10.1007/3-540-28137-1_7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
580 Lee RC, Kanhere H, Trochsler M, Broadbridge V, Maddern G, Price TJ. Pancreatic, periampullary and biliary cancer with liver metastases: Should we consider resection in selected cases? World J Gastrointest Oncol 2018; 10(8): 211-220 [PMID: 30147847 DOI: 10.4251/wjgo.v10.i8.211] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
581 Shimada H, Tanaka K, Matsuo K, Togo S. Treatment for multiple bilobar liver metastases of colorectal cancer. Langenbecks Arch Surg 2006;391:130-42. [DOI: 10.1007/s00423-005-0003-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
582 Nathan H, de Jong MC, Pulitano C, Ribero D, Strub J, Mentha G, Gigot J, Schulick RD, Choti MA, Aldrighetti L, Capussotti L, Pawlik TM. Conditional Survival after Surgical Resection of Colorectal Liver Metastasis: An International Multi-Institutional Analysis of 949 Patients. Journal of the American College of Surgeons 2010;210:755-64. [DOI: 10.1016/j.jamcollsurg.2009.12.041] [Cited by in Crossref: 84] [Cited by in F6Publishing: 83] [Article Influence: 7.0] [Reference Citation Analysis]
583 Metcalfe MS, Mullin EJ, Texler M, Berry DP, Dennison AR, Maddern GJ. The safety and efficacy of radiofrequency and electrolytic ablation created adjacent to large hepatic veins in a porcine model. Eur J Surg Oncol. 2007;33:662-667. [PMID: 17412548 DOI: 10.1016/j.ejso.2007.02.011] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
584 Yamashita S, Brudvik KW, Kopetz SE, Maru D, Clarke CN, Passot G, Conrad C, Chun YS, Aloia TA, Vauthey JN. Embryonic Origin of Primary Colon Cancer Predicts Pathologic Response and Survival in Patients Undergoing Resection for Colon Cancer Liver Metastases. Ann Surg. 2018;267:514-520. [PMID: 28002060 DOI: 10.1097/sla.0000000000002087] [Cited by in Crossref: 36] [Cited by in F6Publishing: 17] [Article Influence: 12.0] [Reference Citation Analysis]
585 Zech CJ, Justo N, Lang A, Ba-Ssalamah A, Kim MJ, Rinde H, Jonas E. Cost evaluation of gadoxetic acid-enhanced magnetic resonance imaging in the diagnosis of colorectal-cancer metastasis in the liver: Results from the VALUE Trial. Eur Radiol 2016;26:4121-30. [PMID: 26905871 DOI: 10.1007/s00330-016-4271-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 3.7] [Reference Citation Analysis]
586 van der Vorst JR, Schaafsma BE, Hutteman M, Verbeek FP, Liefers GJ, Hartgrink HH, Smit VT, Löwik CW, van de Velde CJ, Frangioni JV. Near-infrared fluorescence-guided resection of colorectal liver metastases. Cancer. 2013;119:3411-3418. [PMID: 23794086 DOI: 10.1002/cncr.28203] [Cited by in Crossref: 163] [Cited by in F6Publishing: 163] [Article Influence: 18.1] [Reference Citation Analysis]
587 Gueorguiev AL, Mackey R, Kowdley GC, Esquivel J, Cunningham SC. Minimally invasive evaluation and treatment of colorectal liver metastases. Int J Surg Oncol 2011;2011:686030. [PMID: 22312518 DOI: 10.1155/2011/686030] [Reference Citation Analysis]
588 Ding Y, Rao SX, Meng T, Chen C, Li R, Zeng MS. Preoperative evaluation of colorectal liver metastases: comparison of gadopentetate dimeglumine and gadoxetic-acid-enhanced 1.5-T MRI. Clin Imaging 2014;38:273-8. [PMID: 24559747 DOI: 10.1016/j.clinimag.2013.12.021] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
589 Spelt L, Andersson B, Nilsson J, Andersson R. Prognostic models for outcome following liver resection for colorectal cancer metastases: A systematic review. Eur J Surg Oncol. 2012;38:16-24. [PMID: 22079259 DOI: 10.1016/j.ejso.2011.10.013] [Cited by in Crossref: 88] [Cited by in F6Publishing: 71] [Article Influence: 8.0] [Reference Citation Analysis]
590 de'Angelis N, Eshkenazy R, Brunetti F, Valente R, Costa M, Disabato M, Salloum C, Compagnon P, Laurent A, Azoulay D. Laparoscopic Versus Open Resection for Colorectal Liver Metastases: A Single-Center Study with Propensity Score Analysis. Journal of Laparoendoscopic & Advanced Surgical Techniques 2015;25:12-20. [DOI: 10.1089/lap.2014.0477] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 4.7] [Reference Citation Analysis]
591 Whitney R, Tatum C, Hahl M, Ellis S, Scoggins CR, McMasters K, Martin RC. Safety of hepatic resection in metastatic disease to the liver after yttrium-90 therapy. J Surg Res. 2011;166:236-240. [PMID: 19691985 DOI: 10.1016/j.jss.2009.05.021] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
592 Leen E, Horgan PG. Radiofrequency ablation of colorectal liver metastases. Surgical Oncology 2007;16:47-51. [DOI: 10.1016/j.suronc.2007.04.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
593 Howard JH, Tzeng CD, Smith JK, Eckhoff DE, Bynon JS, Wang T, Arnoletti JP, Heslin MJ. Radiofrequency Ablation for Unresectable Tumors of the Liver. The American Surgeon 2008;74:594-601. [DOI: 10.1177/000313480807400705] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
594 Ahmadzadehfar H, Meyer C, Ezziddin S, Sabet A, Hoff-meyer A, Muckle M, Logvinski T, Schild HH, Biersack HJ, Wilhelm K. Hepatic volume changes induced by radioembolization with 90Y resin microspheres. A single-centre study. Eur J Nucl Med Mol Imaging 2013;40:80-90. [DOI: 10.1007/s00259-012-2253-2] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
595 Fong Y, Wong J. Evolution in surgery: influence of minimally invasive approaches on the hepatobiliary surgeon. Surg Infect (Larchmt) 2009;10:399-406. [PMID: 19943774 DOI: 10.1089/sur.2009.9936] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
596 Vogl TJ, Dommermuth A, Heinle B, Nour-Eldin NE, Lehnert T, Eichler K, Zangos S, Bechstein WO, Naguib NN. Colorectal cancer liver metastases: long-term survival and progression-free survival after thermal ablation using magnetic resonance-guided laser-induced interstitial thermotherapy in 594 patients: analysis of prognostic factors. Invest Radiol. 2014;49:48-56. [PMID: 24056114 DOI: 10.1097/rli.0b013e3182a6094e] [Cited by in Crossref: 33] [Cited by in F6Publishing: 11] [Article Influence: 4.1] [Reference Citation Analysis]
597 Chen YG, Liu Z, Wang XS. Classifying the stage IV colorectal cancer: prognostic impact of radical resection for colorectal liver metastases and proposal for a new staging system. Cell Biochem Biophys 2013;67:1445-9. [PMID: 23532608 DOI: 10.1007/s12013-013-9577-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
598 Tang W, Ren L, Liu T, Ye Q, Wei Y, He G, Lin Q, Wang X, Wang M, Liang F, Cui Y, Xu J. Bevacizumab Plus mFOLFOX6 Versus mFOLFOX6 Alone as First-Line Treatment for RAS Mutant Unresectable Colorectal Liver-Limited Metastases: The BECOME Randomized Controlled Trial.J Clin Oncol. 2020;38:3175-3184. [PMID: 32749938 DOI: 10.1200/JCO.20.00174] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
599 Abbott DE, Sohn VY, Hanseman D, Curley SA. Cost-effectiveness of simultaneous resection and RFA versus 2-stage hepatectomy for bilobar colorectal liver metastases. J Surg Oncol 2014;109:516-20. [PMID: 24374772 DOI: 10.1002/jso.23539] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
600 Martins SF, Reis RM, Rodrigues AM, Baltazar F, Filho AL. Role of endoglin and VEGF family expression in colorectal cancer prognosis and anti-angiogenic therapies. World J Clin Oncol 2011; 2(6): 272-280 [PMID: 21773077 DOI: 10.5306/wjco.v2.i6.272] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
601 Brouquet A, Abdalla EK, Kopetz S, Garrett CR, Overman MJ, Eng C, Andreou A, Loyer EM, Madoff DC, Curley SA, Vauthey JN. High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome. J Clin Oncol. 2011;29:1083-1090. [PMID: 21263087 DOI: 10.1200/jco.2010.32.6132] [Cited by in Crossref: 256] [Cited by in F6Publishing: 95] [Article Influence: 23.3] [Reference Citation Analysis]
602 Verghese M, Pathak S, Poston GJ. Increasing long-term survival in advanced colorectal cancer. Eur J Surg Oncol 2007;33 Suppl 2:S1-4. [PMID: 18036766 DOI: 10.1016/j.ejso.2007.09.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
603 Khan K, Wale A, Brown G, Chau I. Colorectal cancer with liver metastases: Neoadjuvant chemotherapy, surgical resection first or palliation alone? World J Gastroenterol 2014; 20(35): 12391-12406 [PMID: 25253940 DOI: 10.3748/wjg.v20.i35.12391] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 26] [Article Influence: 4.4] [Reference Citation Analysis]
604 Dobbins C, Wemyss-Holden SA, Cockburn J, Maddern GJ. Bimodal electric tissue ablation-modified radiofrequency ablation with a le veen electrode in a pig model. J Surg Res 2008;144:111-6. [PMID: 17640668 DOI: 10.1016/j.jss.2007.03.066] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
605 Meijerink MR, Puijk RS, van Tilborg AAJM, Henningsen KH, Fernandez LG, Neyt M, Heymans J, Frankema JS, de Jong KP, Richel DJ, Prevoo W, Vlayen J. Radiofrequency and Microwave Ablation Compared to Systemic Chemotherapy and to Partial Hepatectomy in the Treatment of Colorectal Liver Metastases: A Systematic Review and Meta-Analysis. Cardiovasc Intervent Radiol. 2018;41:1189-1204. [PMID: 29666906 DOI: 10.1007/s00270-018-1959-3] [Cited by in Crossref: 63] [Cited by in F6Publishing: 56] [Article Influence: 15.8] [Reference Citation Analysis]
606 Morin C, Drolet S, Daigle C, Deshaies I, Ouellet JF, Ball CG, Dixon E, Marceau J, Ouellet JB. Additional value of gadoxetic acid-enhanced MRI to conventional extracellular gadolinium-enhanced MRI for the surgical management of colorectal and neuroendocrine liver metastases. HPB (Oxford) 2020;22:710-5. [PMID: 31640929 DOI: 10.1016/j.hpb.2019.09.009] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
607 Pawlik TM, Scoggins CR, Zorzi D, Abdalla EK, Andres A, Eng C, Curley SA, Loyer EM, Muratore A, Mentha G, Capussotti L, Vauthey JN. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 2005;241:715-22, discussion 722-4. [PMID: 15849507 DOI: 10.1097/01.sla.0000160703.75808.7d] [Cited by in Crossref: 730] [Cited by in F6Publishing: 664] [Article Influence: 42.9] [Reference Citation Analysis]
608 Ren H, Campos-Nanez E, Yaniv Z, Banovac F, Abeledo H, Hata N, Cleary K. Treatment planning and image guidance for radiofrequency ablation of large tumors. IEEE J Biomed Health Inform 2014;18:920-8. [PMID: 24235279 DOI: 10.1109/JBHI.2013.2287202] [Cited by in Crossref: 31] [Cited by in F6Publishing: 4] [Article Influence: 3.4] [Reference Citation Analysis]
609 Mann CD, Metcalfe MS, Lloyd DM, Maddern GJ, Dennison AR. The safety and efficacy of ablative techniques adjacent to the hepatic vasculature and biliary system. ANZ J Surg 2010;80:41-9. [PMID: 20575879 DOI: 10.1111/j.1445-2197.2009.05174.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
610 Kulkarni S, Shetty NS, Polnaya AM, Patil S, Gala K, Chivate R, Ostwal V, Ramaswamy A, Shrikhande SV, Goel M, Patkar S, Bhandare M, Rangarajan V, Nilendu P. Early outcomes of radiofrequency ablation in unresectable metastatic colorectal cancer from a tertiary cancer hospital in India. Indian J Radiol Imaging 2017;27:200-6. [PMID: 28744081 DOI: 10.4103/ijri.IJRI_24_17] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
611 Lewis AM, Martin RC. The Treatment of Hepatic Metastases in Colorectal Carcinoma. The American Surgeon 2006;72:466-73. [DOI: 10.1177/000313480607200602] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
612 Katz M, Vauthey JN. Potentially curable metastatic colorectal cancer. Curr Oncol Rep 2008;10:225-31. [PMID: 18765153 DOI: 10.1007/s11912-008-0035-6] [Reference Citation Analysis]
613 Vernaleone M, Bonomo P, Di Cataldo V, Saieva C, Masi L, Desideri I, Greto D, Francolini G, Becherini C, Livi L. Robotic stereotactic radiotherapy for liver oligometastases from colorectal cancer: a single-center experience. Radiol Med 2019;124:870-6. [PMID: 31104277 DOI: 10.1007/s11547-019-01042-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
614 Tsai MS, Su YH, Ho MC, Liang JT, Chen TP, Lai HS, Lee PH. Clinicopathological features and prognosis in resectable synchronous and metachronous colorectal liver metastasis. Ann Surg Oncol. 2007;14:786-794. [PMID: 17103254 DOI: 10.1245/s10434-006-9215-5] [Cited by in Crossref: 111] [Cited by in F6Publishing: 94] [Article Influence: 6.9] [Reference Citation Analysis]
615 Passot G, Odisio BC, Zorzi D, Mahvash A, Gupta S, Wallace MJ, Kim BJ, Yamashita S, Conrad C, Aloia TA, Vauthey JN, Chun YS. Eradication of Missing Liver Metastases After Fiducial Placement.J Gastrointest Surg. 2016;20:1173-1178. [PMID: 26791387 DOI: 10.1007/s11605-016-3079-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
616 Knudsen AR, Kannerup AS, Grønbæk H, Andersen KJ, Funch-Jensen P, Frystyk J, Flyvbjerg A, Mortensen FV. Effects of ischemic pre- and postconditioning on HIF-1α, VEGF and TGF-β expression after warm ischemia and reperfusion in the rat liver. Comp Hepatol 2011;10:3. [PMID: 21771288 DOI: 10.1186/1476-5926-10-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
617 Huo YR, Pillai K, Akhter J, Morris DL. "Edgeboost": A Novel Technique to Extend the Ablation Zone Lateral to a Two-Probe Bipolar Radiofrequency Device. Cardiovasc Intervent Radiol 2016;39:97-105. [PMID: 26155781 DOI: 10.1007/s00270-015-1168-2] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
618 Lillemoe HA, Vauthey JN. Surgical approach to synchronous colorectal liver metastases: staged, combined, or reverse strategy. Hepatobiliary Surg Nutr 2020;9:25-34. [PMID: 32140476 DOI: 10.21037/hbsn.2019.05.14] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
619 Takahashi M, Hasegawa K, Oba M, Saiura A, Arita J, Sakamoto Y, Shinozaki E, Mizunuma N, Matsuyama Y, Kokudo N. Phase 1 study on S-1 and oxaliplatin therapy as an adjuvant after hepatectomy for colorectal liver metastases. Invest New Drugs 2016;34:468-73. [PMID: 27155613 DOI: 10.1007/s10637-016-0356-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
620 Gillams AR, Lees WR. Five-year survival following radiofrequency ablation of small, solitary, hepatic colorectal metastases. J Vasc Interv Radiol. 2008;19:712-717. [PMID: 18440460 DOI: 10.1016/j.jvir.2008.01.016] [Cited by in Crossref: 78] [Cited by in F6Publishing: 72] [Article Influence: 5.6] [Reference Citation Analysis]
621 Spelt L, Norman P, Törnqvist L, Tingstedt B, Andersson R. Combined portal vein embolization and preoperative chemotherapy prior to liver resection for colorectal cancer metastases. Scand J Gastroenterol 2012;47:975-83. [PMID: 22631611 DOI: 10.3109/00365521.2012.685751] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
622 Yamamoto M, Yoshida M, Furuse J, Sano K, Ohtsuka M, Yamashita S, Beppu T, Iwashita Y, Wada K, Nakajima TE, Sakamoto K, Hayano K, Mori Y, Asai K, Matsuyama R, Hirashita T, Hibi T, Sakai N, Tabata T, Kawakami H, Takeda H, Mizukami T, Ozaka M, Ueno M, Naito Y, Okano N, Ueno T, Hijioka S, Shikata S, Ukai T, Strasberg S, Sarr MG, Jagannath P, Hwang TL, Han HS, Yoon YS, Wang HJ, Luo SC, Adam R, Gimenez M, Scatton O, Oh DY, Takada T. Clinical practice guidelines for the management of liver metastases from extrahepatic primary cancers 2021. J Hepatobiliary Pancreat Sci 2021;28:1-25. [PMID: 33200538 DOI: 10.1002/jhbp.868] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
623 Rocha FG, D’Angelica M. Treatment of liver colorectal metastases: role of laparoscopy, radiofrequency ablation, and microwave coagulation. J Surg Oncol. 2010;102:968-974. [PMID: 21166000 DOI: 10.1002/jso.21720] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
624 Wicherts DA, de Haas RJ, Andreani P, Sotirov D, Salloum C, Castaing D, Adam R, Azoulay D. Impact of portal vein embolization on long-term survival of patients with primarily unresectable colorectal liver metastases. Br J Surg. 2010;97:240-250. [PMID: 20087967 DOI: 10.1002/bjs.6756] [Cited by in Crossref: 86] [Cited by in F6Publishing: 74] [Article Influence: 7.2] [Reference Citation Analysis]
625 Homayounfar K, Bleckmann A, Conradi LC, Sprenger T, Lorf T, Niessner M, Sahlmann CO, Meller J, Liersch T, Ghadimi BM. Metastatic recurrence after complete resection of colorectal liver metastases: impact of surgery and chemotherapy on survival. Int J Colorectal Dis 2013;28:1009-17. [PMID: 23371333 DOI: 10.1007/s00384-013-1648-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
626 Machi J, Oishi AJ, Sumida K, Sakamoto K, Furumoto NL, Oishi RH, Kylstra JW. Long-Term Outcome of Radiofrequency Ablation for Unresectable Liver Metastases from Colorectal Cancer: Evaluation of Prognostic Factors and Effectiveness in First- and Second-Line Management. The Cancer Journal 2006;12:318-26. [DOI: 10.1097/00130404-200607000-00011] [Cited by in Crossref: 97] [Cited by in F6Publishing: 76] [Article Influence: 6.1] [Reference Citation Analysis]
627 Yang C, Rahbari NN, Mees ST, Schaab F, Koch M, Weitz J, Reissfelder C. Staged resection of bilobar colorectal liver metastases: surgical strategies. Langenbecks Arch Surg. 2015;400:633-640. [PMID: 26049744 DOI: 10.1007/s00423-015-1310-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.9] [Reference Citation Analysis]
628 Tsitskari M, Filippiadis D, Kostantos C, Palialexis K, Zavridis P, Kelekis N, Brountzos E. The role of interventional oncology in the treatment of colorectal cancer liver metastases. Ann Gastroenterol. 2019;32:147-155. [PMID: 30837787 DOI: 10.20524/aog.2018.0338] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
629 Yang G, Wang G, Sun J, Xiong Y, Li W, Tang T, Li J. The prognosis of radiofrequency ablation versus hepatic resection for patients with colorectal liver metastases: A systematic review and meta-analysis based on 22 studies. Int J Surg 2021;87:105896. [PMID: 33588125 DOI: 10.1016/j.ijsu.2021.105896] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
630 Kaufman MS, Radhakrishnan N, Roy R, Gecelter G, Tsang J, Thomas A, Nissel-Horowitz S, Mehrotra B. Influence of palliative surgical resection on overall survival in patients with advanced colorectal cancer: a retrospective single institutional study. Colorectal Dis. 2008;10:498-502. [PMID: 17949445 DOI: 10.1111/j.1463-1318.2007.01384.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 2.1] [Reference Citation Analysis]
631 Zaidi N, Okoh A, Yigitbas H, Yazici P, Ali N, Berber E. Laparoscopic microwave thermosphere ablation of malignant liver tumors: An analysis of 53 cases. J Surg Oncol. 2016;113:130-134. [PMID: 26659827 DOI: 10.1002/jso.24127] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
632 Paulet E, Aubé C, Pessaux P, Lebigot J, Lhermitte E, Oberti F, Ponthieux A, Calès P, Ridereau-Zins C, Pereira PL. Factors limiting complete tumor ablation by radiofrequency ablation. Cardiovasc Intervent Radiol 2008;31:107-15. [PMID: 17968620 DOI: 10.1007/s00270-007-9208-1] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.0] [Reference Citation Analysis]
633 Jouffret L, Ewald J, Marchese U, Garnier J, Gilabert M, Mokart D, Piana G, Delpero JR, Turrini O. Is progression in the future liver remnant a contraindication for second-stage hepatectomy? HPB (Oxford) 2019;21:1478-84. [PMID: 30962135 DOI: 10.1016/j.hpb.2019.03.357] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
634 Alsina J, Choti MA. Liver-Directed Therapies in Colorectal Cancer. Seminars in Oncology 2011;38:561-7. [DOI: 10.1053/j.seminoncol.2011.05.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
635 Imai K, Adam R, Baba H. How to increase the resectability of initially unresectable colorectal liver metastases: A surgical perspective. Ann Gastroenterol Surg 2019;3:476-86. [PMID: 31549007 DOI: 10.1002/ags3.12276] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
636 Govaert KM, van Kessel CS, Steller EJ, Emmink BL, Molenaar IQ, Kranenburg O, van Hillegersberg R, Borel Rinkes IH. Recurrence location after resection of colorectal liver metastases influences prognosis. J Gastrointest Surg 2014;18:952-60. [PMID: 24474631 DOI: 10.1007/s11605-014-2461-0] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
637 Jutric Z, Grendar J, Brown WL, Cassera MA, Wolf RF, Hansen PD, Hammill CW. Novel Simulation Device for Targeting Tumors in Laparoscopic Ablation: A Learning Curve Study. Surg Innov 2017;24:492-8. [DOI: 10.1177/1553350617715833] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
638 Miller CL, Taylor MS, Qadan M, Deshpande V, Worthington S, Smalley R, Collura C, Ryan DP, Allen JN, Blaszkowsky LS, Clark JW, Murphy JE, Parikh AR, Berger D, Tanabe KK, Lillemoe KD, Ferrone CR. Prognostic Significance of Surgical Margin Size After Neoadjuvant FOLFOX and/or FOLFIRI for Colorectal Liver Metastases. J Gastrointest Surg. 2017;21:1831-1840. [PMID: 28884391 DOI: 10.1007/s11605-017-3557-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
639 White RR, Jarnagin WR. The Role of Aggressive Regional Therapy for Colorectal Liver Metastases. Cancer Investigation 2009;25:458-63. [DOI: 10.1080/07357900701508561] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
640 Groeschl RT, Nachmany I, Steel JL, Reddy SK, Glazer ES, de Jong MC, Pawlik TM, Geller DA, Tsung A, Marsh JW, Clary BM, Curley SA, Gamblin TC. Hepatectomy for Noncolorectal Non-Neuroendocrine Metastatic Cancer: A Multi-Institutional Analysis. Journal of the American College of Surgeons 2012;214:769-77. [DOI: 10.1016/j.jamcollsurg.2011.12.048] [Cited by in Crossref: 87] [Cited by in F6Publishing: 78] [Article Influence: 8.7] [Reference Citation Analysis]
641 Hasegawa K, Saiura A, Takayama T, Miyagawa S, Yamamoto J, Ijichi M, Teruya M, Yoshimi F, Kawasaki S, Koyama H, Oba M, Takahashi M, Mizunuma N, Matsuyama Y, Watanabe T, Makuuchi M, Kokudo N. Adjuvant Oral Uracil-Tegafur with Leucovorin for Colorectal Cancer Liver Metastases: A Randomized Controlled Trial. PLoS One 2016;11:e0162400. [PMID: 27588959 DOI: 10.1371/journal.pone.0162400] [Cited by in Crossref: 42] [Cited by in F6Publishing: 30] [Article Influence: 7.0] [Reference Citation Analysis]
642 Simoneau E, Hassanain M, Shaheen M, Aljiffry M, Molla N, Chaudhury P, Anil S, Khashper A, Valenti D, Metrakos P. Portal vein embolization and its effect on tumour progression for colorectal cancer liver metastases. Br J Surg. 2015;102:1240-1249. [PMID: 26109487 DOI: 10.1002/bjs.9872] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 5.1] [Reference Citation Analysis]
643 Kim JY, Kim JS, Baek MJ, Kim CN, Choi WJ, Park DK, Namgung H, Lee SC, Lee SJ. Prospective multicenter phase II clinical trial of FOLFIRI chemotherapy as a neoadjuvant treatment for colorectal cancer with multiple liver metastases. J Korean Surg Soc 2013;85:154-60. [PMID: 24106681 DOI: 10.4174/jkss.2013.85.4.154] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
644 Kovar FM, Thallinger C, Marsik CL, Perkmann T, Puhalla H, Haslacher H, Wrba F, Wagner OF, Gruenberger T, Endler G. The EGF 61A/G polymorphism - a predictive marker for recurrence of liver metastases from colorectal cancer. Wien Klin Wochenschr 2009;121:638-43. [PMID: 19921131 DOI: 10.1007/s00508-009-1250-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
645 Rhim H, Lim HK, Choi D. Current status of radiofrequency ablation of hepatocellular carcinoma. World J Gastrointest Surg 2010; 2(4): 128-136 [PMID: 21160861 DOI: 10.4240/wjgs.v2.i4.128] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
646 Hirokawa F, Hayashi M, Miyamoto Y, Asakuma M, Shimizu T, Komeda K, Inoue Y, Uchiyama K. Reconsideration of the indications for adjuvant chemotherapy for liver metastases from colorectal cancer after initial hepatectomy. Ann Surg Oncol 2014;21:139-46. [PMID: 24121880 DOI: 10.1245/s10434-013-3310-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
647 van der Bilt JD, Kranenburg O, Verheem A, van Hillegersberg R, Borel Rinkes IH. Selective portal clamping to minimize hepatic ischaemia-reperfusion damage and avoid accelerated outgrowth of experimental colorectal liver metastases. Br J Surg. 2006;93:1015-1022. [PMID: 16736538 DOI: 10.1002/bjs.5382] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
648 Wong SL, Mangu PB, Choti MA, Crocenzi TS, Dodd GD, Dorfman GS, Eng C, Fong Y, Giusti AF, Lu D, Marsland TA, Michelson R, Poston GJ, Schrag D, Seidenfeld J, Benson AB. American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer. J Clin Oncol. 2010;28:493-508. [PMID: 19841322 DOI: 10.1200/jco.2009.23.4450] [Cited by in Crossref: 305] [Cited by in F6Publishing: 123] [Article Influence: 23.5] [Reference Citation Analysis]
649 Shady W, Sotirchos VS, Do RK, Pandit-Taskar N, Carrasquillo JA, Gonen M, Sofocleous CT. Surrogate Imaging Biomarkers of Response of Colorectal Liver Metastases After Salvage Radioembolization Using 90Y-Loaded Resin Microspheres. AJR Am J Roentgenol 2016;207:661-70. [PMID: 27384594 DOI: 10.2214/AJR.15.15202] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
650 Almqvist Y, Steffen AC, Lundqvist H, Jensen H, Tolmachev V, Sundin A. Biodistribution of 211At-labeled humanized monoclonal antibody A33. Cancer Biother Radiopharm 2007;22:480-7. [PMID: 17803442 DOI: 10.1089/cbr.2007.349A] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
651 Tsitskari M, Filippiadis D, Zavridis P, Mazioti A, Vrachliotis T, Alevizos L, Brountzos E, Kelekis N. Efficacy and safety of percutaneous computed tomography-guided microwave ablation for colorectal cancer, oligometastatic liver-only disease: a single center's experience. Ann Gastroenterol 2021;34:61-7. [PMID: 33414623 DOI: 10.20524/aog.2020.0545] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
652 Ali MA, Di Sandro S, Lauterio A, Concone G, Mangoni I, Ferla F, Rotiroti V, Cusumano C, Giacomoni A, De Carlis L. Repeat Hepatectomy for Recurrent Colorectal Liver Metastases: Is it Worth the Challenge? J Gastrointest Surg. 2015;19:2192-2198. [PMID: 26361773 DOI: 10.1007/s11605-015-2939-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
653 Chiou SY, Liu JB, Needleman L. Current status of sonographically guided radiofrequency ablation techniques. J Ultrasound Med 2007;26:487-99. [PMID: 17384046 DOI: 10.7863/jum.2007.26.4.487] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
654 She WH, Cheung TT, Ma KW, Tsang SHY, Dai WC, Chan ACY, Lo CM. Anatomical Versus Nonanatomical Resection for Colorectal Liver Metastasis. World J Surg 2020;44:2743-51. [PMID: 32535643 DOI: 10.1007/s00268-020-05506-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
655 Dobbins C, Brennan C, Wemyss-Holden S, Cockburn J, Maddern G. Bimodal electric tissue ablation-long term studies of morbidity and pathological change. J Surg Res 2008;148:251-9. [PMID: 18395751 DOI: 10.1016/j.jss.2007.09.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
656 Ercolani G, Vetrone G, Grazi GL, Aramaki O, Cescon M, Ravaioli M, Serra C, Brandi G, Pinna AD. Intrahepatic cholangiocarcinoma: primary liver resection and aggressive multimodal treatment of recurrence significantly prolong survival. Ann Surg. 2010;252:107-114. [PMID: 20531002 DOI: 10.1097/sla.0b013e3181e462e6] [Cited by in Crossref: 111] [Cited by in F6Publishing: 45] [Article Influence: 9.3] [Reference Citation Analysis]
657 Makowiec F, Möhrle S, Neeff H, Drognitz O, Illerhaus G, Opitz OG, Hopt UT, zur Hausen A. Chemotherapy, Liver Injury, and Postoperative Complications in Colorectal Liver Metastases. J Gastrointest Surg 2011;15:153-64. [DOI: 10.1007/s11605-010-1368-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
658 Mason T, Berber E, Graybill JC, Siperstein A. Histological, CT, and intraoperative ultrasound appearance of hepatic tumors previously treated by laparoscopic radiofrequency ablation. J Gastrointest Surg 2007;11:1333-8. [PMID: 17653812 DOI: 10.1007/s11605-007-0214-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
659 Yonemura K, Kajiwara Y, Ao T, Mochizuki S, Shinto E, Okamoto K, Hase K, Ueno H. Prognostic Value of Poorly Differentiated Clusters in Liver Metastatic Lesions of Colorectal Carcinoma. Am J Surg Pathol 2019;43:1341-8. [PMID: 31318710 DOI: 10.1097/PAS.0000000000001329] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
660 Kawaguchi Y, Kopetz S, Panettieri E, Hwang H, Wang X, Cao HST, Tzeng CD, Chun YS, Aloia TA, Vauthey JN. Improved Survival over Time After Resection of Colorectal Liver Metastases and Clinical Impact of Multigene Alteration Testing in Patients with Metastatic Colorectal Cancer. J Gastrointest Surg 2021. [PMID: 34506029 DOI: 10.1007/s11605-021-05110-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
661 Schuld J, Richter S, Oberkircher LW, Seeland U, Debnar-Daumler KI, Rauch J, Menger MD, Schilling MK, Kollmar O. Evidence for tumor cell spread during local hepatic ablation of colorectal liver metastases. J Surg Res 2012;178:268-79. [PMID: 22482753 DOI: 10.1016/j.jss.2012.03.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
662 Aussilhou B, Dokmak S, Faivre S, Paradis V, Vilgrain V, Belghiti J. Preoperative liver hypertrophy induced by portal flow occlusion before major hepatic resection for colorectal metastases can be impaired by bevacizumab. Ann Surg Oncol. 2009;16:1553-1559. [PMID: 19363584 DOI: 10.1245/s10434-009-0447-z] [Cited by in Crossref: 77] [Cited by in F6Publishing: 55] [Article Influence: 5.9] [Reference Citation Analysis]
663 Bai XM, Yang W, Zhang ZY, Jiang AN, Wu W, Lee JC, Chen MH, Yan K. Long-term outcomes and prognostic analysis of percutaneous radiofrequency ablation in liver metastasis from breast cancer. Int J Hyperthermia 2019;35:183-93. [PMID: 30200791 DOI: 10.1080/02656736.2018.1488279] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
664 Evrard S, Rivoire M, Arnaud J, Lermite E, Bellera C, Fonck M, Becouarn Y, Lalet C, Pulido M, Mathoulin-pelissier S. Unresectable colorectal cancer liver metastases treated by intraoperative radiofrequency ablation with or without resection19. British Journal of Surgery 2012;99:558-65. [DOI: 10.1002/bjs.8665] [Cited by in Crossref: 53] [Cited by in F6Publishing: 27] [Article Influence: 5.3] [Reference Citation Analysis]
665 Kim WW, Kim KH, Kim SH, Kim JS, Park SJ, Kim KH, Choi CS, Choi YK. Comparison of Hepatic Resection and Radiofrequency Ablation for the Treatment of Colorectal Liver Metastasis. Indian J Surg 2015;77:1126-30. [PMID: 27011523 DOI: 10.1007/s12262-015-1211-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
666 Imai K, Allard M, Castro Benitez C, Vibert E, Sa Cunha A, Cherqui D, Castaing D, Baba H, Adam R. Long-term outcomes of radiofrequency ablation combined with hepatectomy compared with hepatectomy alone for colorectal liver metastases. British Journal of Surgery 2017;104:570-9. [DOI: 10.1002/bjs.10447] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 8.4] [Reference Citation Analysis]
667 Kasivisvanathan R, Abbassi-Ghadi N, Prout J, Clevenger B, Fusai GK, Mallett SV. A prospective cohort study of intrathecal versus epidural analgesia for patients undergoing hepatic resection. HPB (Oxford). 2014;16:768-775. [PMID: 24467320 DOI: 10.1111/hpb.12222] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
668 Dawood O, Mahadevan A, Goodman KA. Stereotactic body radiation therapy for liver metastases. Eur J Cancer. 2009;45:2947-2959. [PMID: 19773153 DOI: 10.1016/j.ejca.2009.08.011] [Cited by in Crossref: 74] [Cited by in F6Publishing: 58] [Article Influence: 5.7] [Reference Citation Analysis]
669 Lang H, Baumgart J, Roth W, Moehler M, Kloth M. Cancer gene related characterization of patterns and point of recurrence after resection of colorectal liver metastases. Ann Transl Med 2021;9:1372. [PMID: 34733924 DOI: 10.21037/atm-21-292] [Reference Citation Analysis]
670 Hur H, Kim NK, Kim HG, Min BS, Lee KY, Shin SJ, Cheon JH, Choi SH. Adenosine triphosphate-based chemotherapy response assay-guided chemotherapy in unresectable colorectal liver metastasis. Br J Cancer. 2012;106:53-60. [PMID: 22068817 DOI: 10.1038/bjc.2011.469] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
671 Reuter NP, Woodall CE, Scoggins CR, Mcmasters KM, Martin RCG. Radiofrequency Ablation vs. Resection for Hepatic Colorectal Metastasis: Therapeutically Equivalent? J Gastrointest Surg 2009;13:486-91. [DOI: 10.1007/s11605-008-0727-0] [Cited by in Crossref: 91] [Cited by in F6Publishing: 75] [Article Influence: 6.5] [Reference Citation Analysis]
672 Zorzi D, Mullen JT, Abdalla EK, Pawlik TM, Andres A, Muratore A, Curley SA, Mentha G, Capussotti L, Vauthey JN. Comparison between hepatic wedge resection and anatomic resection for colorectal liver metastases. J Gastrointest Surg 2006;10:86-94. [PMID: 16368496 DOI: 10.1016/j.gassur.2005.07.022] [Cited by in Crossref: 111] [Cited by in F6Publishing: 91] [Article Influence: 6.9] [Reference Citation Analysis]
673 Liu CH, Huang SC, Chao YJ, Lin XZ, Lee GB. Hemostasis Plug for an Electromagnetic Thermotherapy and Its Application for Liver Laceration. Ann Biomed Eng 2016;44:1310-20. [PMID: 26139296 DOI: 10.1007/s10439-015-1365-9] [Reference Citation Analysis]
674 Chan G, Chee CE. Perioperative Chemotherapy for Liver Metastasis of Colorectal Cancer. Cancers (Basel) 2020;12:E3535. [PMID: 33256170 DOI: 10.3390/cancers12123535] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
675 Denbo JW, Yamashita S, Passot G, Egger M, Chun YS, Kopetz SE, Maru D, Brudvik KW, Wei SH, Conrad C, Vauthey JN, Aloia TA. RAS Mutation Is Associated with Decreased Survival in Patients Undergoing Repeat Hepatectomy for Colorectal Liver Metastases. J Gastrointest Surg. 2017;21:68-77. [PMID: 27334313 DOI: 10.1007/s11605-016-3189-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
676 Derbel O, Wang Q, Desseigne F, Rivoire M, Meeus P, Peyrat P, Stella M, Martel-Lafay I, Lemaistre AI, de La Fouchardière C. Impact of KRAS, BRAF and PI3KCA mutations in rectal carcinomas treated with neoadjuvant radiochemotherapy and surgery. BMC Cancer 2013;13:200. [PMID: 23617638 DOI: 10.1186/1471-2407-13-200] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
677 Chun YS, Vauthey JN, Ribero D, Donadon M, Mullen JT, Eng C, Madoff DC, Chang DZ, Ho L, Kopetz S. Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases: perioperative safety and survival. J Gastrointest Surg. 2007;11:1498-1504; discussion 1504-1505. [PMID: 17849166 DOI: 10.1007/s11605-007-0272-2] [Cited by in Crossref: 117] [Cited by in F6Publishing: 94] [Article Influence: 7.8] [Reference Citation Analysis]
678 Pawlik T, Abdalla E, Ellis L, Vauthey J, Curley S. Debunking Dogma: Surgery for Four or More Colorectal Liver Metastases Is Justified. Journal of Gastrointestinal Surgery 2006;10:240-8. [DOI: 10.1016/j.gassur.2005.07.027] [Cited by in Crossref: 74] [Cited by in F6Publishing: 53] [Article Influence: 4.6] [Reference Citation Analysis]
679